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The persistence of biofilms in hospital settings are associated with Healthcare Associated 
Infections (HCAI), causing increased morbidity, mortality and healthcare costs. The resistance 
of biofilms against commonly used hospital disinfectants has been well reported. Metal and 
metal oxide nanoparticles (NP) such as silver (Ag), copper (Cu), zinc oxide (ZnO) and copper 
oxide (CuO) exhibit antimicrobial properties against various pathogens. 
Methods:  
Biofilm formation of Pseudomonas aeruginosa and Staphylococcus aureus in a Centre for 
Disease Control (CDC) biofilm reactor and a 96 well plate was compared. A three stage 
approach including Minimum Biofilm Reduction Concentration (MBRC), R2 values and log(10) 
reductions was used to assess the efficacy of Ag and ZnO NPs both alone and in combination 
against P. aeruginosa and S. aureus biofilms. Atomic Absorption Spectroscopy (AAS), 
Scanning Electron Microscopy (SEM) and Confocal Laser Scanning Microscopy (CLSM) was 
used to further assess the antimicrobial ability of the metal and metal oxide NPs. The prevention 
of P. aeruginosa and S. aureus adherence on Ag and ZnO thin film coating on silicon (Si) 
surfaces was also investigated, as well as icaC, ebpS and fnbB gene expression in S. aureus 
biofilms.  
Results:  
The CDC biofilm reactor demonstrated to be the most effective method for P. aeruginosa and S. 
aureus biofilm production in comparison to 96 well plates, with lower standard errors of the 
mean (SE) and higher replicability. Individual MBRC of ZnO and Ag NPs in suspension were 
256 and 50 µg/ml for P. aeruginosa and 16 and 50 µg/ml for S. aureus respectively. The 
concentrations in combination were reduced by at least a half, with concentrations of 32/25 
µg/ml of ZnO/Ag NPs in suspension resulting in a significant (p ≤0.05) reduction of 3.77 log(10) 
against P. aeruginosa biofilms and 8/12 µg/ml of ZnO/Ag NPs in suspension resulted in a 3.91 
log(10) (p ≤0.05) against S. aureus biofilms. Both combinations showed an additive effect. Time 
point analysis confirmed that a 24 hour treatment is vital for any significant (p ≤0.05) 
antimicrobial activity. AAS data suggested that the Ag+ ions quenched Zn2+ ions, therefore the 
antimicrobial efficacy of the combination is mainly due to Ag+ ions. Damage of the biofilms 
from Ag and ZnO NPs was observed in the SEM imaging and energy dispersive X-ray (EDX) 
analysis confirmed the adherence of Zn and Ag within the biofilms. CLSM imaging showed 
dead (red) cells of P. aeruginosa and S. aureus biofilms throughout the depth of the biofilm. P. 
aeruginosa formation was reduced by 1.41 log(10) and 1.43 log(10) on Ag and ZnO thin film 
coatings respectively. For S. aureus, a reduction of 1.82 log(10) and 1.65 log(10) was obtained for 
Ag and ZnO coating respectively. Only low levels of ribonucleic acid (RNA) were achieved so 
no further gene analysis could occur. 
Conclusion: 
Reductions of ≥3 log(10) were observed for P. aeruginosa and S. aureus biofilm treatment with 
ZnO/Ag NP suspensions. It can be concluded that the ZnO/Ag NP suspensions had greater 
antimicrobial activity than Ag and ZnO coated surfaces owing to large concentrations of Ag+ and 
Zn2+ ions acting upon the biofilms. The slower release of ions from coated surfaces suggest an 
inadequate concentration of ions in the media, which are therefore unable to prevent biofilm 
formation as rapidly as NP suspensions, however provide a sustained release of ions over time. 
The results from this investigation propose that Ag and ZnO NPs in suspension could be a 
potential alternative to disinfectants for use in nosocomial environments against P. aeruginosa 
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Chapter 1: Introduction 
 
The World Health Organisation (WHO) defines Healthcare Associated Infections (HCAIs) as 
infections that develop in patients after 48 hours of hospitalisation or when they reside at a 
healthcare facility. The infection, however, should not have been present or incubating when the 
patient was admitted. Infections occurring within four weeks after discharge are also considered 
as a HCAI (World Health Organization, 2002). HCAIs have become an increasing problem over 
the last decade leading to an increase in medical costs, patient stays in hospital, morbidity and 
mortality (Hensley & Monson, 2015). The increase in HCAI correlates with the improved 
capability of bacteria to withstand and adapt to harsh environments i.e. in the vicinity of 
antimicrobial agents in the form of a biofilm, making the environment a continuous reservoir for 
pathogens (Abreu et al., 2013).        
S. aureus and P. aeruginosa are included in the top five pathogens responsible for HCAIs, and 
are the cause of 15.6 and 7.5% of HCAIs respectively (Rutala & Weber, 2014). Both S. aureus 
and P. aeruginosa are commonly isolated nosocomial pathogens that have the ability to form 
biofilm related infections by colonising on central venous catheters (Pérez-Zárate et al., 2015), 
lower respiratory tract infections from contaminated ventilators (Humphreys et al., 2010), and 
urinary tract infections from catheters (Barbadoro et al., 2015).  The ubiquitous bacterium P. 
aeruginosa is present in the environment, requiring minimal conditions to survive and can adapt 
to a range of environmental stresses (Gaynes & Edwards, 2005). P. aeruginosa mainly resides in 
humid environments, and in a hospital setting, including areas such as taps and sinks (Blanc et 
al., 2016). S. aureus colonises on the skin or nares of healthy individuals and is also a common 
cause of nosocomial infections and indwelling medical device related infections (Hensley & 
Monson, 2015). Methicillin resistant S. aureus (MRSA) still remains a major cause of HCAIs 
since it was reported fifty years ago, only after two years of methicillin usage (Jevons, 1961). 
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The residence of bacteria on hospital surfaces and transmission via the hands of healthcare 
workers can potentially cause HCAIs (Dancer et al., 2009; Pittet et al., 2006). Claro et al. (2015) 
found that the most contaminated surface within hospitals were the toilet door handles and bedside 
lockers with 7.97 colony forming units (cfu)/cm2 and 7.34 cfu/cm2 respectively. As stated by the 
Healthcare Infection Control Practices Advisory Committee (HICPAC) and the CDC, non-critical 
medical equipment should be disinfected routinely when it has visibly been soiled (Centre for 
Disease Control, 2008). Contaminated non-critical medical equipment including stethoscopes can 
be a cause of cross contamination as it can transfer organisms between patients and an examiner 
if not cleaned. S. aureus, P. aeruginosa, vancomycin resistant Enterococcus (VRE), and 
Clostridium difficile are among those bacterium that have been isolated from stethoscopes 
(O’Flaherty & Fenelon, 2015).    
Biocide tolerance can be acquired when it is used at lower concentrations than stated by 
manufacturers, accidently diluted more than required, organic matter interferes with its activity, 
or when it is utilised at an incorrect pH and temperature (Condell et al., 2012). Often one key 
factor overlooked in many disinfectant related studies is the ability of bacteria to construct a 
biofilm, shielding them from environmental stress, including antimicrobials.  
The judicious use of antimicrobials is detrimental for managing bacterial resistance. Currently  
disinfectants used in hospitals contain active ingredients such as alcohols, sodium hypochlorite, 
hydrogen peroxide (H2O2) and quaternary ammonium compounds (QAC) (Rutala & Weber, 
2016; Wessels & Ingmer, 2013). The susceptibility of P. aeruginosa and Burkholderia cepacia 
biofilms against chlorine dioxide was reduced in multispecies biofilms in comparison to 
monospecies biofilms (Behnke & Camper, 2012), similar to the findings by Behnke et. al (2011), 
whereby a multispecies biofilm of P. aeruginosa and B. cepacia had greater resistance to sodium 
hypochlorite in comparison to a monospecies biofilm. S. aureus biofilms had ten up to >100 times 
reduced susceptibility to chlorhexidine (Xing et al., 2012) whereas Staphylococcus epidermidis 
treatment with chlorhexidine showed a 16 fold increase in minimum inhibitory concentration 
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(MIC) for biofilms in comparison to planktonic cells (Karpanen et al., 2008). The antimicrobial 
activity of household bleach, a sodium dichloroisocyanurate (NaDCC) based disinfectant and eco-
friendly cleaning agent (EFCA) was determined against four S. aureus strains. Bleach and 
NaDCC showed a > 5 log(10) reduction in suspension, whereas only a <3 log(10) reduction occurred 
on surfaces (Adukwu et al., 2015). Kotb et al. (2015) showed that MRSA had no susceptibility to 
3% H2O2. Furthermore, P. aeruginosa showed resistance to triclosan (de Abreu et al., 2014), 
possibly due to multidrug efflux systems to eliminate the biocide (Chuanchuen et al., 2003). All 
these studies suggest that alternatives for antimicrobials are required to overcome this resistance 
and prevent biofilm formation particularly in the healthcare sector. 
In recent years, metal and metal oxide nanoparticles (NPs) have gained significant attention as 
antimicrobials, including silver (Ag) (Hanh et al., 2016), copper (Cu) (Kruk et al., 2015), copper 
oxide (CuO) (Ren et al., 2009), zinc oxide (ZnO) (Abdulkareem et al., 2015) and titanium dioxide 
(TiO2) (Combarros et al., 2016). NPs tend to have enhanced antimicrobial characteristics in 
comparison to the bulk material as they are smaller in size and have an increased surface area to 
volume ratio (Arakha et al., 2015).       
Research conducted on the efficacy of metal and metal oxide NPs against biofilms is limited. Ag 
NPs have shown to have antimicrobial activity against Escherichia coli, P. aeruginosa and S. 
aureus with a MIC of 14.38, 6.74 and 14.38 µg/ml respectively (Guzman et al., 2012), similar 
MICs of 1 ppm were found by Song et al. (2006) and Sondi et al. (2004) at 10 ppm. A zone of 
inhibition (ZOI) of 22 ± 1.8 mm for P. aeruginosa was observed against 25 µg/ml of ZnO NPs 
(Jayaseelan et al., 2012). An agar well diffusion method gave a ZOI of 19 and 16 mm for S. 
aureus and E. coli respectively after treatment with ZnO NPs (Ambika & Sundrarajan, 2015). 
The green synthesis of ZnO NPs using Trifolium pratense flower extract demonstrated that ZnO 
NPs gave a larger antimicrobial effect against P. aeruginosa in comparison to gentamicin with a 
ZOI of 20 and 13 mm at a concentration of 256 µg/ml (Dobrucka & Długaszewska, 2016). The 
antimicrobial effect of nanocrystalline CuO on woven and non-woven fabrics against S. aureus 
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and E. coli was established, with ZOI of 15 and 16 mm for E. coli and 21 and 20 mm for S. aureus 
for woven and non-woven fabrics respectively (Subramanian et al., 2014).     
With the high costs associated with HCAIs and the inadequacy of many commonly utilised 
disinfectants, against either resistant bacterial species or biofilms, further investigation into novel 
antimicrobials for use as disinfectants is required. A disinfectant should aim to be effective against 
bacteria that are a common cause of outbreaks and HCAIs (Rutala & Weber, 2016), whilst 
considering their efficacy against biofilms in the environment and potential future resistance. 
Although there has been substantial research into the antimicrobial effect of NPs on bacteria, the 
majority of the research has focussed on their efficacy against vegetative cells and not biofilms. 
This study aims to fill this gap in the knowledge and establish the efficacy of metal and metal 
oxide NPs on both the treatment and prevention of P. aeruginosa and S. aureus biofilms. Thus, 
going some way to establish whether metal based nanotechnology could be a feasible option for 


















Chapter 2: Literature Review 
2.1 S. aureus 
S. aureus is an opportunistic Gram-positive coccus is globally established as one of most common 
microorganisms liable for nosocomial infections (Sarkar et al., 2016). S. aureus commonly 
colonises on human skin of healthy individuals (Otto, 2010), however its access to the body can 
lead to disease formation such as skin and soft tissue infections, septic arthritis, osteomyelitis, 
endocarditis, bacteraemia, sepsis and pneumonia (Kim et al., 2012; David & Daum, 2010). The 
emergence of S. aureus mutations has led to the persistence of S. aureus derived infections. S. 
aureus mutations, which are predominantly resistant to the majority of β-lactam antibiotics, are 
known as MRSA. MRSA is difficult to eliminate and results in high numbers of morbidity and 
mortality (de Kraker et al., 2011). MRSA is often present as a biofilm in hospitals which results 
in prolonged permanence of the bacteria (Sakoulas et al., 2006; Vickery et al., 2012; Wagenvoort 
et al., 2000). It has the capability of surviving on hospital surfaces for several weeks and can be 
transmitted to patients indirectly or directly, for instance, through contaminated hands or gloves 
of the healthcare workers (Huang et al., 2006; Weber & Rutala, 2013; Wagenvoort et al., 2000; 
Vickery et al., 2012; Kramer et al., 2006).  
Furthermore, S. aureus has the ability to adhere to indwelling medical devices via immediate 
interaction with its polymer surface or indirectly, by creating connections to human matrix 
proteins once they have covered the indwelling device. This is then followed by proliferation via 
the production of an extracellular matrix, leading to intercellular aggregation. The matrix of 
staphylococci, also known as the “slime” layer, contain many secreted polymers including 
exopolysaccharides, teichoic acids, and specific and DNA (deoxyribonucleic acid) from lysed 
cells (Otto, 2008).  
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Death certificates mentioning MRSA have reduced by 20% between 2011 and 2012. However, 
out of the 292 deaths noted in 2012, 13% were due to the organism itself. Furthermore, MRSA 
death rates increase with age (Office for National Statistics, 2013). Between 2014 and 2015, 801 
cases of MRSA were reported by the English National Health Service (NHS) Acute Trusts, which 
is a 7.1% reduction from 2013/2014 where 862 cases were noted. There was an overall reduction 
of 82% from the number of cases from 2007/2008 (4,451 cases). It should be noted that even 
though the number of MRSA cases over the years has decreased, the decline rate has slowed down 
over time. For instance, a 22% reduction of cases between 2009/2010 and 2010/2011, compared 
with a 7.1% reduction between 2013/2014 and 2014/2015 (Public Health England, 2015a). 
Although there has been a drop in the morbidity and mortality rates of MRSA, it still poses a high 
risk to immunocomprised patients.   
Cuervo et al. (2016) found that out the of the 579 cases of MRSA bacteraemia studied, 231 
(39.9%) was present in patients ≥75 years of age, with the cause unknown. Out of 68 
staphylococcal bacteraemia instances, over half were due to MRSA, although the resistance in 
the 22 cases that were over 70 years of age was not certain (Malani et al., 2008). This is in 
compliance with studies by Bader (2006) and Big and Malani (2010), who also observed 
methicillin resistance in patients over 60 and 80 with resistance of 56 and 60% respectively. The 
resemblance of clones between older and younger patients implies frequent clonal exchange 
within hospitals and healthcare facilities, especially due to regular hospital admissions with the 
elderly population.  
Three outbreaks of MRSA were traced in the UK; whereby whole genome sequencing was used 
to identify the cause of the outbreaks (Lindsay, 2014). Whole genome sequencing enables the 
comparison of clinical isolates with reference sequences to study the evolution of isolates, down 
to differences in single nucleotides (Young et al., 2012). It provides important information about 
the spreading of isolates and the way they have evolved (Lindsay, 2013). Two out of the three 
outbreaks involved the MRSA CC22 SCCmecIV clone. Firstly, the NHS Foundation Trust in 
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Cambridge reported eleven colonised infants and another baby that had developed bacteraemia, 
this led to the unit’s closure for nine days. The isolates derived from two patients with bacteraemia 
that were placed in adjacent beds for six days (Köser et al., 2012). Secondly, The Oxford 
University Hospitals NHS Trust in Oxfordshire had two outbreaks between July and October 
2011. An intensive care unit (ICU) was identified with seven carriers, alongside a bacteraemia 
and colonisation occurrence in the ICU two months after (Eyre et al., 2012). Thirdly, in 2011 at 
The Rosie Hospital in the Cambridge University NHS Foundation Trust, 12 infants were 
colonised with MRSA in a 6-month period. Whole genome sequencing was used to identify that 
the MRSA was carried by a member of the hospital staff, which lead to the outbreak (Harris et 
al., 2013). The recurring MRSA cases in hospitals and its risk to patients, colonisation on 
healthcare staff and surfaces suggests that MRSA still resides in high numbers in hospital 
environments and alternative disinfection methods may need to be considered. 
 
2.2 P. aeruginosa 
P. aeruginosa is of concern within the healthcare sector as it is accountable for a range of acute 
and chronic infections for instance bacteraemia, pneumonia, urinary tract infections (Dosler & 
Karaaslan, 2014) and cystic fibrosis (Winstanley et al., 2016). P. aeruginosa infections can be 
acquired in the community, however, the majority of P. aeruginosa infections are obtained in a 
healthcare environment, particularly in immunosuppressed patients and vulnerable patients in 
ICU. Infections derived from P. aeruginosa can lead to mortality and morbidity, even with the 
various therapeutic choices available for treatment due to the emerging resistance of P. 
aeruginosa against antibiotics including quinolones (Jiang et al., 2014), carbapenams (Wang et 
al., 2016a) and aminoglycosides such as tobramycin (Wu et al., 2015a). The severity and potential 
of P. aeruginosa infections and the problems related to multidrug resistant strains of P. 
13 
 
aeruginosa means that it is fundamental to find effective strategies to prevent their growth and 
prevalence. 
P. aeruginosa residing in the reservoirs of healthcare environments poses a serious health risk 
(Kerr & Snelling, 2009). P. aeruginosa can be found in the hospital environment usually in moist 
environments (Loveday et al., 2014) including taps and tap water (Walker et al., 2013), potable 
water systems (Eckmanns et al., 2008), water from drinking fountains (Costa et al., 2015), sinks, 
showers and toilets (Breathnach et al., 2012) as well as nebulisers for home treatment of cystic 
fibrosis (Blau et al., 2007). There are various reasons as to why P. aeruginosa can survive in a 
hospital environment. Firstly, it is highly resistant to disinfectants including biguanides and QAC 
due to multidrug efflux pumps. It can form a biofilm on various inanimate surfaces, which adds 
to its resistance to disinfectants in addition to making its physical removal problematic (Kerr & 
Snelling, 2009).  
In January 2012, three premature babies died following a pseudomonas outbreak in Royal Jubilee 
Maternity Hospital in Belfast in the neonatal ICU. Prior to this, there was another outbreak in 
December 2011 in the Altnagelvin Hospital in Londonderry, where another baby died due to a 
Pseudomonas infection; however, this was due to a different strain (Wise, 2012). A study by 
Walker et al. (2013) further investigated the outbreak in Northern Ireland to see whether P. 
aeruginosa was colonised within the neonatal unit taps and if the waterborne isolates matched 
with the patient isolates. When 30 taps and eight flow straighteners were grouped and dismantled 
into 494 components, the greatest counts of P. aeruginosa were obtained from the flow 
straighteners (52, 033 cfu/ml), metal support collars (71, 970 cfu/ml) and the tap bodies (634 
cfu/ml) surrounding the two parts. Biofilms of P. aeruginosa were mostly found in flow 
straighteners and its components. These were identified as the likely source of infection, 




The overall occurrence of Pseudomonas spp. bacteraemia in England, Wales and Northern Ireland 
was 6.2 per 100, 000 population in 2014, showing an 11% decline from 2007 with a value of 
6.9/100, 000. Pseudomonas spp. was the most prevalent in England with a value of 6.4/100, 000, 
followed by Northern Ireland (4.1) and Wales (3.1). A greater reduction has been noted in the 
Pseudomonas spp. bacteraemia in Wales and Northern Ireland with decreased rates of infection 
by 36% and 26% respectively in comparison to England over the last five years which only had 
a 6% decrease in the infection rate between 2010 and 2014 (Public Health England, 2015b).   
Cases of P. aeruginosa infection in vulnerable patients has been reported for many years (Ayliffe 
et al., 1974). P. aeruginosa is often associated with hospital water reservoirs and after four pre-
term babies died in Northern Ireland in 2011/2012 (Walker & Moore, 2014), specific guidelines 
of P. aeruginosa and water quality in augmented care units was released by the Department of 
Health in 2012/2013 (Department of Health, 2012). P. aeruginosa is readily present in the 
environment, especially at hand wash stations and water outlets and is a still a major concern 
within the hospital environment (Trautmann et al., 2005; Trautmann et al., 2006; Trautmann et 
al., 2009; Crivaro et al., 2009; Jefferies et al., 2012). The recurring outbreaks of P. aeruginosa in 
hospitals over recent years highlights the issues that are faced within healthcare environments in 
terms of reducing contamination from this bacterium, in particular, due to its ability to form 
biofilms. Alternative disinfection methods to tackle this problem need to be considered.    
 
2.3 Biofilms 
Biofilms are a structured community of bacterial cells enclosed in a self-derived matrix that attach 
to biotic and abiotic surfaces including living tissues, industrial surfaces, indwelling devices such 
as catheters, waterlines of dental units, cardiac pacemakers, and contact lenses (Donlan, 2002; 
Donlan, 2001). The adherence of planktonic cells to an abiotic surface leads to the formation of 
sessile aggregates, surrounded by an extracellular polymeric substances (EPS) matrix, that acts 
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as a barrier (Feng et al., 2015; Bjarnsholt, 2013). The EPS matrix is comprised of polysaccharides, 
proteins, extracellular DNA (eDNA) and lipids (Flemming et al., 2007). The bond between 
bacterial cells and the substratum is enhanced by the EPS and it protects the colony from any 
stress in the environment (Donlan, 2002). Dense networks are then formed by secondary 
colonisers. Dispersion of cells from the cell community can either spread to form new biofilms 
or thrive as planktonic cells (Sun et al., 2013).  
Biofilms can be an accumulation of either single species or multispecies of bacteria surrounded 
by an extracellular polymeric matrix (Pereira et al., 2016) though it is the sessile form that is 
problematic in numerous industries, particularly in the healthcare sector such as hospitals where 
patients are at a high risk of infection (Pérez-Zárate et al., 2015). Sessile cells, mainly present in 
the inner layers of the biofilm and have slower metabolic and growth rates, hence reducing the 
efficacy of antimicrobials (de Oliveira et al., 2012). The EPS acts as an adsorbent, lowering the 
concentration of antimicrobials able to diffuse to the bottom of the biofilm (Davenport et al., 
2014). Sessile cells differentiate from planktonic cells as they have the ability to express specific 
protection factors in order to protect the biofilm (Gilbert et al., 2002). However, bacteria in 
biofilms are up to 1000-fold more resistant to antimicrobials in comparison to their planktonic 
counterparts (Liao & Sauer, 2012). In addition to this, properties that biofilms possess such as 
high stress tolerance, antibiotic resistance and resistance against other biocides (Rendueles et al., 
2013) makes it challenging to treat biofilms with antibiotics and antimicrobial agents (Murugan 
et al., 2016). 
2.4 Biofilm Formation 
Biofilm formation occurs in a four stage process as shown in Figure 2.1: adhesion of bacteria to 
a surface, microcolony formation, maturation of the biofilm, and finally dispersion, whereby the 












Cell attachment to a substrate is vital for biofilm formation, it is reversible and aided by physical, 
chemical and biological interactions (Renner & Weibel, 2011). The adhesion process is highly 
influenced by the physicochemical property of the bacterial cell surface (Ferreira et al., 2010). 
Forces such as Lifshitz-van der Waals, Lewis acid-base, and electrostatic interactions all aid in 
bacterial adhesion when bacteria are in close proximity to a substrate (Meireles et al., 2015; 
Habimana et al., 2014). These imposed forces enable reversible adhesion onto the surface 
(Karatan & Watnick, 2009). If repulsive forces exceed the attractive forces, bacterial cells can 
detach from the surface and revert back to their planktonic state (Garrett et al., 2008). Motile 
bacteria can feel the drag on the motor of their flagella due to the substratum interactions with the 
bacterial appendage, initiating gene expression required in biofilm formation (Karatan & 
Watnick, 2009). This is followed by repression of  flagella synthesis, so that motility is prevented 
(Karatan & Watnick, 2009).  
Apart from physicochemical properties of bacterial cells, the chemical composition and physical 
properties of a substrate influence bacterial adhesion (Bayoudh et al., 2006). Typically, most 
surfaces can be favourable substrates for biofilm formation such as plastic, glass, metal, wood 
and food products. Factors such as texture, i.e. the roughness and smoothness of a surface 
Figure 2.1: The four stage process of biofilm formation adapted from Abdallah et al. (2014). 
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(Donlan, 2002), surface charge (Ferreira et al., 2010),  pH, temperature (Nilsson et al., 2011), 
nutrient composition of the pre-conditioning solution (Donlan, 2002; Gerstel & Romling, 2001), 
and organic matter, all influence the adhesion of cells to abiotic surfaces (Geng & Henry, 2011). 
These environmental conditions can alter the substrata and bacterial surface properties, affecting 
the adherence of bacteria to abiotic surfaces (Abdallah et al., 2014). Sinde and Carballo (2000) 
demonstrated that Salmonella sp. and Listeria monocytogenes have enhanced adhesion to 
hydrophobic surfaces in comparison to hydrophilic surfaces as attachment was the greatest on 
polytetrafluorethylene (PTFE) being the most hydrophobic, followed by rubber and stainless steel 
(SS), which was the most hydrophilic with values of 78.7, 37.3 and 8.1 cfu mm-2 for Salmonella 
ES3 respectively and 668.0, 601.5 and 312.3 cfu mm-2 for L. monocytogenes ES15 respectively.  
The conditioning layer consists of organic and inorganic particles and is the base on which 
biofilms develop. The gravitational force or movement of flow allows particles present in the bulk 
fluid to settle onto the substrate forming part of the conditioning layer, altering the substrata, 
making it easier for bacteria accessibility.  Interactions that occur between the conditioning layer 
and substrate can change the surface charge, potential and tensions. The substrate supplies 
anchorage and nutrients allowing for bacterial growth (Garrett et al., 2008). The nature of 
conditioning films vary according to the environment the substrate surface is surrounded by 
(Lorite et al., 2011).  
The conversion from a reversible to an irreversible attachment is a result of the change from weak 
interactions between the bacteria and the substrate to permanent bonding with the EPS (Stoodley 
et al., 2002b). Irreversible attachment makes biofilms challenging to remove due to strong shear 
forces or chemical breakdown of the attachment forces having to be overcome using enzymes, 
surfactants, detergents, sanitisers (Sinde & Carballo, 2000) or heat (Augustin et al., 2004; 
Maukonen et al., 2003; Sinde & Carballo, 2000). Even though biofilms are made up of non-motile 
cells, some biofilm forming species require motility for growth or cell attachment to a substrate 
(Abee et al., 2011). The initial stage of attachment in P. aeruginosa biofilm formation involves 
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reversible tethering through the flagella, whereby the bacteria position themselves in an 
orientation where their long axes is perpendicular to the substrate. This is followed by semi-
permanent attachment in a horizontal position (Conrad et al., 2011).  
S. aureus on the other hand is a non-flagellated bacterium (Kaito & Sekimizu, 2007). Biofilm 
associated proteins (Bap) aid in initial attachment and biofilm formation in S. aureus on biotic 
and abiotic surfaces (Latasa et al., 2006). All Bap positive S. aureus isolates tested by Cucarella 
et al. (2001) produced strong and adherent biofilms. Microbial Surface Components Recognizing 
Adhesive Matrix Molecules (MSCRAMM) in S. aureus also mediate initial cell attachment to an 
abiotic or biotic surface via ionic or hydrophobic interactions (Heilmann, 2011).   
 
2.4.2 Microcolony Formation and Biofilm Maturation 
During microcolony formation and biofilm formation, cells begin to replicate and adhesion that 
was reversible, becomes irreversible due to the secretion of EPS that constitute the biofilm matrix 
(Flemming & Wingender, 2010). The EPS enables the attachment of bacteria to a surface and to 
each other (Steinberg & Kolodkin-Gal, 2015). Biofilms mature to form an enclosed biofilm 
structure where the cells grow in a sessile form in heterogeneous complex-enclosed 
microcolonies, contained in an EPS matrix, with an efficient network of water channels (Dunne, 
2002; Davey & O’Toole, 2000). This matrix forms a scaffold to stabilise this 3D biofilm structure 
(Dunne, 2002).  
P. aeruginosa biofilms develop a mushroom-like structure comprising of microcolonies in the 
stalk and cap, with structural integrity provided by Pel and Psl polysaccharides and eDNA (Yang 
et al., 2009a; Barken et al., 2008; Yang et al., 2011a). In S. aureus biofilms, the polymer poly-N-
acetyl-β-(1-6)-glucosamine (PNAG) (also known as polysaccharide intercellular adhesin (PIA)) 
is predominant in the S. aureus EPS matrix and plays an important role in S. aureus biofilm 
morphology. A weak PNAG producing S. aureus strain will have a simple morphology, similar 
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to that of a young biofilm, whereas a strong PNAG producing S. aureus strain will form a compact 
biofilm with mushroom like colonies with channels (Jefferson, 2004). PNAG facilitates biofilm 
formation and helps in providing resistance to antimicrobials (Ganeshnarayan et al., 2009).  
Quorum sensing (QS) is a bacterial cell-to-cell communication mechanism by which signalling 
molecules, known as autoinducers (AI), are released and detected (Rutherford & Bassler, 2012; 
Mund et al., 2016). P. aeruginosa has the Las and Rhl QS systems, both of which are acylated 
homoserine lactone (AHL) based (De Kievit, 2009). Genes encoding for extracellular proteases 
such as elastase are activated by the LasR system (Park et al., 2014). During QS, transcription of 
the pel operon in P. aeruginosa encodes for proteins that are necessary for the formation of 
glucose rich exopolysaccharide (Sakuragi & Kolter, 2007). The AI peptide-based QS system in 
S. aureus is encoded by the accessory gene regulator (agr) locus (Boles & Horswill, 2008), which 
is involved in biofilm structuring (Periasamy et al., 2012).  
 
2.4.3 Dispersion 
Biofilms are dynamic structures as the sessile cells can detach from the biofilm matrix and revert 
back to their planktonic state to undergo the dispersion process (Kaplan, 2010; Sauer et al., 2002). 
Active dispersal is triggered though a regulated procedure, whereas passive dispersion can occur 
due to external forces such as fluid shear and abrasion. Biofilm dispersal can be a result of 
variation in environmental factors such as nutrient availability and oxygen depletion, regardless 
of whether this would have a positive or negative impact on the biofilm (Kaplan, 2010) which 
leads to the expression of genes necessary for dispersion (McDougald et al., 2011). Factors such 
as an increase in fluid shear (Stoodley et al., 2002a), internal biofilm processes, endogenous 
enzymatic degradation, EPS release or surface binding proteins release (Kaplan et al., 2004, 
Kaplan et al., 2003) as well as variation in nutrient levels (Schleheck et al., 2009) can all lead to 
biofilm detachment.  
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An example of this is demonstrated by P. aeruginosa biofilm production as they have the ability 
to disperse when there is a rapid increase in the nutrients succinate, glutamate and glucose. A ~80, 
72 and 54% reduction in surface-associated biofilm biomass was observed in the presence of 
succinate, glutamate and glucose respectively (Sauer et al., 2004). An escalation in nutrient levels, 
hence carbon levels, led to increased flagella expression and a decreased pilus expression, 
enabling twitching motility in dispersed cells (Sauer et al., 2004). A decrease in nutrient levels 
produced a 90% reduction of P. aeruginosa PA01 biofilm cells (Hunt et al., 2004). In this case, 
detachment was a result of starvation. Dispersal enables cells to colonise in areas of plentiful 
nutrients when nutrients are limited, allowing bacteria to survive, resulting in the expansion of 
the bacterial community (Wood et al., 2011; Karatan & Watnick, 2009). In P. aeruginosa, 
detachment is first triggered in the centre of the caps (Harmsen et al., 2010). This leads to the 
formation of a fluid filled cavity within the cap, enabling the planktonic cells to be seen (Sauer et 
al., 2002). As the cavity enlarges, the planktonic cells are released and form new biofilms 
elsewhere (Boles et al., 2005; Sauer et al., 2002). In S. aureus biofilms, glucose depletion is also 
known to encourage biofilm disassembly. Under normal growth conditions of biofilms, i.e. in the 
presence of glucose, the agr QS system remains repressed via the excretion of acidic metabolites 
generating a low pH. Depletion of glucose levels in the environment reactivates the agr system, 
leading to matrix degrading enzyme production as well as surfactants, resulting in biofilm 
breakdown (Boles & Horswill, 2008). The agr locus positively regulates various protease 
expressions, encouraging the dispersion of S. aureus biofilms (Boles & Horswill, 2008). 
2.5 Biofilms in a Clinical Setting 
In 2011, the occurrence of HCAIs was 6.4% in the English NHS hospitals (Health Protection 
Agency, 2012). HCAIs cost the NHS around £1 billion per annum (National Audit Office, 2009; 
National Patient Safety Agency, 2004). Antimicrobial resistance is a major problem in the health 
care services, as fewer antimicrobials are being introduced into the market and at the same time, 
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pathogenic microorganisms are becoming increasingly resistant to the common antimicrobials 
(World Health Organisation, 2014).   
Over the last 10 years, various schemes have been established in the UK to promote antimicrobial 
stewardship and to address the issue of antimicrobial resistance (Cooke et al., 2014). This involves 
evidence-based standard setting, education and communication as well as audits of practice. 
These methods are  fundamental to the control of antimicrobial resistance (Cooke et al., 2010). 
Campaigns such as Essential Steps to Safe, Clean Care: Reducing Healthcare-Associated 
Infections (Department of Health, 2006), Saving Lives (Department of Health, 2007), The Special 
Advisory Committee on Antimicrobial Resistance (SACAR) Antimicrobial Framework 
(SACAR, 2007), C. difficile Infection: How to deal with the problem (Department of Health and 
the Health Protection Agency, 2008), Clean, Safe Care: Reducing Infections and Saving Lives 
(Department of Health, 2008a), The Health and Social Care Act 2008, Code of Practice 
(Department of Health, 2008b), Start SMART then FOCUS (Department of Health Advisory 
Committee on antimicrobial resistance and healthcare associated infection (ARHAI), 2011), the 
UK Five-Year Antimicrobial Resistance Strategy (Department of Health, 2013) and regional 
programs such as ‘Hand in Hand’ in 2007 in the East Midlands region all aim to increase 
awareness of antimicrobial resistance and improve infection control (Newitt et al., 2015).  
S. aureus, E. coli, P. aeruginosa, Acinetobacter baumannii are examples of bacterial strains that 
form biofilms on clinical surfaces and medical devices. They are resistant to well-known 
eradication techniques such as desiccation, antibiotic treatment and nutrient deprivation (Gaddy 
& Actis, 2009). One reason for this could be due to bacteria in the deeper layers of the biofilm 
having reduced metabolic and growth rates, therefore, they are more resistant to antimicrobials. 
Furthermore, biofilms’ high cell density lowers the efficacy of antimicrobials, the extracellular 
polymers comprising the matrix act as adsorbents preventing the interaction of the antimicrobial 
with the biofilm cells as well as lowering the penetration of the bactericidal agent into the cell 
hindering inactivation. Physiological variations between planktonic and sessile cells and the 
22 
 
expression of specific protection factors by sessile cells make them more difficult to target 
(Gilbert et al., 2002). Biofilms remain unaffected by the host immune response which allows 
further growth and infection regardless of the antibiotic treatments utilised (Gaddy & Actis, 2009; 
Rogers et al., 2010). A particular concern is the persistence of biofilms on indwelling medical 
devices, which act as a continuous source of infection (Richards & Melander, 2009). The extent 
of this problem is seen worldwide, for instance, a total of 1834 patients over the age of 18 were 
admitted to eleven ICUs in a tertiary care hospital in North India (Kumar et al., 2014). The use of 
indwelling devices and HCAIs had a predominant link as 27% of the patients surveyed had a 
medical device and out of the 129 HCAIs noted, 35% were related to indwelling devices, 18% 
were from ventilated patients, 4% were due to patients with a urinary catheter, and 15% were 
from patients with a central venous catheter (Kumar et al., 2014).    
The residence of biofilms on dry surfaces have been reported by many studies (Vickery et al., 
2012; Espinal et al., 2012). A terminal cleaning procedure was carried out in a 16 bed ICU ward 
by cleaning with a neutral detergent first, and then disinfecting with 500 ppm chlorine (Vickery 
et al., 2012). Despite terminal cleaning, SEM imaging confirmed the presence of MRSA on the 
venetian blind cord, curtain and mattress bay. The production of a thin film of water due to surface 
condensation could be the reason for biofilm formation even on dry surfaces. Alternatively, the 
relative humidity in ICUs could be adequate for biofilm formation on ICU surfaces. Following 
the formation of the biofilm, the EPS surrounds the biofilm, guarding it from disinfectants 
(Vickery et al., 2012). Espinal et al. (2012) found that the survival time of A. baumannii on 
hospital dry surfaces was higher for biofilm forming strains in comparison to the non-biofilm 
forming ones with 36 and 15 day survival respectively. These studies suggest that biofilms on dry 
surfaces in hospital environments act as a reservoir for the initiation of infections in patients.          
Vancomycin intermediate S. aureus (VISA) have thick cell walls and the ability to readily form 
dense biofilms (Howden et al., 2014). Methicillin susceptible S. aureus (MSSA) 25923, MRSA 
ATCC 33591, and VISA was obtained from a patient suffering with endocarditis that was treated 
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with vancomycin. All three strains survived on vinyl flooring and formica for a minimum of 40 
days, whereas VISA survived for over 45 days (Zarpellon et al., 2015). All three strains were 
highly hydrophobic with a hydrophobicity index (HI) values of above 50% (Zarpellon et al., 
2015). Bacterial hydrophobicity can encourage colonisation, permanence and dissemination of 
pathogens in healthcare settings (Di Ciccio et al., 2015). Rougher surfaces have been known to 
harbour bacteria in comparison to smoother surfaces as demonstrated by Huang et al. (2006). 
MRSA has been shown to survive for nine days, 11 days and over 12 days on a cloth curtain, 
plastic patient chart, and a laminated table top respectively, suggesting that rougher surfaces 
encourage biofilm growth (Huang et al., 2006). Tajeddin et al. (2016) established the 
contamination rate of the hands of healthcare workers and environmental surfaces in ICUs, A. 
baumannii (1.4 and 16.5% respectively), S. aureus (5.9 and 8.1% respectively), S. epidermidis 
(20.9 and 18.7% respectively) and Enterococcus spp. (1 and 1.3% respectively) were the most 
frequently isolated bacteria. Results showed that the oxygen masks from patients, bed linens and 
ventilators were the most contaminated surfaces (Tajeddin et al., 2016). P. aeruginosa in a biofilm 
form enables the persistence of P. aeruginosa for lengthy periods in hospital water systems, 
leading to nosocomial infections. Out of 11 hospitals examined, 82% of hospital water systems 
were positive for P. aeruginosa (Baghal Asghari et al., 2013).  
 
2.6 Disinfectant Resistance 
The growth phase of the planktonic bacteria is vital when investigating biocide susceptibility. 
Clinical isolates of MRSA and P. aeruginosa biofilms were grown on discs made of SS, Teflon 
and polyethylene, and treated with the most commonly used disinfectants, Anticide Bac-50, 
MediHex-4 and Mediscrub containing the antimicrobial compounds benzalkonium chloride (1% 
w/v), chlorhexidine gluconate (4% w/v) and Triclosan (1% w/v). For MRSA and P. aeruginosa 
planktonic cells, the minimum bactericidal concentrations (MBC) were 100 to 1000 fold and ten 
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to 100 fold lower than the manufacturer’s recommended concentration for MRSA and P. 
aeruginosa respectively. However, the biocides were unable to kill bacteria in the biofilm at the 
concentrations suggested by the manufacturer, 0-11% and up to 80% of MRSA and P. aeruginosa 
cell viability was noted respectively post treatment (Smith & Hunter, 2008), demonstrating that 
bacteria attached to a surface in the form of a biofilm in a hospital environment are less susceptible 
to the antimicrobial in comparison to their planktonic counterparts (Lewis, 2001; Mah & O’Toole, 
2001; Gilbert et al., 2002). A lower susceptibility of P. aeruginosa biofilms to chlorhexidine was 
exhibited with an MIC of <145 µg/ml in comparison to its planktonic counterpart (Bonez et al., 
2013), similar to the findings by Totè et al. (2010) showing only a 40% decrease in P. aeruginosa 
biofilm viability. The increased resistance of microorganisms to commonly used antimicrobials 
in hospitals is concerning especially due to the virulence factors exhibited by biofilms. Therefore, 
further research is required in order to find new and novel antimicrobials. In addition, when 
assessing the efficacy of antimicrobials, their ability to penetrate biofilms should also be 
determined. There is also another factor that needs to be considered; the impact of multispecies 
biofilms. 
When biofilms are present in a multispecies form, they possess improved protective 
characteristics in comparison to monospecies biofilms. When single or four species of marine 
bacterial biofilms composed of Microbacterium phyllosphaerae, Shewanella japonica, Dokdonia 
donghaensis, and Acinetobacter lwoffii were exposed to 1,700 µg/ml of H2O2 or 20 µg/ml of 
tetracycline, mixed species biofilm increased in biomass by >167% in comparison to single 
isolates (Burmølle et al., 2006). This may be due to mixed species biofilms reducing the 
permeability and diffusion of the antimicrobials (Burmølle et al., 2006). Multispecies biofilms 
comprising of organisms found in drinking water, as well as opportunistic pathogens exhibited 
greater chlorine resistance in comparison to planktonic cells and monospecies biofilms 
(Schwering et al., 2013). Planktonic cells of Bradyrhizobium sp. B1-1, Methylobacterium 
isbiliense MWI-1, Mycobacterium sp. MWI-2, Sediminibacterium sp. C0-3, Novosphingobium 
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subterraneum FH-D, Sphingomonas sp. FH-G, Blastomonas natatoria FH-J, Variovorax sp. A2-
1, Cupriavidus respiraculi A3-2, Kocuria rhizophila C0-6 and the opportunistic pathogenic 
strains E. coli MEC-8, Enterobacter cloacae MTC-21, P. aeruginosa PAE-1 and 
Stenotrophomonas maltophilia FH-W1 were all eliminated at chlorine concentrations of 0.2-5.0 
mg l-1. However, higher chlorine concentrations between 1.6-40 fold, was needed to remove their 
biofilms. Approximately 70% of biofilms were unaffected by 5.0 mg l-1 of chlorine. An average 
of ∼700–1100 mg l−1 of chlorine was needed to eradicate pathogens within the biofilm, which is 
50-300 fold greater than the concentration required for single species biofilms (Schwering et al., 
2013).  
Lee et al. (2014b) investigated the spatial and relative species distribution of a multispecies 
biofilm consisting of P. aeruginosa PA01, Pseudomonas protegens Pf-5 and Klebsiella 
pneumoniae KP-1. Various resistance levels were seen with monospecies biofilms of these 
microorganisms towards 10 µg ml-1 tobramycin and 0.1 % w/v sodium dodecyl sulphate (SDS). 
Monospecies biofilms of PA01, Pf-5 and KP-1 showed a reduction in biovolume of 33.6 ± 14.0%, 
8.8 ± 2.3% and 37.2 ± 8.4% respectively when treated with tobramycin whereas in a multispecies 
biofilm, a reduction of 7.6 ± 7.0% was noted. With SDS treatment, the biovolume of P. protegens 
Pf-5, P. aeruginosa PA01 and K. pneumoniae KP-1 biofilms were reduced by 61.9 ± 8.8%, 9.7 ± 
2.3% and 15.9 ± 2.0% respectively. Treatment of the multispecies biofilm with SDS exhibited 
resistance with a biovolume reduction of 11.5 ± 4.2% only, similar to tobramycin. Interestingly, 
when a mixed community of planktonic cells of the three strains were grown and treated with 10 
g ml-1  tobramycin, only the tobramycin resistance strain Pf-5 survived, showing that community 
resistance is only observed in biofilms, where the extracellular matrix and the unique spatial 
arrangement of the biofilm can exhibit these effects (Lee et al., 2014b).             
Due to most biofilms naturally existing as a multispecies biofilm (Yang et al., 2011b), it is vital 
that when novel antimicrobials are designed, that they are able to have an inhibitory effect on the 
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biofilm as a whole and not just individual species due to the resistance exhibited by multispecies 
biofilms in comparison to monospecies biofilms.    
2.7 NPs as Antimicrobial Agents 
The ability to produce particulates of any shape or size has led nanotechnology researchers to 
assess new strategies for the use of NPs as biocidal agents (Janaki et al., 2015). It is known that 
antibiotics can eliminate approximately six different disease causing microorganisms, whereas 
nanomaterials have bactericidal properties against at least 650 cell types (Sungkaworn et al., 
2007). Metal NPs are versatile in that they have properties such as catalytical, magnetic, 
electronic, optical as well as antimicrobial (Ingle et al., 2008; Durán et al., 2005), wound-healing 
and anti-inflammatory benefits (Taylor et al., 2005). Therefore, metal and metal oxide NPs may 
be an effective alternative to current antimicrobials that have been rendered ineffective against 
resistant bacteria.       
The individual characteristics, potency and spectra of activity of metal NPs and their derivatives 
such as Ag, silver oxide (Ag2O), CuO, Cu, gold (Au), titanium (Ti), TiO2, zinc (Zn), ZnO, calcium 
oxide (CaO) and magnesium oxide (MgO) have made them ideal candidates for antimicrobial 
agents (Dizaj et al., 2014). The properties of metal NPs completely differ from their metal 
counterparts due to the surface/volume ratio of the NPs being greater as their size decreases (Rai 
& Bai, 2011; Buzea et al., 2007). There is ongoing research into the mechanisms by which NPs 
act to exert an antimicrobial effect, however, the current proposed mechanisms are: a) free metal 
ion toxicity derived as a result of dissolution of the metal/metal oxide NPs’ surface and b) 
oxidative stress exerted due to reactive oxygen species (ROS) formed from the NPs surface 
(Besinis et al., 2014). 
Ag NPs are the most commonly used inorganic metal NPs for antimicrobial agents (Zinjarde, 
2012). The antifungal (Jo et al., 2009), anti-viral (Rogers et al., 2008), anti-inflammatory 
(Nadworny et al., 2008), and anti-angiogenic (Gurunathan et al., 2009) properties make Ag NPs 
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ideal for antimicrobial use. Furthermore, Ag NPs are non-toxic to the human body at low 
concentrations. Ag additives are safe, cost effective and long lasting, therefore, have been used in 
polymers, paints and textiles (Yuan Gao & Cranston, 2008; Appendini & Hotchkiss, 2002). 
Published studies have also shown that Ag NPs have lower toxicity in comparison to other 
disinfectants, making them suitable for use for a range of applications (Marambio-Jones & Hoek, 
2010) such as burn treatments (Parikh, 2005; Ulkür et al., 2005), the reduction of bacterial 
colonisation on medical devices such as catheters (Rupp et al., 2004; Samuel & Guggenbichler, 
2004), antimicrobial textile fabrics (Yuranova et al., 2003; Jeong et al., 2005) and water 
disinfection treatment (Chou et al., 2005). 
ZnO NPs are considered to have low toxicity and to be safe when in close proximity with human 
skin, making them ideal for usage in the textiles industry and also for surfaces in contact with 
humans (Liu et al., 2014; Saraf, 2013). ZnO is commonly used for a range of cosmetics, 
sunscreens, toothpastes, food colouring, paints as well as coatings for vitamin supplements (Yu 
& Li, 2011). Bacterial growth requires Zn in small quantities for DNA synthesis, transcription 
and translations, however, in excessive concentrations; it can be toxic to bacterial cells (Blindauer 
et al., 2001).  
Cu NPs possess unique chemical, biological and physical characteristics and bactericidal 
properties in addition to being inexpensive to prepare, making it a popular candidate for 
antimicrobial use (Ahamed et al., 2014; Wu et al., 2002; Usman et al., 2013). Cu is utilised as an 
antimicrobial due to its bactericidal properties against fungi and bacteria, and that it shares similar 
properties to other expensive noble metals with antimicrobial properties such as Au and Ag 
(Usman et al., 2013). The advantages of utilising CuO as an antimicrobial agent is that it can be 
readily mixed with polymers and has stable physical and chemical properties. CuO is an example 
of highly ionic metal oxide NP, which can be developed to have a large surface area and various 
crystal morphologies (Stoimenov et al., 2002).   
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2.8 Antimicrobial Efficacy of NPs 
Mirzajani et al. (2011) tested the antimicrobial efficacy of Ag NPs against S. aureus PTCC1431. 
Results demonstrated that 4 µg/ml of Ag NPs showed complete inhibition of bacteria (Mirzajani 
et al., 2011). A two hour treatment of the biofilms with 100 nM of Ag NPs gave a 95% and 98% 
reduction of P. aeruginosa and S. epidermidis biofilms respectively, whereas 50 nM Ag NPs 
reduced the biofilm of both microorganisms by 50% (Kalishwaralal et al., 2010). 
Antimicrobial efficacy is impacted by the shapes and sizes of NPs. E. coli was almost completely 
reduced at 1 µg of Ag truncated triangular nanoplates, whereas, lower antimicrobial efficacy was 
exhibited by spherical, rod-shaped and Ag+ (in the form of silver nitrate (AgNO3)) (Pal et al., 
2007). The high-atom-density surface of the triangular nanoplates is thought to be the cause of 
biocidal activity (Pal et al., 2007). Bera et al. (2014) reported that 1.5 nm Ag NPs gave an MIC 
of 1.5 µg/ml for S. epidermidis, P. aeruginosa and E. coli, whereas 40 nm triangular Ag NPs gave 
an MIC of 3.90 µg/ml for P. aeruginosa and E. coli and 7.81 µg/ml for S. epidermidis. Ag NPs 
at 1.5 nm can penetrate directly though the cell membrane owing to their small size. The 
antimicrobial efficacy of ZnO ultrafine powder (> 1µm), ZnO NPs (8 nm), and ZnO nanopowder 
(50-70 nm) against S. aureus was assessed. ZnO nanopowder and ultrafine powder showed only 
a circa 50 % reduction, 8 nm ZnO NPs (1mM) showed over a 95% reduction, whilst 50-70nm 
ZnO NPs (5 mM) only showed a 40-50% reduction, suggesting that smaller sized NPs have 
greater antimicrobial efficacy than larger ones (Jones et al., 2008), similar to the findings of Bera 
et al. (2014).  
The antimicrobial activity of ZnO (19.89 ± 1.43 nm), CuO (29.11 ± 1.61 nm) and Fe2O3 (35.16 ± 
1.47 nm) NPs was tested against E. coli, P. aeruginosa, B. subtilis and S. aureus (Azam et al., 
2012a). MBC values for ZnO, CuO and Fe2O3 against E. coli were 18, 25 and 65 µg/ml 
respectively, 14, 28 and 120 µg/ml against P. aeruginosa respectively; 12, 20 and 78 µg/ml 
respectively against B. subtilis and 16, 22, and 80 µg/ml against S. aureus respectively, suggesting 
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the enhanced efficacy of metal oxide NPs against Gram-positives with decreasing particle size. 
This correlates with findings by Premanathan et al. (2011) whereby strains of E. coli, S. aureus 
and P. aeruginosa were treated with ZnO NPs, and the MICs observed were 500, 125 and 500 
µg/ml respectively. Lee et al. (2014a) reported that ZnO NPs (<50nm) treatment lowered 
virulence factor expression and inhibited P. aeruginosa biofilm formation by over 95% on a 
polystyrene surface at a concentration of 1 mM, whilst Feris et al. (2010) found the MICs of ZnO 
NPs (<13 nm) were >4.25 mM against P. aeruginosa. The efficacy of crystalline flower shaped 
ZnO nanostructures was determined, with an MIC of 25 mg/l against S. aureus and E. coli (Mohan 
Kumar et al., 2013). This suggests that the ZnO NP toxicity to bacterial cells varies according to 
the concentration, bacterial species and particle size (Ma et al., 2013).  
The complete inhibition of P. aeruginosa, S. aureus (Oxford), epidemic MRSA (EMRSA)-16 and 
S. epidermidis SE-51 was observed after exposure to 1000 µg/ml of CuO NPs over 4 hours (Ren 
et al., 2009). The antimicrobial efficacy of CuO NPs (23 nm) and its MIC was determined against 
various bacteria such as E. coli, P. aeruginosa and S. aureus, with MICs of 31.25, 125 and 62.5 
µg/ml respectively (Ahamed et al., 2014). Padil and Černik (2013) found CuO NP (4.8 nm) MIC 
values of 103 and 120 µg/ml were effective against E. coli and S. aureus respectively. Azam et 
al. (2012b) also reported MICs of 103 and 120 µg/ml for E. coli and S. aureus respectively 
although the CuO NP size was larger at 20 nm. Most published research has been based on the 
antimicrobial activity of metal and metal oxide NPs against planktonic cultures. Due to the 
continuing occurrence of biofilm related infections and the well-known antimicrobial properties 
of metal and metal oxide NPs, further research needs to be focussed towards the anti-biofilm 




2.9 Modes of Action of NPs 












One of the mechanisms by which Ag NPs destroy bacterial cells is via damage to the bacterial 
outer membrane of the cell (Lok et al., 2006). Many studies have reported the formation of pits 
when Ag NPs accumulate on the membrane of the bacteria, followed by fragmentation of the 
membrane (Ansari et al., 2014a; Sondi & Salopek-Sondi, 2004; Li et al., 2010; Rajesh et al., 
2014). The interaction of Ag with bacterial membranes containing sulfur can lead to inhibition of 
proteins and membrane bound enzymes, disrupting metabolic processes (Pal et al., 2007; Holt & 
Bard, 2005). Ag NP treatment also causes intracellular leakage of cell contents (Rajesh et al., 
2014). Ag NPs can penetrate to the cytoplasm, interacting with elements containing phosphorous 
e.g. DNA (Yuan et al., 2013; Morones et al., 2005; Bondarenko et al., 2013), hindering 
replication. In the cytoplasm, ROS can be formed from Ag NPs as described in numerous studies, 
Figure 2.2: Modes of action of metal/metal oxide NPs adapted from Wyszogrodzka et al. (2016). 
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with smaller NPs forming more ROS (Bae et al., 2011; Ivask et al., 2014; Bondarenko et al., 
2013; Ansari et al., 2014a) due to smaller NPs being able to reach the cytoplasm more efficiently 
than larger NPs (Durán et al., 2015).  
Although Ag NPs have shown to exert antimicrobial activity directly, research has also suggested 
the importance of Ag+ ions released from Ag NPs (Marambio-Jones & Hoek, 2010; Reidy et al., 
2013; Manke et al., 2013; Rajeshkumar & Malarkodi, 2014; Dos Santos et al., 2014). Ag NPs can 
rupture bacterial cell membranes directly, however, it is the Ag+ form that results in increased 
permeability of membranes, cellular contents leakage, interruption of DNA replication and de-
energisation of bacterial cells. Samberg et al. (2011) suggested that a synergistic effect between 
the Ag+ ions binding to the cell wall, their uptake, and accumulation in the cell is what exerts the 
antimicrobial effect.  
One proposed mechanism by which ZnO exerts its antimicrobial properties is via the production 
ROS such as of H2O2, O2-,1O2 and ·OH on the surface of the NPs (Zhang et al., 2008). Brayner et 
al. (2006) and Huang et al. (2008) have also reported the internalisation of ZnO NPs.  Electrostatic 
forces between the ZnO NPs and the bacterial cell membrane encourage contact between the two 
and formation of ROS close to membrane results in an antimicrobial effect (Zhang et al., 2008). 
The release of Zn2+ ions from ZnO NPs leads to an increased intracellular concentration of Zn2+, 
resulting in an over generation of ROS within the cell leading to plasma membrane leakage, 
mitochondria dysfunction and cell death (Wang et al., 2014a).  
CuO NPs also generate ROS species producing ·O2-, which interacts with the outer wall of the 
bacterial cell. The free radical species can then enter the cell, disrupting the inner contents, leading 
to cell deformation and leakage (Hassan et al., 2012). Perelshtein et al. (2009) suggested that the 
antimicrobial efficacy of CuO NP was due to the NP itself. However, Aruoja et al. (2009) and 





Extensive research has been carried out on novel ways by which biofilm formation can be 
controlled, yet antimicrobial biofilm resistance still remains an issue within the clinical arena.  
Problems such as cross contamination, infections derived from nosocomial pathogens and disease 
associated with biofilm formation on medical equipment have yet to be fully addressed. The 
requirement for novel agents that can overcome the resistance of bacterial biofilms to current 
antimicrobials is of paramount importance. The majority of currently published research has 
focussed on metal/metal oxide NPs as antimicrobials against planktonic cells rather than biofilms. 
However, bacteria commonly reside in a biofilm form rather than planktonic state, and most 
available antimicrobial agents are only effective at concentrations that inhibit planktonic cells, 
hence their inefficacy at decontaminating healthcare environments. Metal and metal oxide NPs 












2.11 Scope of this Work 
Aim: 
This study aims to determine the antimicrobial efficacy of metal and metal oxide NPs against P. 
aeruginosa and S. aureus biofilms.  
 
Objectives: 
 To establish the best method for biofilm formation that can replicate biofilms in hospital 
and healthcare arenas. 
 To investigate the inhibitory effect of metal and metal oxide NP suspensions alone and 
in combination against biofilms of S. aureus and P. aeruginosa.  
 To determine the effect of thin film coating of metal and metal oxide NPs on the formation 
of S. aureus and P. aeruginosa biofilms.  































Chapter 3: In vitro Biofilm Formation 
 
3.1 Introduction 
Biofilms can be defined as a community of microorganisms adhered to a biotic or abiotic surface. 
Biofilm formation is a multistep process where bacterial cells undergo adhesion to a surface which 
is initially reversible. However, extracellular matrix production consisting of polysaccharides, 
protein and DNA, enables a stronger cell attachment, which eventually becomes irreversible 
(Sauer, 2003; Stoodley et al., 2002b).  
Biofilm production is highly reliant on the experimental conditions (Reisner et al., 2006; Hancock 
et al., 2011). Methods used to assess biofilm formation in vitro can be standardised poorly, 
therefore, it can be challenging when data in the published literature is compared. Moreover, what 
one study defines as a strong biofilm producer may differ considerably from another study 
(Skyberg et al., 2007; Naves et al., 2008).  
Published research has used various methods to form biofilms in vitro, each posing different 
advantages and disadvantages. For instance, static biofilm methods such as microtiter plates 
(MTP) are compact and can hold a number of samples so replicates can be obtained rapidly with 
low costs (Campbell et al., 2003). Conversely, flow systems such as the CDC biofilm reactor 
enable biofilm formation on surfaces including SS and plastics e.g. polycarbonate (PC). These 
materials are readily found in a healthcare environment and are a common substrate for biofilm 
formation (Smith & Hunter, 2008).  
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3.1.1 In vitro Biofilm Model Systems 
3.1.1.1 MTP 
MTP based systems are commonly used to assess biofilms (Toté et al., 2008; Uppuluri et al., 
2009; Silva et al., 2010). Most commonly, 96 well plates are used whereby biofilms are formed 
on the walls of the MTP plates on in the bottom of the wells. Alternatively, they are grown on 
coupon surfaces which are then placed in the wells of a 6, 12 or 24 well MTP (Heersink & Goeres, 
2003). The plates are inoculated with organisms, incubated for 24 to 48 hours followed by a 
crystal violet assay used to determine the biomass of the biofilm (Crémet et al., 2013; Moreira et 
al., 2013). This method was first outlined by Christensen et al. (1985). Such systems are known 
as closed or batch reactor-like systems, as there is no fresh flow of nutrients in and out of the 
plates throughout the course of the experiment (Heersink & Goeres, 2003). Therefore, the 
environmental conditions of the well alter as the experiment proceeds, as nutrients deplete and 
signalling molecules accumulate. In order to avoid such changes in conditions, the culture media 
needs to be replenished (Coenye & Nelis, 2010). 
MTP based models have many advantages as they are usually simple to operate, cost effective 
due to only minimal volumes or reagents required and numerous tests can be undertaken 
simultaneously (Sandberg et al., 2008; Stepanović et al., 2000; Pitts et al., 2003; Knezevic & 
Petrovic, 2008). They are, therefore, ideal to use for screening of antimicrobials against biofilms 
(Niu & Gilbert, 2004). These systems have been widely utilised for screening the antimicrobial 
and anti-biofilm properties of many antibiotics and disinfectants (Tremblay et al., 2014; Abbanat 
et al., 2014; Perumal et al., 2014). MTP based models can allow in depth assessments of the 
biofilm formation on modified, coated and impregnated materials different stages of formation 
(Mowat et al., 2007; Imamura et al., 2008; De Prijck et al., 2010, 2007; Chandra et al., 2001). 
The MTP system also enables researchers to alter various conditions such as growth media, 
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incubation temperature, humidity, shear stress and O2 and CO2 levels (Krom et al. 2007; 
Stepanović et al. 2003). 
Even though the crystal violet assay is laborious, it is commonly used for studying biofilm 
formation. The process itself is lengthy and hard to standardise (Crémet et al., 2013). Many 
published studies have used this method, although the number of washing steps, washing 
conditions (i.e. automation, and use of buffer or water for washing) and the time of crystal violet 
staining differs as well as its concentration (Chavant et al., 2007; Naves et al., 2008; Reisner et 
al., 2006; Skyberg et al., 2007; Wang et al., 2009). This method primarily measures biomass 
rather than the biofilm cell viability (Crémet et al., 2013).  
Flow displacement systems contrast to MTP based systems as they are “open” systems. In flow 
systems, growth media containing nutrients are continuously or semi-continuously introduced 
into the system and waste products are eliminated (Heersink & Goeres, 2003; Busscher & Van 
Der Mei, 2006).   
 
3.1.1.2 Flow Systems 
The CDC biofilm reactor is a continuous flow system which involves a glass vessel with a 
polyethylene top containing eight holes to place polypropylene rods, which are perpendicular to 
the rotating baffle in the middle of the glass vessel (Buckingham-Meyer et al., 2007; Donlan et 
al., 2004; Goeres et al., 2005). Three removable coupons can be placed in each rod on which the 
biofilms are formed (Donlan et al., 2004; Goeres et al., 2005). Each coupon is 12.7 mm in 
diameter with a 2.52 cm2 surface area. The coupons can be made from various materials, such as 
PC, mild steel, SS and polyvinyl chloride (PVC), vinyl, glass etc. depending on the purpose of 
the assay and the bacteria (Macià et al., 2014). The glass reactor is joined to a flask containing 
sterile broth pumped through the system via a peristaltic pump to provide a continuous source of 
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fresh nutrients to the biofilm. Bacteria are inoculated into the CDC biofilm reactor and biofilms 
then form on the coupons. A magnetic stirrer in the centre of the vessel rotates the nutrients, 
enabling high shear conditions for the biofilm to grow (Macià et al., 2014). Previous studies have 
demonstrated the reliability of the CDC biofilm reactor for the formation of biofilms across a 
wide range of organisms such as Pseudomonas putida (Thuptimdang et al., 2015), S. epidermidis 
(Paredes et al., 2012) and P. aeruginosa (Nagant et al., 2013). A total of 24 ‘identical’ biofilms 
can be grown on coupons at once and enumerated. This system is ideal to study the growth of the 
biofilm over longer periods of time (Honraet et al., 2005; Nailis et al., 2009), the antimicrobial 
effect of coated materials (Agostinho et al., 2009) and evaluation of disinfection methods and 
cleaning procedures (Buckingham-Meyer et al., 2007; Hadi et al., 2010). The CDC biofilm 
reactor has a large capacity of 500-1000 ml, therefore testing the efficacy of antimicrobials in the 
CDC biofilm reactor can be costly due to the large volumes of media required (Coenye & Nelis, 
2010). Recently, the CDC biofilm reactor was used to test the efficacy of sodium hypochlorite, a 
commonly used disinfectant, on dry surface biofilms of S. aureus. A 7 log(10) kill was observed, 
with a reduction in biomass. However, CLSM demonstrated the persistence of S. aureus cells 
(Almatroudi et al., 2016).  The CDC biofilm reactor is well established for its ability to produce 
P. aeruginosa biofilms under conditions of high shear and continuous flow and is used by the 
American Society for Testing and Materials (ASTM E2562) (Coenye & Nelis, 2010; American 
















 Figure 3.1: Setup of a CDC biofilm reactor (BioSurface Technologies Corporation, 2010) 
 
Other flow systems include a drip flow reactor, which is a plug flow reactor where biofilms grow 
in conditions of low shear in close proximity to the air/liquid interface (Goeres et al., 2009). 
Biofilms grown using the drip-flow method have been previously used to analyse: the effect of 
powdered brushing on biofilm plaque removal (Adams et al., 2002); to evaluate the reduction of 
S. epidermidis biofilm formation by bacteriophages (Curtin & Donlan, 2006); and to investigate 
the efficacy of a range of disinfectants (Stewart et al., 2001; Buckingham-Meyer et al., 2007).  
3.1.1.3 Rotating Disc Reactor 
The rotating disc reactor includes a Teflon disc which holds 6 x 12.7 mm diameter coupons. A 
magnetic stirring bar at the bottom of the rotating disc allows the disc to rotate, creating a liquid 
surface shear on the coupons. The disc that holds the coupons is put in a reactor vessel and growth 
media (in the absence or presence of an antimicrobial) is distributed throughout the vessel whilst 
the disc is rotating (Buckingham-Meyer et al., 2003). The rotating disc reactor has been utilised 
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to investigate many properties of biofilms such as the cohesive strength of P. aeruginosa and S. 
epidermidis biofilms (Aggarwal et al., 2010), resistance of P. aeruginosa to heavy metals (Teitzel 
& Parsek, 2003) and multispecies biofilm interactions (Komlos et al., 2005). 
 
3.1.2 Comparison of in Vitro Biofilm Models 
Often in vitro biofilm formation methods can be modified to suit the needs of a study. Bacterial 
contaminants in commercial fuel ethanol production facilities are usually present as a multispecies 
biofilm under laboratory conditions (Rich et al., 2011). Rich et al. (2011) assessed the ability of 
the pure cultures to form monospecies biofilms using a modified method by Gross et al. (2007) 
and their susceptibility to virginiamycin. In this assay, 96 well MTP contained 96-pin replicator 
lids, which were exposed to plates containing medium, encouraging biofilm growth. Crystal violet 
was then used to analyse the biomass that adhered to the pin. The MTP based method was 
advantageous as it allows simultaneous assays of different bacterial species under a range of 
conditions. Furthermore, this assay is less labour intensive as set-up time, data analysis, as well 
as cleaning-up is also reduced. MTP based assays require less media and in this particular study, 
antibiotics, therefore more cost effective (Rich et al., 2011). Skinner-Nemec et al. (2007) studied 
multispecies biofilms of bacterial contaminants in commercial fuel ethanol production facilities, 
but in a CDC biofilm reactor. This method permits precise biofilm growth measurements and 
regulation of parameters, though only one organism can be assayed at a time (Rich et al., 2011).   
The crystal violet assay and the CDC biofilm reactor can be used in conjunction with each other 
to test the efficacy of antimicrobials. A CDC biofilm reactor was used to grow biofilms of P. 
aeruginosa ATCC 25619 on polytetrafluoroethylene coupons and subjected to commercial 
surgical equipment disinfectants. The biofilms were hydrolysed and the crystal violet assay and a 
commercially available protein assay were used to detect the remaining biofilm. Sodium 
hydroxide (NaOH) at a concentration of 1% gave the highest reduction of 77.3%, whereas Tween 
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20 gave the lowest reduction of 18.7%. No significant difference was found in between the results 
obtained for the percentage reduction values acquired for crystal violet or the protein assay, thus 
suggesting that the crystal violet assay is an appropriate method to use for the detection of 
remaining biofilms after treatment (Hadi et al., 2010).   
In conclusion, there are various methods that can be used to investigate biofilm formation, each 
having its advantages and disadvantages. Biofilms are a concern in the healthcare sector, due to 
increasing antimicrobial resistance. Methods to replicate these biofilms in vitro for further study 
are vital in order to assess their structure and formation to develop antimicrobials for prevention 
and elimination of biofilms. Furthermore, the study of biofilm formation on various surfaces is of 
paramount importance as the topography and chemical composition of a surface can also affect 





3.1.3 Aims and Objectives 
 
Aim:  
The aim of this investigation was to determine which method of biofilm formation is most 
appropriate for forming biofilms of P. aeruginosa and S. aureus for the assessment of metal/metal 
oxide NPs as antimicrobials. 
 
Objectives: 
 To compare a static and a flow system for the formation of P. aeruginosa and S. 
aureus biofilms. 
 To evaluate P. aeruginosa and S. aureus biofilm formation by measurement of 
protein. 
 To compare the surface topography of P. aeruginosa and S. aureus biofilms using 
SEM. 
 










3.2 Methods  
3.2.1 Culture Methods and Microorganisms 
The test organisms used were P. aeruginosa NCTC 6749 and S. aureus ATCC 6538. All culture 
media was acquired from Oxoid Ltd. (Hampshire, UK) unless otherwise stated.  
Strains were stored on beads (Technical Service Consultant Ltd., Lancashire, UK) at -80°C. 
Cetrimide agar (CM0579) for P. aeruginosa and Mannitol salt agar (CM0085) for S. aureus was 
used to phenotypically determine the organisms.    
Organisms were grown on Nutrient agar (NA) (CM0003) and then 1 colony per 10 ml of 
Nutrient broth (NB) (CM0001) was grown aerobically for 24 hours at 37 °C. NA was used to 
culture the bacteria for viable count enumeration. 
 
3.2.2 Biofilm Formation in 96 Well Plates 
Aliquots of 200 μl of a 24-hour culture of either P. aeruginosa or S. aureus were plated into 96 
well plates and incubated in a rotating incubator (Innova 44, New Brunswick Scientific, 
Stevenage, UK) at 37°C for 10 days at 100 rpm. The wells were replenished at 5 and 9 days with 
200 μl of sterile NB. Planktonic bacteria were removed by washing plates twice with phosphate 
buffered saline (PBS, BR0014G). The cells were then fixed with 200 μl of ethanol for 10 minutes 
(mins), stained with 50 μl of 0.1 % crystal violet for 15 mins, washed three times with PBS and 
dried. Aliquots of 200 μl of 10 % (v/v) glacial acetic acid were then added to each well in order 
to solubilise the crystal violet and the absorbance was read at 595 nm using a micro plate reader 
(Molecular Devices Thermo Max Microplate Reader, Berkshire, UK)(Christensen et al., 1985).    




3.2.3 Biofilm Formation in a CDC Biofilm Reactor 
3.2.3.1 Batch Phase 
PC and SS coupons were placed in CDC biofilm reactor (CBR 90, Biosurface Technologies 
Corporation, Montana, USA) containing 500 ml of NB and 1 ml of an overnight culture of either 
P. aeruginosa or S. aureus. The CDC biofilm reactor was then placed on a stirring plate (125 
rpm) and incubated at room temperature for 24 hours. 
 
3.2.3.2 Continuous Flow 
After 24 hours in batch phase, a continuous flow of NB medium was passed through the CDC 
biofilm reactor at a flow rate of 11.7 ± 0.2 ml/min for P. aeruginosa and S. aureus for 24 hours. 
The flow rate was maintained using a peristaltic pump (120S Watson Marlow Pumps, Cornwall, 
UK). 
The flow rate was calculated using the following equation: 
Flow rate=CDC Biofilm Reactor Volume/Residence Time 
The CDC biofilm reactor volume is approximately 350 ml once the rods and baffles are 
assembled. The residence time for P. aeruginosa and S. aureus is 30 mins (BioSurface 
Technologies Corporation, 2010; Barber et al., 2015).  
 
3.2.3.3 Validation of Removal of Biofilms from Coupons 
Biofilms were formed on PC (RD128-PC, Biosurface Technologies, Montana, USA) or SS 
(RD128-316P, Biosurface Technologies, Montana, USA) coupons in the CDC biofilm reactor. 
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The biofilm was physically removed using a glass rod by scraping one surface of sample in a 
circular motion for 5 seconds each and placing the scraped cells into 9 ml of PBS. This was 
repeated 5 times. The surface of the coupon was then rinsed with 1 ml of PBS and added to the 
9ml of PBS containing the cells. The solution was then homogenised (Ultra-Turrax T25, IKA-
Labortechnik, Staufen im Breisgau, Germany) at 20,500 rpm for 30 seconds. The solution was 
spread plated and incubated at 37°C for 24 hours. Alternatively, the coupon was stomached for 1 
min in 1 ml of PBS and the resulting solution was spread plated and incubated at 37°C for 24 
hours. Colonies were then enumerated. 
The homogenising probe was cleaned between samples by rinsing for 30 seconds at 20,500 rpm 
in sterile water, followed by a rinse at 20,500 rpm for 15 seconds in 70% ethanol, then immersed 
in ethanol for 1 min and rinsed with sterile water at 20,500 rpm for 30 seconds.  
3.2.4 Protein Assay 
Protein standards were prepared in 10% v/v NaOH using bovine serum albumin (BSA, A9056, 
Sigma Aldrich, Dorset, UK) at the following doubling concentrations: 0, 0.156, 0.313, 0.625, 
1.25, 2.5, 5 and 10 mg/ml.  Aliquots of 5 µl of protein standard were added to 96 well plates. 
Aliquots of 250 µl of Bradford reagent (B6916, Sigma Aldrich, Dorset, UK) was then added to 
each of the wells and thoroughly mixed for 30 seconds. Samples were then incubated at room 
temperature for 10 mins and absorbance read at 595 nm using a microplate reader. 
Aliquots (200 μl) of a 24 hour culture of either P. aeruginosa or S. aureus were placed in 96 well 
plates and incubated in a rotating incubator at 100 rpm at 37°C for 10 days. The wells were 
replenished daily with 200 μl of NB. The wells were then washed with PBS to remove any 
planktonic bacteria and 250 µl of Bradford reagent added and mixed for 30 seconds, incubated at 
room temperature for 10 mins and the absorbance was then read at 595 nm using a microplate 
reader (Spectramax Plus 384, Molecular Devices, Berkshire, UK). 
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3.2.5 Depth and Topography of P. aeruginosa and S. aureus Biofilms  
A PC coupon was cut in half and then placed back together into the hole of the CDC biofilm 
reactor rod to form a divide by which the biofilm thickness can be measured. Biofilms of S. aureus 
and P. aeruginosa were formed in the CDC biofilm reactor as per method described in Sections 
3.2.3.1 and 3.2.3.2 The coupons were then removed and cut using a scalpel along the divide in 
the coupon made. Samples were then washed with PBS and fixed with 95 % ethanol for viewing 
under the SEM (Evo HD 15 Carl Zeiss, Cambridge, UK). The samples were pre-coated with a 15 
nm coating of gold (Q150RS, Quorum Technologies, East Sussex, UK). The thickness of the 
biofilm was determined. To view the topography of the biofilm, biofilms S. aureus and P. 
aeruginosa were formed in the CDC biofilm reactor as per method described in Method 3.2.3.1 
and 3.2.3.2 on PC coupons, washed with PBS and fixed with 95% ethanol.  
 
3.2.6 Statistical Analysis 
Statistical analysis was undertaken to observe if there was a significant difference in P. 
aeruginosa and S. aureus biofilm formation on PC and SS coupons, and between the absorbance 
obtained for P. aeruginosa and S. aureus biofilms over 10 days when the broth in the MTP assays 
was replenished at 5 and 9 days and daily. IBM SPSS Statistics Version 20 for Windows was 
used for all statistical analysis tests with the significance value set at p ≤0.05. Assumption of 
normality was tested using Kolmogorov-Smirnov test if sample sizes were ≥50 or the Shapiro-
Wilcox test used if samples were <50. For non-parametric data, a Kruskal Wallis test was used to 
analyse significant differences between more than two group means or a Mann-Whitney U test 
for two means. An example of Mann-Whitney U output can be found in Appendix I.   




Figure 3.2: Comparison of biofilms for S. aureus and P. aeruginosa using 96 well plate method 
when broth was replenished at 5 and 9 days (n=6 ± SE)            S. aureus               P. aeruginosa 
3.3 Results 
3.3.1 Biofilm Formation in 96 well plates 
When no replenishment of broth was conducted, evaporation of the nutrients occurred in the 
rotating incubator, leaving a residue in the wells. This therefore caused an increased absorbance 
of the crystal violet in the dried wells, creating invalid data, large variations and SE. The broth 
was replenished at 5 and 9 days due to the evaporation. Between day 1 and 3 of biofilm formation, 
no visible biofilms could be seen in the 96 well plates.       
When biofilms were replenished at 5 and 9 days, the highest biofilm formation (p ≤0.05) was seen 
at day 9 (1.57 au) for S. aureus biofilm formation in comparison to day 4 when biofilm formation 
was the lowest (0.26 au) (Figure 3.2). For P. aeruginosa biofilms, the highest biofilm formation 
was at day 8 (3.26 au) (p ≤0.05) in comparison to day 4 (0.63 au) (Figure 3.2). A significant drop 
(p ≤0.05) in biofilm formation occurred at day 6 (0.45 au) for S. aureus biofilms in comparison 
to day 5 (0.94 au). A significant (p ≤0.05) decrease in absorbance for P. aeruginosa biofilms was 
observed at day 4 (0.63 au) and 10 (2.09 au). P. aeruginosa biofilms generally gave a higher 
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When broth was replenished daily, biofilm formation for S. aureus was the highest at day 9 (1.66 
au) (p ≤0.05) in comparison to day 4 (0.25 au), when S. aureus biofilm formation was the lowest 
(Figure 3.3). P. aeruginosa biofilm formation was the highest at day 3 (2.04 au) and 9 (2.00 au) 
in comparison to day 5, where there was a significant (p ≤0.05) decrease in biofilm formation.  A 
significant (p ≤0.05) reduction in biofilm formation occurred at day 4 and 10 for S. aureus with 
absorbance readings of 0.25 au and 1.19 au respectively (Figure 3.3). For P. aeruginosa biofilms, 
there was a significant (p ≤0.05) drop at days 4, 7 and 10 with absorbance values of 0.98, 1.02 
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Figure 3.3: Comparison of biofilms for S. aureus and P. aeruginosa using 96 well plate method 
when broth was replenished daily (n=6 ± SE)            S. aureus                  P. aeruginosa 
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3.3.2 Protein Assay Using the Bradford Reagent 
The highest absorbance for a P. aeruginosa biofilm was observed for day 8 (0.36 au), with a 
significant (p ≤0.05) increase from day 3 (0.07 au), where the lowest absorbance was obtained. 
Overall the protein content per well increased over 10 days (Figure 3.4). A significant (p ≤0.05) 
decrease in absorbance was seen between day 8 (0.36 au) and 10 (day 0.25 au), and day 4 (0.26 
au) and 6 (0.17 au). When the absorbance values were converted into concentration of protein, a 
protein concentration of 0.005 mg/ml was determined for P. aeruginosa at day 8 only, as all other 
concentrations were below the limit of detection of the standard curve.  
A minimal change in absorbance was noted over the first 8 days for S. aureus biofilms, with a 
significant (p ≤0.05) increase at day 9 (0.36 au) and 10 (0.47 au) (Figure 3.5) from day 7 (0.07 
au), where a slight increase in absorbance was noted. When the absorbance values were converted 
into protein content, values of 0.13 mg/ml and 0.28 mg/ml were only found at 9 and 10 days only. 























































































Period of Biofilm Growth (Days)
Figure 3.4: Protein assay using Bradford Reagent to quantify protein content of P. aeruginosa 
biofilm between 1 to 10 days (n=6 ± SE). 
Figure 3.5: Protein assay using Bradford reagent to quantify protein content of S. aureus biofilm 





Figure 3.6: Comparison of log (10) cfu/ml of S. aureus and P. aeruginosa biofilms formed on 
PC and SS coupons (n=6 ± SE)                     S. aureus                P. aeruginosa  
3.3.3 Biofilm Formation in the CDC Biofilm Reactor 
Stomaching removed 6.05 ± 0.03 log(10) and 6.12 ± 0.12 log(10) from S. aureus biofilms on PC and 
SS coupons respectively, and 6.56 ± 0.18 log(10) and 6.04 ± 0.10 log(10) from P. aeruginosa 
biofilms from PC and SS coupons respectively.  
Scraping removed 7.86 ± 0.19 and 7.85 ± 0.17 log (10) cfu/ml from P. aeruginosa biofilms on PC 
and SS coupons respectively, and 7.09 ± 0.05 and 7.06 ± 0.04 log (10) cfu/ml from S. aureus 
biofilms on PC and SS coupons respectively (Figure 3.6). There was no significant difference (p 
>0.05) between the quantity of biofilm formed on PC and SS coupons for S. aureus or P. 
aeruginosa, however P. aeruginosa did form the most biofilm on both surfaces in comparison to 
S. aureus.  
However, there was a difference of ~1 log(10) between the log (10) cfu/ml counts using scraping and 









































3.3.4 Depth and Topography of S. aureus and P. aeruginosa Biofilms 
SEM images obtained after growth of a biofilm on PC coupons (Figure 3.7) show S. aureus 
(Figure 3.7a) and P. aeruginosa (Figure 3.7b) embedded in a layer of EPS. Greater magnification 
shows the cocci cells of S. aureus agglomerated together (Figure 3.7a). In Figure 3.7b, a P. 
aeruginosa biofilm can be seen across the surface of the coupon. Figure 3.7e and 3.7f show the 
depth of S. aureus and P. aeruginosa biofilm respectively. S. aureus biofilm thickness ranged 
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Figure 3.7: SEM images showing the individual cells in the biofilm, EPS formation, 
topography and depth of 48 hour biofilms of P. aeruginosa and S. aureus formed in the 
CDC biofilm reactor on PC coupons; a) S. aureus biofilm, b) P. aeruginosa biofilm, c) S. 
aureus cells surrounded by EPS, d) P. aeruginosa cells surrounded by EPS, e) cross 












3.4 Discussion  
Hospital acquired infections cause high morbidity and mortality, and can be costly to treat. The 
presence of bacteria on inanimate surfaces in hospitals can encourage infections due to the 
transmission from the environment to immunocomprised patients (Hu et al., 2015). It is, therefore, 
important to use in vitro methods to study biofilms in depth in order to be able to understand their 
growth process, persistence in the environment and the prevention of infections. The high-
throughput biofilm screening MTP methods, and the low costs associated, facilitate the process 
of identifying genes that are crucial for production of surface-attached biomass in growth medium 
(Pitts et al., 2003). MTP based methods are also suitable for the mass screening of anti-biofilm 
compounds by quantifying the reduction in the surface attached biomass post treatment (Pitts et 
al., 2003; Jakobsen et al., 2012). Flow systems such as the CDC biofilm reactor mimic conditions 
that a biofilm would experience in nature such as shear forces and a renewable nutrients, therefore 
forming biofilms that are comparable to those found in the environment (Williams & Bloebaum, 
2010). In this study, two methods were used to quantify and compare biofilm formation in a 96 
well plate assay and the CDC biofilm reactor flow system.  
 
3.4.1 Biofilm Formation in 96 Well Plates 
When using the 96 well plate assay without the replenishment of nutrients, the wells were found 
to dry out, leaving a residue of broth and the cells. As a result, during the crystal violet assay, 
darker wells were seen for those that had dried out giving highly variable absorbance values. 
Biofilm growth for P. aeruginosa and S. aureus was assessed by replenishing nutrients at 5 and 
9 days as it was around those days that the wells were observed to dry out. The wells were also 
replenished daily to observe whether there was any difference in growth. Furthermore, for biofilm 
formation at day 1 and 2, no visible biofilm was seen whereas between day 3 and 10, a biofilm 
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was observed at the bottom and the walls of the wells. Often the crystal violet dye adhered to the 
dried NB in the wells, giving an absorbance reading is not representative of biofilm growth 
(Figure 3.2 and 3.3).   
Biofilm replenishment at 5 and 9 days (Figure 3.2) show that the greatest biofilm formation was 
at day 9 (1.57 au) and day 8 (3.26 au) for S. aureus and P. aeruginosa respectively. When 
replenished daily (Figure 3.3), the highest growth for S. aureus was again at day 9 (1.66 au), 
similar to the results in Figure 3.2, whereas the highest growth for P. aeruginosa was at day 3 
(2.04 au) and 9 (2.00 au) (Figure 3.3). Both Figure 3.2 and 3.3 are similar in that the biofilm 
formation was the highest at day 8/9 for P. aeruginosa and day 9 for S. aureus. The rise and fall 
in biofilm formation was initially thought to be a result of broth replenishment at 5 and 9 days 
(Figure 3.2). However, when the broth in the wells were replenished daily, a similar ‘up down’ 
pattern was observed (Figure 3.3). Due to the large SE obtained using the MTP method, 
conclusions about biofilm formation cannot be drawn without any further investigation.    
The protein assay was carried out in conjunction with biofilm formation in 96 well plates to 
measure secreted extracellular protein and cells that have lysed ‘naturally’ in the biofilm over the 
10 days of growth. For S. aureus biofilms, an increase in protein concentrations is only seen at 
day 9 (0.36 au) and 10 (0.47 au), whereas between days 1 to 8, the absorbance levels were found 
to be below 0.1 au (Figure 3.5). This correlates to the large absorbance values obtained at day 9 
(1.57, 1.66 au) and 10 (1.43, 1.19 au) for S. aureus biofilms when the broth was replenished at 5 
and 9 days and daily (Figure 3.2 and 3.3). A large absorbance is also seen for day 8 for S. aureus 
in Figure 3.2 (1.36 au) and 3.3 (1.30 au), however, a negative protein value was seen for day 8 
for S. aureus in Figure 3.5. A limitation of nutrients present in the wells could limit growth, thus 
the amount of protein produced. 
Previous studies have shown that when the 96 well plates were used to determine biofilm 
formation over time, the crystal violet assay was inappropriate for P. aeruginosa biofilm biomass 
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quantification as large standard deviations were seen between experiments and data (Peeters et 
al., 2008). Absorbance values reported for P. aeruginosa strains were much lower than that of the 
absorbance values obtained for the other species tested, even though a 0.5% crystal violet 
concentration were used throughout. This could be due to the inadequate fixing of P. aeruginosa 
biofilms due to the large quantities of water present in the slime layer of P. aeruginosa biofilms 
(Peeters et al., 2008). Similar findings were observed in the present research as large SE in biofilm 
formation of both organisms, particularly P. aeruginosa were also seen when the broth was 
replenished daily and at 5 and 9 days (Figure 3.2 and 3.3). The ability of S. aureus and P. 
aeruginosa to form exopolysaccharides may have also influenced the protein assay results, again 
large SE were observed, particularly in Figure 3.4. 
During initial biofilm growth, reversible attachment occurs, therefore washing wells with PBS or 
water could mean that cells are being washed out from the wells. For P. aeruginosa, absorbance 
for Bradford reagent increased overtime, with a drop at 3, 6 and 10 days (Figure 3.4). Biofilm 
growth varies over the 10 days of incubation that were studied therefore, it would be expected 
that changes in the presence of protein would also do so (Figure 3.2, 3.3, 3.4 and 3.5). Lutskiy et 
al. (2015) used a 96 well plate method to measure early stage of biofilm formation of Klebsiella 
oxytoca on reverse-osmosis (RO) and nanofiltration (NF) polyamide membranes under static 
conditions. The incubation period between 5 to 10 hours was critical for biofilm development as 
during this period, the growth accelerated the most, beyond this time period the biofilm growth 
resulted in a daily ‘up down’ pattern in the growth curve (Lutskiy et al., 2015), similar to the 
results obtained in Figure 3.3 and 3.4. Moreover, there is a possibility that after a certain time, 
possibly around day 9 and 10 (Figure 3.2 and 3.3), there was a limitation of nutrients within the 
biofilm due to an increase in cells; therefore, dispersion lowered the overall biofilm biomass, 
hence giving the irregular pattern observed in Figure 3.3 and 3.4.  
A study by Oja et al. (2014) monitored the biofilm development of S. aureus ATCC 25923, using 
a static method. Glass coupons were placed on agar covered with filter paper, and growth of 
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biofilms was monitored over 48 hours using the crystal violet assay and viable counts. In the first 
2 hours, no significant change in the viable counts occurred. However, there was a steady increase 
in the viable counts between 4 and 24 hours with values of 7.36 ± 0.03 log cfu/cm3 and 8.23 ± 
0.62 log cfu/cm3 respectively (Oja et al., 2014). Static biofilm formation methods are useful for 
analysis of established biofilms and monitoring the early stages of biofilm development, such as 
adhesion on different substrates (Oja et al., 2014). MTP based assays enable high throughput 
assays and multiplexing, meaning several organisms can be treated with several treatments 
simultaneously (Coenye & Nelis, 2010).  
 
3.4.2 CDC Biofilm Reactor 
P. aeruginosa and S. aureus formed biofilms of 7.86 and 7.09 log10 cfu/ml on PC coupons, and 
7.85 and 7.06 log10 cfu/ml on SS coupons respectively (Figure 3.6). There was no significant 
difference (p >0.05) found between the two surfaces for either microorganism with very low SE 
values of 0.12 and 0.11 for P. aeruginosa biofilms on PC coupons and SS coupons respectively 
and 0.03 and 0.02 for S. aureus biofilms for PC and SS coupons respectively. When compared to 
the data collected from the 96 well plates, the SE ranged from 0.05 to 0.51 and 0.34 to 0.62 for S. 
aureus and P. aeruginosa biofilms respectively during 5 and 9 day replenishment (Figure 3.2) 
and 0.07 to 0.33 and 0.18 to 0.19 for S. aureus and P. aeruginosa biofilms respectively for daily 
replenishment (Figure 3.3). Thus, the low SE and reproducibility of data indicates that the CDC 
biofilm reactor is a more reliable method of producing biofilms for quantification purposes.  
In the CDC biofilm reactor, biofilm formation on both PC and SS coupon surfaces were tested, 
whereas adhesion to polystyrene surfaces only could be tested in 96 well plates. An advantage of 
the CDC biofilm reactor is that biofilms can be formed on various surface materials in a coupon 
form. Materials such as SS are readily found in medical devices and healthcare associated 
environments, therefore, results from a CDC reactor would replicate hospital environments more 
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accurately (Liu & Zhao, 2005; Wilks et al., 2005). The use of crystal violet in the MTP assays for 
measuring absorbance only gives a semi-quantitative measure of the amount of biofilm formed. 
This absorbance gives no indication of the activity of the biofilm nor the bactericidal effects of 
the anti-biofilm agent, however, it assesses the destruction of the biofilm (Pitts et al., 2003).  
The production of a dense biofilm structure for P. aeruginosa and S. aureus biofilms when formed 
in a CDC biofilm reactor can be seen in Figure 3.7e and 3.7f. The EPS can be seen surrounding 
the embedded cells in Figure 3.7c and 3.7d.  The EPS forms a barrier around the cells that the 
antimicrobial has to overcome to be effective. The thickness and maturity of these biofilms poses 
a challenge to antimicrobials, it is, therefore, essential to ensure the antimicrobial penetrates the 
biofilm completely in order to exert its antimicrobial effect. Shen et al. (2011) suggested that the 
maturity of a biofilm and its age should be accounted for when comparing the antimicrobial 
efficacy of disinfectants. Multispecies biofilms from plaque bacteria increased in thickness from 
57 µm to 201 µm between 2 days to 12 weeks respectively (Shen et al., 2011). When exposed to 
1, 3 and 10 mins of 2% chlorhexidine, the proportion of non-viable cells was higher in the younger 
biofilms compared with mature biofilms, indicating that nutrient limited biofilms in their mature 
stages of growth have greater resistance against disinfectants (Shen et al., 2011). The depth of P. 
aeruginosa and S. aureus biofilms obtained in the SEM images (Figure 3.7e and f) were between 
18 to 19 µm and ~7 µm for S. aureus and P. aeruginosa biofilms respectively, therefore not as 
high as seen in the study by Shen et al. (2011). However, the biofilms in the CDC biofilm reactor 
were grown over 48 hours with plentiful nutrients. The morphology and structure between 
biofilms of 48 hours and 12 weeks with nutrient limited conditions are likely to differ greatly.  
Stimulating the same growth conditions for biofilms that the natural environment provides is 
complicated in a lab setting. The CDC biofilm reactor offers reliable, repetitive and realistic 
conditions for biofilms to develop, where they can express their natural phenotype (Williams & 
Bloebaum, 2010). The CDC biofilm reactor has been extensively used to form hydrated biofilms 
that are well adhered and statistically reproducible on 24 coupons (Goeres et al., 2005; Hadi et 
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al., 2010). Almatroudi et al. (2015) developed a method that was reproducible in producing 
dehydrated S. aureus biofilms, comparable to those formed on dry hospital clinical surfaces in 
ICUs for disinfectant testing. S. aureus ATCC 25923 biofilms grown on PC coupons in a CDC 
biofilm were dehydrated using alternating cycles of dehydration for 12 days. Multi-layered 
biofilms were surrounded by dense EPS containing 107 cfu/coupon. Biofilms formed in the CDC 
biofilm reactor were with 30.74 ± 2.1 µm thick whereas biofilms on clinical surfaces were 
between 24 and 47 µm. The coefficient of variation within each run was 9.5% and between each 
run was 10.1% suggesting that this model is appropriate to replicate clinical biofilms as well as 
being user friendly and cost effective (Almatroudi et al., 2015). The biofilms of S. aureus formed 
in vitro in this chapter ranged between 18 to 19 µm, which in comparison to the work by 
Almatroudi et al. (2015), is thinner.     
The in vitro method chosen to form biofilms can affect biofilm growth, and characteristics such 
as cell density of biofilm growth can vary depending on the chosen method. For these reasons, 
the results obtained from 96 well plates and CDC biofilm reactor are not directly comparable. The 
crystal violet assay was used to assess biofilms of P. putida KT2440 at various stages of growth 
in 96 well plates (Thuptimdang et al., 2015). Biofilm formation at 12 hours and 48 hours were 6 
and 5 times higher than the formation at 6 hours under static conditions. The CDC biofilm reactor 
was used to study the growth of P. putida KT2440 biofilms under dynamic conditions and the 
total carbohydrate content was measured. The biofilms at 30 hours and 48 hours were 2 and 3 
times greater respectively in comparison to 12 hours under dynamic conditions. This variation in 
growth could be due the different in vitro methods used to determine biofilm growth. The total 
carbohydrate assay solely measures the carbohydrate content in the EPS of the biofilm, as opposed 
to the crystal violet assay that measures the total biomass from the EPS, live and dead cells 
combined (Thuptimdang et al., 2015). S. epidermidis ATCC 12228 was unable to form biofilms 
in 96 well plate models using the crystal violet assay, whereas formed biofilms readily in flow 
cells (Dice et al., 2009). This illustrates that biofilm growth cannot be solely determined from 96 
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well plate methods as this is a less robust system in comparison to the CDC biofilm reactor. 
Similar observations were made during this study whereby when P. aeruginosa (7.86 and 7.85 
log(10) cfu/ml on PC and SS coupons respectively) and S. aureus (7.09 and 7.06 log(10) cfu/ml on 
PC and SS coupons respectively) biofilms were produced in the CDC biofilm reactor (Figure 3.6), 
analysis of biofilm topography and depth could be assessed (Figure 3.7e and f). 
 
3.4.3 Conclusion 
In conclusion, after the comparison of the 96 well plate and CDC biofilm reactor methods for 
biofilm formation, an understanding of the advantages and disadvantages of both methods has 
been obtained allowing for an informed approach to studying biofilms related to HCAIs. The 
crystal violet assay allows for high throughput screening thus being ideal for the initial screening 
of antimicrobials, although the semi-quantitative data produced only gives an indication of 
efficacy and can be highly variable thus not suitable for in depth analysis of antimicrobials effects 
against biofilms. However, the CDC biofilm reactor provides a quantitative method that can go 
further than the 96 well assays in replicating environmental conditions, the data generated is also 
reproducible with low SE. With the increasing resistance to antimicrobials, and the demand for 




















Chapter 4: Metals in a Suspension 
4.1 Introduction 
 
4.1.1 Metal and Metal Oxide NPs as Antimicrobials 
Multidrug resistant bacteria are a major concern in the healthcare arena due to infectious diseases 
commonly being the reason for mortality. This has arisen due to the broad use and misuse of 
antibacterial drugs (Chen et al., 2014). Furthermore, the environment serves as a reservoir for 
microorganisms, and although there are various disinfectants available on the market, they have 
moderate or insufficient disinfection capabilities (Pitten et al., 2003). The effective management 
of bacterial infections and the development of alternative means to tackle antibiotic and 
disinfectant resistance are vital to control and prevent persister cells residing in biofilms, the 
spread of HCAIs and cross-resistance (Simões et al., 2007).  
Alternative antimicrobial candidates that bacteria have limited resistance to include metal and 
metal oxide NPs, including Ag (Sotiriou & Pratsinis, 2010), Cu (Yoon et al., 2007), CuO (Ren et 
al., 2009), Cu2O (Ren et al., 2009) and ZnO (Liu et al., 2009). NPs are typically less than 100 nm 
in size; their small size and high surface to volume ratio allows for close interactions with the 
bacterial cell, increasing their efficacy as an antimicrobial (Allaker, 2010; Morones et al., 2005). 
Inorganic antimicrobial agents including metal and metal oxides are favourable for antimicrobial 






4.1.2 The Antimicrobial Efficacy of Metal/Metal Oxide NPs 
Over 90% of bacteria are known to live in biofilms (Toole et al., 2000), which enable them to 
reside on surfaces, and build protection mechanisms to prevent eradication by commercial 
antimicrobials and disinfectants at working concentrations. Yet, the majority of studies published 
on the antimicrobial efficacy of metal/metal oxide NPs are based on planktonic cells. In order to 
combat HCAIs, it is essential to assess new novel antimicrobials such as metal/metal oxide NPs 
against biofilms.  
Over the last few decades, with the aid of nanoscience and nanotechnology, metal and metal oxide 
NPs such as Ag, Cu and CuO NPs have been utilised for their antimicrobial properties 
(Pandiyarajan et al., 2013). The antimicrobial efficacy of Ag+ and Cu2+ ions have been extensively 
used for treatment of burn wounds, dental applications and catheters (Kim et al., 2007). CuO 
nanostructures are widely used due to their sensory (Umar et al., 2009), catalytic (Yang et al., 
2010), optical (Yu et al., 2004) and antimicrobial (Azam et al., 2012a) applications. 
S. aureus, K. pneumoniae (Hanh et al., 2016), E. coli and P. aeruginosa (Logeswari et al., 2015) 
are all examples of bacterial species that have shown susceptibility to Ag NPs. The antimicrobial 
properties of Ag+ ions and Ag based antimicrobial agents against various bacterial species make 
them ideal for use in the medical industry (Furno et al., 2004; Prakash et al., 2013). Ag is usually 
in the form of a nitrate when exhibiting an antimicrobial activity, however, when Ag NPs are 
used, there is an increase in surface area, resulting in greater antimicrobial activity (Ahmed et al., 
2015). Ag NPs are known to work on bacterial cells by causing cell lysis or growth prevention 
through many modes of action (Kim et al., 2007; Prabhu & Poulose, 2012). For instance, Ag can 
bind with thiol groups, inactivating enzymes (Feng et al., 2000; Chen & Schluesener, 2008). 
The antimicrobial effect of Ag NPs (concentrations ranging from 0.0976 to 100 µg/ml), Ag 
nanorods and Ag nanoplates against S. aureus ATCC 51153 and E. coli ATCC 35218 was 
investigated (Sadeghi et al., 2012). Ag nanoplates, Ag nanorods and Ag NPs exhibited growth 
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inhibition zones of 9 and 4 mm, 6 and 3 mm and 2 and 1 mm for S. aureus and E. coli respectively. 
Ag nanoplates had the largest surface area and greatest antimicrobial efficacy, highlighting the 
importance of surface area on antimicrobial activity. A 2 log(10) reduction was observed by 
Velázques-Velázquez et al. (2015) when commercial dressings containing 250 ppm of Ag NPs 
(9.3 ± 1.1 nm) were used against P. aeruginosa. Park et al. (2013) compared the antimicrobial 
efficacy of 10 mg/l Ag NPs and 1.0 mg/l Ag+ ions against biofilms of P. aeruginosa PA01. In two 
day old P. aeruginosa biofilms grown on glass coupons, the Ag+ ions resulted in more than a 2 
log(10) reduction after a 150 mins, whereas only a 0.3 log(10) reduction was observed with a 150 
min exposure to Ag NPs, suggesting the antimicrobial effect was predominantly due to Ag+ ions, 
possibly due to lower penetration of Ag NPs into the biofilm. An MIC of 12.5 µg/ml of spherical 
shaped Ag NPs against both P. aeruginosa and E. coli after 24 hours was reported by Mohan et 
al. (2014). Bae et al. (2010) and Choi and Hu et al. (2008) have shown that Ag NPs give higher 
toxicity to bacteria than Ag+ ions, contrasting with findings from Park et al. (2013), however, 
factors such as surface coatings (El Badawy et al., 2011), variation in particle sizes (Choi & Hu, 
2008) and ionic ratios (Bae et al., 2010) could have contributed.   
Lee et al. (2014a) studied the effect of ZnO NPs (<50 nm) against P. aeruginosa PA01, E. coli 
0157:H7 (ATCC 43895), MSSA (ATCC 6538) and MRSA (ATCC BAA-1707). P. aeruginosa 
biofilm growth was inhibited on a polystyrene surface at 1 mM by more than 95%. The reduction 
in optical density showed that biofilms of MSSA, MRSA and E. coli 0157:H7 were inhibited at 
5mM of ZnO NPs (Lee et al., 2014a). This correlates with findings by Ragupathi et al. (2011) 
where a 5 mM colloidal suspension of ZnO NPs with an average diameter of 12 nm showed a 
95% growth inhibition of a range of hospital and community acquired MRSA strains and MSSA. 
Jones et al. (2008) compared the effect of ZnO ultrafine powder (>1 µm), ZnO NP (mean particle 
size 8 nm) and ZnO nanopowder (mean particle size 50-70 nm) to test their antimicrobial activity 
against S. aureus RN6390. A ca 50% reduction in growth rates of S. aureus RN6390 was observed 
for ZnO ultrafine powder and ZnO nanopowder, which had larger particle sizes in comparison to 
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ZnO NPs. ZnO NPs showed a 99% growth reduction in a colloidal suspension at 2 mM, 
demonstrating that smaller particle sizes have an enhance antimicrobial effect. Emami-Karvani 
and Chehrazi (2012) reported the ZnO NPs MIC values of E. coli and S. aureus were 1 and 0.5 
mg/ml respectively. ZOI of 29 and 19 mm for S. aureus and E. coli were observed respectively 
for 10 mg/ml of ZnO NPs, suggesting the enhanced effectivity of ZnO NPs against Gram-positive 
bacteria.   
CuO NPs with a particle size ranging between 15-30 nm were assessed for their antimicrobial 
efficacy against vegetative cultures of P. aeruginosa BS3, Bacillus circulens BP2, E. coli and S. 
aureus at concentrations of 1, 2.5 and 4 mg/ml (Das et al., 2013). A concentration of 1 mg/ml and 
4 mg/ml showed inhibition of E. coli after 9 hours and 3 hours respectively. All concentrations 
tested against S. aureus showed inhibition at 6 hours, while Bacillus cereus was inhibited at all 
concentrations after 12 hours. Notably, a significant decrease of P. aeruginosa growth was shown 
after a 4 hour treatment with 4 mg/ml of CuO NPs (Das et al., 2013). Gram-negative bacteria 
have between 3-20 fold less negatively charged peptidoglycans, therefore are less susceptible to 
positively charged antimicrobials (Kawahara et al., 2000).  
Many studies have shown MIC concentrations of CuO NPs between a range of 31.25 to 120 µg/ml 
(Padil & Černík, 2013; Ahamed et al., 2014; Azam et al., 2012b). Azam et al. (2012b) and Padil 
and Černik (2013) determined the MIC of CuO NPs as 120 µg/ml and 103 µg/ml against S. aureus 
and E. coli respectively; Azam et al. (2012b) used particle sizes of 20 nm, whereas Padil and 
Černik (2013) used particle sizes of 4.8 nm. Ahamed et al. (2014) determined the MIC of CuO 
NPs (23 nm) as 31.25 µg/ml against E. coli, which is lower than the those found by Azam et al. 
(2012b) and Padil and Černik (2013). Smaller particle sizes have shown to have enhanced 
antimicrobial efficacy (Jones et al., 2008), however a lower MIC value was obtained by Ahamed 
et al. (2014), even though Azam et al. (2012b) and Padil and Černik (2013) used a larger CuO 
NP particle size. 
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4.1.3 Antimicrobial Action of Metals in Synergy 
Synergistic approaches are widely used when developing antimicrobials because they often have 
positive clinical implications and can lower the occurrence of resistance, especially with 
multidrug resistance being an ongoing problem (Cassone & Otvos, 2010; Anantharaman et al., 
2010; Sueke et al., 2010; Worthington & Melander, 2013). The combination of two antimicrobials 
are only effective if there are no antagonistic interactions present between components resulting 
in a reduced antimicrobial effect of one or both components in the presence of each other. 
Furthermore, additivity or synergy can lower the concentrations of toxic ions required to inhibit 
bacterial cells, thus reducing potential adverse side effects (Walkenhorst et al., 2014). Prior 
studies have reported the use of metals in combination with another antimicrobial such as Ag+ 
ions with Menthapiperita essential oil (Ahmad et al., 2014), Ag NPs with amoxicillin (Jyoti et 
al., 2015; Fayaz et al., 2010) or banana peel extract (Ibrahim, 2015), resulting in a greater 
inhibitory effect at lower concentrations than using the metal NPs alone. 
It is important to consider the impact of NPs on humans and the environment. For instance, the 
toxicity of Ag NPs has been investigated in humans and have shown to exhibit cytotoxic 
behaviour even in low concentrations, which can affect the physiology of eukaryotic cells, 
preventing replication as well as damaging the morphology of the structure, leading to the loss of 
vital cell functions (Arora et al., 2008; Shin et al., 2007). Furthermore, the impregnation of Ag 
NPs in clothes and washing systems can mean that the NPs can leach into the environment during 
washing, harming beneficial bacteria that are essential for the environment, and can endanger 
organisms in the lakes and streams (Impellitteri et al., 2009). When investigating the antimicrobial 
efficacy of metal NPs, it is vital to minimise the toxic effects of the metal NPs to humans and the 
environment by keeping the concentrations low, or considering synergism with other metal/metal 
oxide NPs. 
Jafari et al. (2011) studied the antibacterial efficacy of mono metallic nanocrystals Ag, ZnO and 
composite nanocrystals of Ag/ZnO in combination, with MICs for ZnO of 512, 256, 128 and 64 
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µg/ml for B. subtilis, S. aureus and P. aeruginosa, S. galinarium and E. coli respectively. The 
MIC for Ag NPs for S. aureus, E. coli, were 1024 and 2048 µg/ml respectively and >4096 µg/ml 
for S. galinarium, B. subtilis and P. aeruginosa. However, the MIC for Ag/ZnO NPs in a 
composite nanocrystal for S. galinarium, E. coli, P. aeruginosa, S. aureus and B. subtilis was 32, 
32, 64, 128 and 128 µg/ml respectively. Lower MICs were found by Egger et al. (2009) when a 
range of microorganisms including E. coli and S. aureus were tested for their susceptibility to Ag-
Si nanocomposites. MIC values ranging between 62.5 and 500 µg/ml (containing 12.5 to 100 
µg/ml of pure Ag) were obtained for Ag-Si nanocomposites. The MICs were higher when 
compared to AgNO3 and silver zeolite as they both dissolve readily, releasing Ag+ rapidly, 
therefore, the effect is instant but short lived. Ag+ in the nanocomposite is released slower, 
providing a sustained release (Egger et al., 2009; Kumar et al., 2005). Ag/silicon dioxide (SiO2) 
samples provided reductions of >5.06, >5.17 and >4.54 log(10) for E. coli, S. aureus and C. 
albicans respectively (Mukha et al., 2010). The efficacy of MgO and nisin (an antibacterial 
peptide) in synergy was observed by Jin and He (2011). In contrast, Vidic et al. (2013) reported 
that 80% of E. coli cells remained viable after a 24 hour treatment with ZnO-MgO in combination, 
showing inefficacy of synergy, whereas a complete inhibition of B. subtilis at 1 mg/ml was noted, 
suggesting a greater affinity of ZnMgO to Gram-positive cell walls. Ag-Au alloy NPs in 
combination with penicillin G and piperacillin against S. aureus gave an increase in ZOI surface 
area by 193.8% (Bahrami et al., 2014).   
 
4.1.4 Mechanisms of Action of Metal/Metal Oxide NPs 
Metal/metal oxide NP vary in the way they exert their antimicrobial effect such as ROS formation, 
oxidative stress, lipid peroxidation, damage to the cell wall, release of metal ion and particle-cell 
interactions (Djurišić et al., 2015). A proposed mechanism of action of Ag NPs (Ag0 metallic and 
Ag+ ions) against biofilms is via interference and/or regulation of exopolysaccharide. For instance, 
in P. aeruginosa, the exopolysaccharide production is controlled by a gene cluster of 15 genes 
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(Matsukawa & Greenberg, 2004), and the inhibition of proteins via Ag NPs hinder 
exopolysaccharide synthesis. Ionisation of Ag NPs to form Ag+ ions interact with the protein and 
enzyme thiol groups (i.e. cysteine) of the bacteria increasing cell damage (Velázquez-Velázquez 
et al., 2015). Ag NPs have a greater capability than elemental Ag for attaching or penetrating into 
bacterial membranes, and therefore accumulate inside bacterial cells enabling a sustained release 
of Ag+ ions within the cell (Ansari et al., 2013, Ansari et al., 2014b; Rai et al., 2009). Ag NPs are 
also thought to hinder the QS process through gene activation/inactivation, preventing the QS 
system working efficiently and reducing biofilm (Majik & Parvatkar, 2014). The resistance of Ag 
NPs to mature biofilms can be due to various factors. Firstly, bacterial cells in mature biofilms 
are usually in the stationary phase and are likely to be less susceptible to antimicrobial agents 
(Anderl et al., 2003). Secondly, dead cells in the outer layers of the mature biofilms can act as a 
source of nutrients to encourage growth in the deeper layers of the biofilm (Ito et al., 2009).  
Cell membrane disruption by CuO causes cell enzyme malfunction, as they are able to pass 
through the cell membranes of bacteria directly (Ren et al., 2009). The Cu2+ ions released can 
bind with bacterial DNA, resulting in damage to its helical structure by initiating cross linking 
among the nucleic acid strands, hindering replication (Pandiyarajan et al., 2013). Additionally, 
Cu2+ ions released from the NPs can attach to the negatively charged cell wall of the bacteria, 
causing rupturing, inducing protein denaturation and cell death (Sondi & Salopek-Sondi, 2004).  
Zn2+ is an crucial trace element required for bacterial growth (Gielda & DiRita, 2012), yet higher 
concentrations of Zn2+ can exhibit toxicity against bacterial cells (Jones et al., 2008). ZnO as an 
antimicrobial is known to inhibit the attachment and viability of microorganisms on nosocomial 
surfaces (Yamamoto et al., 2001; Brayner et al., 2006). The release of Zn2+ from ZnO NPs and 
the generation of ROS results in inhibition of  bacterial species (Sirelkhatim et al., 2015) such as 
S. aureus, E. coli and L. monocytogenes at concentrations between 5 and 8 mM of ZnO 
(Firouzabadi et al., 2014). However, Premanathan et al. (2011) reported MICs for ZnO of 500, 
500 and 125 µg/ml for E. coli, P. aeruginosa and S. aureus respectively. Various mechanisms of 
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action of ZnO have been proposed. For instance, ZnO NPs are able to interact with membrane 
lipids, hindering the structure of the membrane, reducing membrane integrity, causing 
malfunction and eventually bacterial cell death (Krishnamoorthy et al., 2012; Zhang et al., 2007). 
ZnO also has the ability to penetrate inside the bacteria at a nanoscale level leading to the 
formation of toxic oxygen radicals, causing DNA, cell membrane or cell protein damage and 
ultimately bacterial growth inhibition and cell death (Applerot et al., 2009; Irzh et al., 2010; 
Makhluf et al., 2005; Zhang et al., 2007). 
 
4.1.5 Conclusion 
As a result of the ever-increasing issue of resistance to disinfectant and antimicrobials, there is a 
constant need for novel antimicrobials. Many studies have focussed on the efficacy of metal/ 
metal oxide NPs on vegetative cells and have shown significant reductions as described above. 
With the lack of knowledge in the differences in disinfectant efficacy between planktonic and 
sessile cells, and their phenotypic variation, this is an area that needs further investigation. 
Antimicrobials that are effective against planktonic cultures will not necessarily have the same 
efficacy on biofilms. Currently, there are no European standards in place for the efficacy of 
biocides on biofilms comprised of Gram-negative organisms (Perumal et al., 2014). BS EN 
13697:2001 is the European Standard for chemical disinfectants and antiseptics that disinfection 
products need to comply to (British Standards Institute, 2001), however this mainly focusses on 
vegetative cells. Future standards need to clarify the efficacy of disinfectants on biofilms, to 
ensure their efficacy in a laboratory is comparable to a clinical setting (Lindsay & von Holy, 
2006). The promising antimicrobial efficacy of metal/metal oxide NPs against a wide variety of 
bacterial species maybe a potential solution to the issue of antimicrobial resistance in biofilms.    
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4.1.6 Aims and Objectives 
 
Aim: 
The aim of this investigation was to establish the antimicrobial properties of Ag, CuO and ZnO 




 To determine the MBRC of Ag, ZnO and CuO against P. aeruginosa and S. aureus 
biofilms. 
 To investigate possible synergistic relationships between metal and metal oxide NPs 
against P. aeruginosa and S. aureus biofilms using the checkerboard method. 
 To assess the effects of metal and metal oxide NPs on P. aeruginosa and S. aureus 







4.2.1 Particle Size Distribution 
Ag nanopowder <100 nm particle size (576832), ZnO nanopowder <50nm particle size 
(677450) and CuO nanopowder (copper (ii) oxide) <50 nm (544868) were all purchased from 
Sigma Aldrich (Dorset, UK).   
The distribution of particle size of Ag NPs and ZnO NPs within the batch was measured using 
zeta sizer (Nanobrook Omni Zeta Sizer, New York, USA). Aliquots of 2 ml of 1 mM potassium 
nitrate (KNO3) was used to dissolve ~1mg of Ag or ZnO NP sample and left to stand for 15 mins 
before the particle size distribution was measured in the zeta sizer at 659 nm.  
 
4.2.2 Neutralisation of Metal/Metal Oxide NPs 
4.2.2.1 Neutraliser Content 
One gram of sodium thioglycollate (S/7140, FSA Laboratories) and 1.46g of sodium thiosulphate 
(S/7420, FSA Laboratories) was added to one litre of distilled water. All neutraliser tests were 
based on BS EN 1276:2009 (E).  
 
4.2.2.2 Neutraliser Toxicity  
A bacterial count of 103 cfu/ml of either P. aeruginosa or S. aureus was prepared from a 24 hour 
culture. A solution of 8 ml of neutraliser, 1 ml of sterile water and 1 ml of bacterial suspension 
was left to stand for 5 mins ± 10 seconds at 20°C ± 1°C. The suspension was then vortexed and 
0.1 ml was spread plated onto NA and incubated at 37°C for 24 hours. The neutraliser was deemed 
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as non-toxic if the log(10) cfu/ml was identical to the log(10) cfu/ml with the samples that were not 
exposed to the neutraliser.  
 
4.2.2.3 Neutraliser Method Validation 
A bacterial count of between 102 cfu/ml and 103 cfu/ml of either P. aeruginosa NCTC 6749 or S. 
aureus ATCC 6538 was prepared from a 24 hour culture. A volume of 2 ml of the highest 
concentration of each of the three metal and metal oxide NP suspensions were added to 1 ml of 
sterile water and 8 ml of neutraliser and left to stand for 5 mins ± 10 seconds at 20°C ± 1°C. After 
5 mins, 1.0 ml of the previously prepared inoculum was added to the tube and left to stand for 30 
mins ± 1 min at 20°C ± 1°C. Aliquots of 0.1 ml of the sample was plated and incubated at 37°C 
± 2°C for 24 hours and then enumerated. Validity of the neutraliser was based on whether the 
log(10) cfu/ml were similar to those of non-neutralised samples post treatment with metal or metal 
oxide NP suspensions.  
 
4.2.3 Culture Methods and Microorganisms 
The test organisms used were P. aeruginosa NCTC 6749 and S. aureus ATCC 6538. All culture 
media was acquired from Oxoid Ltd. unless otherwise stated. Clinical strains of MRSA NCTC 
12497 and P. aeruginosa MG756624Z were obtained from a skin lesion and a sputum sample 
from a cystic fibrosis patient respectively. 
Strains were stored on beads at -80°C. Cetrimide agar for P. aeruginosa and Mannitol salt agar 
for S. aureus was used to phenotypically determine the organisms.    
Organisms were grown on NA and then 1 colony per 10 ml of NB was grown aerobically for 24 
hours at 37 °C. NA was used to culture the bacteria for viable count enumeration. 
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4.2.4 Determination of MBRC Using 96 well Plates 
A 24 hour culture of P. aeruginosa or S. aureus in NB was prepared and placed in a rotating 
incubator at 100 rpm at 37°C. Aliquots of 200 μl of culture was then transferred into 96 well 
plates and incubated in rotating incubator at 37°C for 9 days for S. aureus and P. aeruginosa. The 
wells were replenished daily with 200 μl of broth. The plates were washed twice with PBS to 
remove any planktonic bacteria. The metal/metal oxide NP suspensions at doubling 
concentrations of metal and metal oxide NP suspension; Ag from 3 to 6400 µg/ml, ZnO; 1 to 
1,024 µg/ml and CuO; 20 to 10,000 µg/ml were sonicated for 10 mins. Aliquots of 200 µl of each 
suspension was added to the wells and placed in the rotating incubator for 24 hours at 100 rpm at 
room temperature. A crystal violet assay was carried out as per Method 3.2.2 and the absorbance 
was read at 595 nm. 
 
4.2.5 MBRC Determination Using a CDC Biofilm Reactor 
P. aeruginosa or S. aureus biofilms were grown according to Method 3.2.3.1 and 3.2.3.2 using 
PC coupons only. 
 
4.2.5.1 Sampling 
PC coupons were removed from the CDC biofilm reactor and placed in 2 ml of doubling 
concentrations of metal and metal oxide NP suspension as stated in Method 4.2.4 and placed in a 
rotating incubator for 24 hours at 100 rpm at room temperature. Metal and metal oxide NP 
suspensions were sonicated for 10 mins prior to usage. Coupons in sterile water were used as 
controls. The coupons were then placed in 8 ml of neutraliser at 20°C for 5 mins. The samples 
were enumerated as per Method 3.2.3.3, spread plated, incubated at 37°C for 24 hours. The 
MBRC was termed as the lowest concentration of metal and metal oxide NP suspensions required 
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to provide a ≥3 log(10) reduction (Dosunmu et al., 2015; Gomes et al., 2012). The correlation 
between metal and metal oxide NP concentrations for Ag, CuO and ZnO up to and including the 
MBRC was plotted against the log(10) cfu/ml and the R2 (correlation coefficient) was determined.  
 
4.2.6 Metal and Metal Oxide Combination Treatment in a CDC Biofilm Reactor 
PC coupons were removed from the CDC biofilm reactor and placed in 2 ml of the following 
concentrations of metal and metal oxide NP suspension combinations of ZnO and Ag 
respectively: 8 and 12 µg/ml, 8 and 25 µg/ml, 8 and 50 µg/ml, 8 and 100 µg/ml, 16 and 12 µg/ml, 
16 and 25, 16 and 50 µg/ml, 16 and 100 µg/ml, 32 and 12 µg/ml, 32 and 25 µg/ml, 32 and 50 
µg/ml, 32 and 100 µg/ml, 64 and 12 µg/ml, 64 and 25 µg/ml, 64 and 50 µg/ml, 64 and 100 µg/ml. 
Metal and metal oxide NP suspensions were sonicated for 10 mins prior to usage. The samples 
were placed in a rotating incubator for 24 hours at 100 rpm (room temperature) and coupons were 
then placed in 8ml of neutraliser at 20°C for 5 mins. The biofilm was enumerated as per Method 
3.2.3.3, spread plated and incubated at 37°C. Coupons in sterile water were used for the controls. 
The factorial inhibitory concentration (FIC) was then calculated. The FIC was calculated using 
the following equation:  
ΣFIC = FICZnO + FICAg = (CZnO/MICZnO) + (CAg/MICAg) 
where MICZnO and MICAg are the MICs of ZnO and Ag alone, and CZnO and CAg are the 
concentrations of Ag and ZnO in combination.  
An FIC value of ≤0.5 = synergy, >0.5 to ≤1.0 = additivity, >1 to ≤4.0 = indifference and >4.0 = 
antagonistic. The most effective combination of ZnO/Ag NP suspensions was tested against a 




4.2.7 Polymicrobial Biofilms in a CDC Biofilm Reactor 
Biofilms were formed in the CDC biofilm reactor as per Method 3.2.3.1 and 3.2.3.2 however; the 
reactor was inoculated with 1 ml of overnight culture of P. aeruginosa and a 1 ml of overnight 
culture of S. aureus simultaneously. Metal and metal oxide NP suspensions were sonicated for 10 
mins prior to usage. Coupons in sterile water were used as a control. The coupons were then 
placed in a suspension of 32/25 µg/ml of ZnO/Ag suspension for 24 hours in a rotating incubator 
at 100 rpm (room temperature) and then enumerated as per Method 3.2.3.3. 
 
4.2.8 Time Point Analysis in a CDC Biofilm Reactor 
Biofilms of P. aeruginosa and S. aureus were grown on PC coupons in the CDC biofilm reactor 
as per Method 3.2.3.1 and 3.2.3.2. Metal and metal oxide NP suspensions were sonicated for 10 
mins. The coupons were individually placed in 2 ml of 8/12 µg/ml of ZnO/Ag suspensions for S. 
aureus biofilms and 32/25 µg/ml of ZnO/Ag suspensions for P. aeruginosa biofilms in a rotating 
incubator at 100 rpm (room temperature) for 24 hours. Coupons in sterile water were used for the 
controls. The coupons were removed from the metal and metal oxide NP suspensions at 1, 2, 4, 
6, 8 and 24 hours, neutralised as per Method 4.2.5.1, enumerated as per Method 3.2.3.3, spread 
plated and incubated at 37°C for 24 hours.   
 
4.2.9 AAS 
Universals containing 10ml of all combination suspensions of ZnO/Ag: 8/12, 8/25, 8/50, 8/100, 
16/12, 16/25, 16/50, 16/100, 32/12, 35/25, 32/50, 32/100, 64/12, 64/25, 64/50 and 64/100 µg/ml 
and individual suspension of Ag: 12, 25, 50 and 100 µg/ml and ZnO: 8, 16, 32 and 64 µg/ml were 
placed in a rotating incubator at room temperature for 24 hours at 100 rpm. The metal and metal 
oxide NP suspensions were pelleted by centrifugation at 4000 rpm for 1 hour and the supernatant 
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was used to measure the concentration of ions present using Atomic Absorption Spectroscopy 
(AAS) (PerkinElmer, AA2DD, Beaconsfield, UK) with a hollow cathode Ag and Zn lamp. The 
concentration of Ag+ ions was determined using a standard curve. 
 
4.2.10 SEM and EDX 
Biofilms of P. aeruginosa and S. aureus were grown on PC coupons in the biofilm reactor as per 
Method 3.2.3.1 and 3.2.3.2. Metal and metal oxide NP suspensions were sonicated for 10 mins 
prior to usage. P. aeruginosa biofilms were treated for 24 hours in 2 ml of 32/25 µg/ml ZnO/Ag 
NP suspensions and S. aureus biofilms were treated with 2 ml of 8/12 µg/ml of ZnO/Ag NP 
suspensions. PC coupons in sterile water was used for the controls. PC coupons were washed with 
PBS and fixed with 95% ethanol for 10 mins at room temperature. PC coupons were then mounted 
onto aluminium stubs and coated with 15 nm of gold in a gold coater (Quorum Q150 RS, East 
Sussex, UK), ready for imaging. Biofilms were visualised using SEM (Evo HD15 Carlzeiss, Jena, 




Biofilms of P. aeruginosa and S. aureus were grown in the CDC biofilm reactor on PC coupons 
as per Method 3.2.3.1 and 3.2.3.2. P. aeruginosa biofilms were treated with 32/25 µg/ml of 
ZnO/Ag suspensions whereas S. aureus biofilms were treated with 8/12 µg/ml of ZnO/Ag 
suspensions for 24 hours. Coupons in sterile water were used as controls. After 24 hours, the 
coupons were washed and placed in a 24 well plate with 2 ml of PBS, enough to cover the surface 
of the coupon. The coupons were then stained with 6 µl of a 1:1 ratio of SYTO® 9 and propidium 
iodide mixture (Live/dead® BacLight™ Bacterial Viability Kit, Life Technologies, Oregon, 
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USA) and incubated at room temperature in the dark for 15 mins. After incubation, the coupons 
were removed from the plate and placed in a new 24 well µ-plate (Ibidi, Martinsried, Germany) 
alongside 50 µl of the solution from the previous plate to keep the coupon moist. The propidium 
iodide and SYTO 9 was excited at 476 and 488 nm respectively, between the green emission 
(500-530 nm) and red emission (600-709 nm). The intact biofilms were observed using the Leica 
DMIRE2 (Wetzler, Germany) confocal microscope using the oil immersion lens. The Leica 
Microsystems Confocal Software V 2.61 Build 1537 was used to analyse the images.  
 
4.2.12 Statistical Analysis 
Assumption of normality was tested using Kolmogorov-Smirnov test if sample sizes were ≥50 or 
Shapiro-Wilcox test if samples were <50. For non-parametric data, the Kruskal Wallis test was 
used and well as the Mann-Whitney U test. Significance was set at p ≤0.05. 


















































4.3.1 Particle Size Distribution 
The particle size distribution curves showed that the ZnO particle sizes are between 45 to 60 nm 















Figure 4.1: Particle size distribution of a) ZnO NPs and b) Ag NPs. 
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4.3.2 MBRC and R2 Correlations  
Initially, 96 well plates were used to screen metal/metal oxide NP suspensions individually in the 
concentrations stated in Method 4.2.4. However, due to the large variation in SE, for example 
0.22, 0.43 and 0.27 for CuO NPs (20 µg/ml), Ag NPs (3 µg/ml) and ZnO NPs (1 µg/ml) 
respectively for P. aeruginosa (data not shown), and the absorbance (data not shown), the data 
was disregarded. The agglomeration of Ag NPs in the suspensions left a residue even after 
washing the wells with PBS, which was hard to eliminate without hindering the actual biofilm 
formed. The irregularity in the data is consistent with the data obtained in Chapter 3. Henceforth, 
only the CDC biofilm reactor was used to determine the MBRC. MBRC was termed as the lowest 
concentration of metal and metal oxide NP suspensions required to provide a ≥3 log(10) reduction 
(Dosunmu et al., 2015; Gomes et al., 2012) (Table 4.1).  
A threshold of  ≥3 log(10) reduction was set in order to consider a metal/metal oxide NP suspension 
as having the potential for development as an antimicrobial. The lowest MBRC required to treat 
S. aureus biofilms was 16 µg/ml of ZnO NPs with a significant reduction (p ≤0.05) from that of 
the controls of 3.61 log(10). For P. aeruginosa, the MBRC was 50 µg/ml of Ag with a significant 
reduction (p ≤0.05) from that of the controls of 3.42 log(10). CuO NPs showed a higher MBRC of 
160 µg/ml for S. aureus in comparison to the MBRCs observed for ZnO and Ag (Table 4.1). An 
MBRC of 200 µg/ml of CuO NPs for P. aeruginosa biofilms was observed, and a lower R2 value 
(0.85) in comparison to ZnO and Ag, therefore, CuO NPs were not taken forward for further 
investigations. Untreated control PC coupons formed biofilms of 8.16  0.02 log(10) and 7.38  
0.01 log(10) for P. aeruginosa and S. aureus respectively (Table 4.1). The R2 value was determined 
by plotting the log(10)cfu/ml against a range of concentrations up to the MBRC and assessing the 
correlation between the two. The R2 values show the strength of the relationship between the 
log(10) cfu/ml and the concentration of the metal/metal oxide NPs. For P. aeruginosa, the highest 
R2 value was observed for ZnO (0.99) and Ag (0.96). For S. aureus, CuO (0.97) and ZnO (0.95) 
showed the highest R2 values (Table 4.1, Figure 4.2 and 4.3). 
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Table 4.1: The MBRC values for metal/metal oxide NPs against P. aeruginosa and S. aureus 





























ZnO 256 0.99 3.52 ± 0.03 16 0.95 3.61 ± 0.02 
Ag 50 0.96 3.42 ± 0.02 50 0.80 3.65 ± 0.02 












































































































































































4.3.3 Fractional Inhibitory Concentration (FIC) and Combination of Ag and ZnO NP 
Suspensions 
A combination of metal and metal oxide NP suspension was deemed effective if there was a ≥3 
log(10) (99.9 %) reduction in the cfu/ml in comparison to untreated samples. A concentration of 
32/25 μg/ml of ZnO/Ag NP suspension respectively was the selected concentration to treat a 
biofilm of P. aeruginosa. This was the lowest concentration of ZnO and Ag NP combinations 
required to exhibit an antibacterial effect, giving a ≥3 log(10) (3.77 log(10)) reduction (p ≤0.05), 
with an additive effect (Table 4.2a), compared with a ZnO (256 µg/ml) and Ag (50 µg/ml) NP 
suspension when used alone (Table 4.1). For S. aureus, 8/12 μg/ml of ZnO/Ag NP suspension 
was the combination with the lowest concentration of ZnO and Ag NPs suspensions required to 
give a ≥3 log(10) (3.91 log(10)) reduction (p ≤0.05) and an additive effect (Table 4.2b), compared 
with a ZnO (16 µg/ml) and Ag (50 µg/ml) NP suspension when used alone (Table 4.1). Although 
an additive effect was seen for combinations of 32/25 μg/ml against P. aeruginosa and 8/12 μg/ml 
against S. aureus of ZnO/Ag NP suspensions, reductions in biofilms counts were still above the 
3 log(10) threshold. Both combinations gave a significant (p ≤0.05) reduction for S. aureus and P. 
aeruginosa biofilms.   
Combinations of 8/12 µg/ml and 32/25 µg/ml of ZnO/Ag NP suspensions were also effective 
against clinical strains of MRSA and P. aeruginosa giving a significant (p≤0.05) reduction of 
approximately 4 log(10) (99.99%) (Table 4.3) compared with the controls of 8.42 log(10) and 8.43 
log(10) for S. aureus and P. aeruginosa respectively. When a polymicrobial biofilm of P. 
aeruginosa and S. aureus was treated with 32/25 µg/ml of ZnO/Ag suspensions, a log(10) reduction 





Table 4.2: Checkerboard showing the FIC relationship and the log(10) reduction for concentrations 
of ZnO and Ag in combination that were effective in inhibiting a) P. aeruginosa (8.36 log(10)) and 
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Table 4.3: MBRC and log(10) reductions of P. aeruginosa type and clinical strains and S. aureus 
type and clinical strains (n=6 ± SE). 
 
Organism MBRC of ZnO/Ag 
NP suspension 
(µg/ml) 
Control (log(10)) Reduction (log(10)) 
P. aeruginosa NCTC 6749 35/25 8.36 3.77 ± 0.01 
P. aeruginosa (clinical isolate) 32/25 8.43 3.69 ± 0.02 
S. aureus ATCC 6538 8/12 7.43 3.91 ± 0.01 














4.3.4 Time Point Assay 
 
The results in Table 4.4 shows that a 24 hour treatment is required to achieve a ≥3 log(10) reduction, 
before this time point, there is limited reductions in the biofilms. There is a significant difference 
in biofilm between 1– 8 and 24 hours for P. aeruginosa and S. aureus (p ≤0.05). 
 
Table 4.4: A 24 hour time point assay for the treatment of P. aeruginosa (8.27 log(10)) and S. aureus 
(7.43 ± 0.02 log(10)) biofilms with 32/25 µg/ml and 8/12 µg/ml of ZnO/Ag suspensions respectively 
(n=6 ± SE). 
 




1 0.08 ± 0.01 0.05± 0.01 
2 0.13 ± 0.01 0.05 ± 0.01 
4 0.15 ± 0.01 0.12 ± 0.01 
6 0.20 ± 0.01 0.15 ± 0.01 
8 0.18 ± 0.01 0.15 ± 0.01 








4.3.5 AAS for Ion Release from Metal and Metal Oxide NP Suspensions. 
 
Table 4.5 shows that levels of ZnO above ≥32 µg/ml with low levels of Ag ≤16 µg/ml, or high 
levels of Ag ≥50 µg/ml with low levels of ZnO ≤16 µg/ml, result in the quenching of Zn2+ ions. 
For example, at individual concentrations of 8 and 50 µg/ml for ZnO and Ag NP suspensions 
respectively, there are 1.98 and 0.71 mg/l of ions present respectively, however, when there is a 
ZnO/Ag NP combination suspension of 8/50 µg/mL, there are 1.30 and 0.45 mg/l of Zn2+ and 
Ag+ ions respectively. For concentrations of 64/100 µg/ml and 64/50 µg/ml of ZnO/Ag NPs 



























Ag+ (mg/l) Zn2+ (mg/l) 
Ag+ in ZnO/Ag 
suspension 
(mg/l) 
Zn2+ in ZnO/Ag 
suspension  (mg/l) 
Relationship between Ag+ 
and Zn2+ 
12 8 0.18 1.98 1.61 2.51 Increase in Ag+/Zn2+ 
12 16 0.18 2.97 0.89 2.91 Increase in Ag
+ 
12 32 0.18 3.58 0.35 0.93 Ag
+ quenches Zn2+ 
12 64 0.18 4.18 0.59 2.24 Ag
+ quenches Zn2+ 
25 8 0.39 1.98 0.68 1.12 Ag
+ quenches Zn2+ 
25 16 0.39 2.97 0.26 3.47 No difference 
25 32 0.39 3.58 0.50 4.67 Increase in Zn2+ 
25 64 0.39 4.18 0.43 2.28 Ag
+ quenches Zn2+ 
50 8 0.71 1.98 0.45 1.30 Ag
+ quenches Zn2+ 
50 16 0.71 2.97 0.91 3.14 No difference 
50 32 0.71 3.58 0.76 2.75 Ag
+ quenches Zn2+ 
50 64 0.71 4.18 0.66 2.68 Ag+ quenches Zn2+ 
100 8 1.35 1.98 0.89 0.85 Ag+/Zn2+ quench each other 
100 16 1.35 2.97 1.87 3.22 No difference 
100 32 1.35 3.58 1.98 1.66 Ag
+ quenches Zn2+ 
100 64 1.35 4.18 0.72 3.13 Ag




4.3.6 SEM and EDX Imaging 
Untreated S. aureus biofilms show island like biofilm clusters with distinct cocci cells (Figure 
4.4a). Similarly, the untreated P. aeruginosa biofilms are uniform across the surface and distinct 
rod shaped cells can be observed (Figure 4.4b). Whereas, the treated biofilms of P. aeruginosa 
and S. aureus show clear fragmentation and cells appear to have disintegrated (Figure 4.4c and 
4.4d). EDX images show the presence of Ag and ZnO in the treated S. aureus and P. aeruginosa 
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 Figure 4.4: SEM/EDX images showing S. aureus and P. aeruginosa 24 hour biofilms on PC 
coupons formed in the CDC biofilm reactor treated with ZnO/Ag NP suspensions; a) Untreated S. 
aureus biofilm, b) Untreated P. aeruginosa biofilm, c) S. aureus biofilm treated with 8/12 µg/ml of 
ZnO/Ag NPs, d) P. aeruginosa biofilm treated with 32/25 µg/ml of ZnO/Ag NPs, e) EDX image 
showing the presence of Ag in the S. aureus biofilm, f) EDX image showing the presence of Ag in 
the P. aeruginosa biofilm, g) EDX image showing the presence of Zn in the S. aureus biofilm and 




Figure 4.5 shows the top, middle and bottom portions of S. aureus and P. aeruginosa biofilms 
after treatment with 8/12 g/ml and 32/25 g/ml of ZnO/Ag NPs suspension respectively. Dead 
(red) portions of biofilms for both organisms were observed throughout the biofilms, suggesting 
that ZnO/Ag NP suspensions have penetrated the depth of the biofilm (Figure 4.5a, b, c, d, e and 
f). In contrast, the untreated biofilms are predominantly live (green) with a denser distribution of 





































S. aureus   P. aeruginosa 
Figure 4.5: Live/dead assays of the top, middle and bottom layers of S. aureus and P. 





Antimicrobials used in clinical settings do not always adequately remove biofilms due to the 
inefficacy of stated disinfectant concentrations by manufacturers and incorrect contact times, thus 
highlighting the antimicrobial resistance of biofilms (Rutala & Weber, 2016; Wong et al., 2010). 
The growth of HCAI organisms growing on surfaces in a biofilm form poses problems within the 
healthcare arena due to cells within a biofilm being more virulent (Wand et al., 2012; Naves et 
al., 2008), thus having greater resistance to disinfectants.  
Nanomaterials such as metal/metal oxide NPs may be a substitute to conventional antimicrobials 
as they can impregnate bacterial cells and ion release from NPs which can hinder metabolic 
processes and damage the cell (Seil & Webster, 2012; Hsueh et al., 2015). Moreover, their high 
surface area to volume ratio owing to their small size enables higher reactivity and strong particle-
cell interactions with biological entities, which is otherwise not observed in the bulk form for 
same material (Jo et al., 2015).    
 
4.4.1 Treatment of S. aureus and P. aeruginosa Biofilms With Metal and Metal Oxide NP 
Suspensions 
In this study, a novel three step approach was used to determine the appropriate metal/metal oxide 
NPs and concentrations required to inhibit biofilms in order to start developing a metal/metal 
oxide NP based antimicrobial, using the MBRC (screening individual metal/metal oxide NPs 
using the CDC Biofilm Reactor, Table 4.1), R2 values (Figure 4.2 and 4.3) and MBRC (log(10) 
reductions of combinations of metal/metal oxide NPs using a CDC biofilm reactor) (Table 4.2a 
and b). The majority of other studies reported in the published literature rely only on viable counts 
(Bailón-Sánchez et al., 2014; Gupta et al., 2013) or absorbance values (Kovaleva et al., 2010; 
Moreno et al., 2015). These studies generally are only related to vegetative cells, however, due to 
the complex nature of a biofilm community, relying on just one method to determine the 
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appropriate antimicrobial concentration for use against biofilms may not be sufficient, an example 
of this is the large SE associated with the 96 well plate method. There was considerable variation 
in the data when using the 96 well plate method, making it only suitable for mass screening of 
metals/metal oxide NPs and giving an indication of the MBRCs had it have been successful, 
therefore one approach of screening for biofilms is not appropriate. Consequently, using a 
combination of data and methods to determine not only the concentration at which a biofilm is 
reduced with individual metal/metal oxide NPs, but also in combination, whilst also taking into 
consideration the R2 value, allows for a predictable inhibitory behaviour of the metals and 
demonstrates the closeness of the values to the line of best fit, describing a linear relationship of 
the inhibitory effect of the metal concentrations below that of the MBRC (Figure 4.2 and 4.3). 
Sessile cells are surrounded by EPS, and persister cells embedded within the biofilm make 
biofilms more tolerant to antimicrobials in comparison to their planktonic counterparts (Yang et 
al., 2015; Spoering & Lewis, 2001), whereas planktonic cells are unbound, having greater 
interactions with disinfectants. Therefore, it is often difficult to compare inhibitory concentrations 
of vegetative cells with biofilm cells. When developing an antimicrobial or disinfectant, a precise 
dose would be mandatory. R2 value further reinforces the strength the relationship between the 
log(10) cfu/ml and the concentrations of NPs. A greater R2 value suggests a strong linear 
relationship. 
After taking into consideration the R2 value and the log(10) reductions, the selected metals for both 
organisms were Ag and ZnO (Table 4.1). Ag and ZnO NPs were chosen for assessment of efficacy 
in combination due to the low MBRC of ZnO (16 µg/ml) and linear R2 value (0.95) (Figure 4.3a), 
giving a reduction of 3.61 log(10) for S. aureus biofilms (Table 4.1). Similarly, a linear R2 value 
was observed for ZnO for P. aeruginosa (0.99) (Figure 4.2a) with an MBRC of 256 µg/ml and a 
reduction of 3.52 log(10) (Table 4.1), compared to a slightly lower MBRC of CuO (200 µg/ml) but 
a lower, more unstable R2 value of 0.85 (Table 4.1). Ag NPs were chosen due to the low MBRC 
of 50 µg/ml (Table 4.1) and stable R2 value against P. aeruginosa (0.96) (Figure 4.2c) and S. 
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aureus (0.80) (Figure 4.3c), with reductions of 3.42 and 3.65 log(10) for P. aeruginosa and S. 
aureus  respectively (Table 4.1). Furthermore, the MBRC of Ag (50 µg/ml) is much lower than 
the MBRC of CuO (200 µg/ml) for P. aeruginosa, therefore a smaller concentration is required 
for a ≥3 log(10) reduction. Although the R2 value is lower for Ag (0.80) than CuO (0.97) for S. 
aureus, there is only a difference of 0.17 between the values. Similar to P. aeruginosa, the MBRC 
of Ag (50 µg/ml) is considerably lower than CuO (160 µg/ml) for S. aureus (Table 4.1). After all 
these factors were taken into account, Ag and ZnO NPs seemed reasonable to use in combination 
for antimicrobial activity and were carried forward for further investigation.  
 
4.4.2 Efficacy of Metal/Metal Oxide NPs  
Durairaj et al. (2012) showed a reduction in P. aeruginosa isolates at 50 g/ml when added in the 
lag phase of growth, giving 100% inhibition. A complete inhibition of S. aureus was reported 
when exposed to 50 ppm of poly-(N-vinyl-pyrrolidone) (PVP) stabilised Ag NPs (Cho et al., 
2005). Studies by Cho et al. (2005) and Durairaj et al. (2012) were conducted on vegetative cells, 
whereas 50 g/ml of Ag NP in this investigation have been proven to be effective on biofilms 
(Table 4.1). Rahim and Mohammad (2015) determined the MIC of Ag NPs against clinical MRSA 
isolates to be 100 g/ml, and MICs of ZnO NPs against P. aeruginosa were between 150 to 158 
g/ml (Hassani Sangani et al., 2015). However, ZnO NPs in the study by Hassani Sangani et al. 
(2015) have a particle size of 20 nm in comparison to the 50 nm ZnO NPs used in this study with 
an MBRC of 256 g/ml for P. aeruginosa when used individually and 32 g/ml in combination 
(Table 4.1). The particle size could have an effect on the antimicrobial efficacy of NPs as 
demonstrated by Yamamoto et al. (2001), whereby increasing particles sizes of ZnO powders 
from 0.1 to 0.8 m increased its antimicrobial efficacy against S. aureus and E. coli, however, 
further investigation would need to be undertaken with a range of sizes in order to confirm this. 
Most of the published studies have used methods such as microdilution assays (Durairaj et al., 
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2012; Abdel Rahim & Ali Mohamed, 2015) to determine the MIC; combining correlations and 
log(10) reductions in the published literature is an approach that has not yet been used for analysing 
the effect of metal/metal oxide NPs suspension against biofilms.   
The toxic effects of metal and metal oxide NPs need to be taken into consideration before the 
development of a metal or metal oxide NP containing product. For instance, exposure of high 
concentrations of Ag in the air can result in breathing problems, as well as lung and throat 
irritation. Skin contact with Ag can result in mild allergic reactions like rashes, swelling and even 
inflammation (Ray et al., 2009). If a product was to be developed containing a metal/metal oxide 
NP combination, there is greater practicality to use the same combination for all types of 
organisms regardless of whether they are Gram-negative or Gram-positive. 
The acceptance criteria for disinfectants require a minimum of a 4 log(10) kill in ≤5 mins (British 
Standards Institute, 2001). The combinations of Ag and ZnO (Table 4.3) or individual usage of 
Ag, ZnO and CuO (Table 4.1) have shown reductions between ca. 3 to 4 log(10) but over 24 hours. 
Even though biofilms are problematic in many industries, standard efficacy testing of 
disinfectants only accounts for planktonic cells (Ali et al., 2006; Toté et al., 2010), it is important 
to take this into account when comparing the efficacy of antimicrobial products for biofilms. 
Lower log(10) reductions may be observed during this study as the efficacy of metal/metal oxide 
NPs were assessed against P. aeruginosa and S. aureus biofilms, with reductions of 3.77 and 3.69 
log(10) for P. aeruginosa type and clinical strain respectively using 32/25 µg/ml of ZnO/Ag NPs 
and 3.91 and 3.81 log(10) reductions for S. aureus type and clinical strain respectively with 8/12 
µg/ml of ZnO/Ag NPs (Table 4.3). This demonstrates that using combinations for both S. aureus 
and P. aeruginosa biofilms has promising antimicrobial characteristics for further development, 
especially due to the closeness of the reductions for the acceptance criteria for disinfectants, even 
though the efficacy testing was against biofilms.   
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Sessile cells are highly resistant and eradication of biofilms using suggested concentrations of 
disinfectants is challenging, therefore increased concentrations, treatment times and even 
mechanical disruption can be required to remove a biofilm (Rajdev et al., 2015). When planktonic 
and biofilm cultures of Acinetobacter spp., K. pneumoniae and P. aeruginosa were treated with 
working concentrations of H2O2 and H2O2 based formulations, MICs were between 0.5 to 20 mM 
H2O2, whereby biofilms showed up to 266 fold more resistance (Perumal et al., 2014). Four 
Candida spp. and two E. coli strains exhibited resistance to sodium hypochlorite, H2O2, ethanol 
and iodine. MICs were >10 fold higher at 5 min and 24 hour treatments in comparison to 
planktonic cells (Leung et al., 2012). This could be owing to barriers in penetration, reduced 
accumulation of biocides, as well as adaptation and selective pressure. Notably, the MIC values 
of iodine and H2O2 treatment for the adhesion and biofilm phases exceeded the commercially 
available concentration of 1% and 3% respectively (Leung et al., 2012). Similarly, C. albicans 
strains in a biofilm form were found to be 8-fold more resistant to chlorhexidine than C. albicans 
in a planktonic state, showing the inefficacy of clinically utilised disinfectants (Lamfon et al., 
2004). This suggests that even though biocides may be effective against planktonic cells, they 
may not necessary eradicate biofilms too, thus unsuccessful in preventing HCAIs derived from 
biofilms (Smith & Hunter, 2008). 
 
4.4.3 Synergistic Combination of Ag and ZnO 
It is noteworthy that even though antagonism is expressed as seen is Table 4.2b, a ≥3 log(10) 
reduction is observed for all the concentrations that have shown to work. This is seen mainly in 
the higher concentration combinations such as 32/100, 64/12, 64/25, 64/50 and 64/100 µg/ml for 
S. aureus biofilms. This suggests that even though one metal/metal oxide NP may be hindering 
the effect of the other, the other metal NP may be in excess, therefore exerting the antimicrobial 
effect alone. For example, at 32/100 µg/ml of ZnO/Ag NPs respectively, the Ag may be in excess, 
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therefore overall the Ag+ ions are exerting the antimicrobial effect, whereas at 64/12 µg/ml, the 
ZnO NPs may be in excess.  
In a study by Liu et al. (2016), an antagonistic effect was seen for ZnO NPs on the toxicity of Cu 
NPs, due to the occurrence of interactions between dissolved and particulates of Cu and Zn (Liu 
et al., 2016). The individual susceptibility of Photobacterium phosphoreum, a commonly used 
organism for bioluminescence inhibitions assays, to metal oxide NPs was tested (Wang et al., 
2014b). The synergistic effect of ZnO, α-Fe2O3, γ-Fe2O3, Fe2O3 and nickel oxide (NiO) NPs were 
tested. ZnO antimicrobial efficacy was a result of dissolved Zn2+ ions, whereas the Fe-oxides and 
NiO antimicrobial effect was due to particle specific toxicity. The interactions between Zn2+ ions 
and are other NPs present in the suspension gave an antagonistic effect. This was confirmed when 
the concentration of Zn2+ ions was measured in individual ZnO NP suspensions and ZnO NPs 
mixed with other NPs, showing the Zn2+ ion concentration was higher in individual ZnO NP 
suspensions in comparison to when in combination with other NPs. Nanomaterials tend to have a 
greater adsorption capacity in comparison to other materials due to their high surface area to 
volume ratio (Liu et al., 2005). Due to the high surface energy of NPs, ions have an affinity for 
the NPs, therefore, it is likely that dissolved Zn2+ ions from the ZnO NPs adsorb onto the surface 
of other NPs in the suspension, reducing the overall ion concentration. In this case, Zn2+ ions are 
absorbed by Fe-oxides and NiO NPs, reducing the overall Zn2+ ion concentration. Zn2+ dissolved 
in the individual ZnO suspensions can adhere to the bacterial cell surface which is negatively 
charged, resulting in an antimicrobial effect. This reduction in available ions in mixed NP 
suspensions could be the reason for an antagonistic effect in combination suspensions (Wang et 
al., 2014b).  
The ion release from combinations of ZnO/Ag NPs and individually was investigated in this 
study using AAS (Table 4.5). After analysis of results in Table 4.5, high levels of ZnO (≥32 
µg/ml) in combination with low levels of Ag (≤16 µg/ml) or high levels of Ag (≥50 µg/ml) with 
low levels of ZnO (≤16 µg/ml) have led to quenching of Zn2+ ions, suggesting the antimicrobial 
99 
 
effect is mainly due to Ag+ ions. However, reductions ≥3 log(10), were observed for P. 
aeruginosa and S. aureus (Table 4.2a and b), showing the antimicrobial efficacy of the lower 
combined concentrations. The pH of the suspension was monitored throughout the study and 
remained stable at pH 7. For ZnO/Ag NP suspensions in combinations of 64/50 µg/ml, 
quenching of Zn2+ is observed, where individually 50 µg/ml and 64 µg/ml of Ag and ZnO NP 
released 0.71 and 4.18 g/l ions respectively, whereas in combination, 0.66 and 2.68 mg/l of ions 
were released respectively. Both Ag+ and Zn2+ ions quenched eachother for 64/100 µg/ml of 
ZnO/Ag NPs, as individually 100 µg/ml and 64 µg/ml of Ag and ZnO respectively released 1.35 
and 4.18 g/l ions respectively, whereas in combination, 0.72 and 3.13 mg/l ions were released 
respectively (Table 4.5). Thus, synergistic relationships between the metal/metal oxide NPs 
were not observed, additive effects mainly occurred (Table 4.2a and b). This may suggest that 
both Ag and ZnO NPs works via different mechanisms and one is influencing more damage 
than the other.    
Talari et al. (2012) evaluated the antimicrobial efficacy of Ag doped ZnO NPs against E. coli and 
S. aureus. The MIC of the NPs, decreased from 80 to 40 µg/ml and 160 to 100 µg/ml for E. coli 
and S. aureus respectively as the concentration of Ag increases from ratios of 0.00 to 0.10. This 
could be due to the combined effect of increased attachment of the Ag doped ZnO NPs to the 
bacterial cell surface, releasing Ag+ ions and the production of H2O2 from ZnO NPs, leading to a 
synergistic antimicrobial action. 
Yıldırım et al. (2013) observed the substitution of Ag+ ions into Zn2+ sites in the ZnO lattice. An 
increased concentration of Ag results in increased occupancy of Ag+ ions in the Zn sites. Some 
results in Table 4.5 correlate with these findings, showing that higher Ag concentrations between 
50 to 100 µg/ml in combination results in a reduction in Ag+ ions, endorsing the fact that 
antimicrobial efficacy here could be mainly due to Zn2+ ions, but contrasting with the hypothesis 
that a high and low combination of Ag and ZnO NPs result in quenching of Zn2+ ions. For 
example, this is seen in the decrease in Ag+ ions in 8/100 µg/ml of ZnO/Ag NP suspension, 
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whereby the initial Ag+ ion concentrations were 1.35 mg/l for 100 µg/ml and in combination, 
decreased to 0.89 mg/l for 8/100 µg/ml. However, this was not seen for 16/50, 8/50, and 16/100 
µg/ml. Studies have also reported that pure Ag NPs had limited antimicrobial efficacy due to the 
agglomeration of Ag NPs into Ag clusters, reducing particle/cell interactions (Lok et al., 2007; 
Liu et al., 2010; Samberg et al., 2011). In addition, the ability of the transition metal Ag to form 
ligands with Zn2+ ions could explain the reasons behind the low concentrations of available Zn2+ 
ions to interact with the bacterial cells.  
Another possible explanation may be that metal oxide NPs and the ions released into the aqueous 
media undergo three main processes which are 1) dissolution, 2) adsorption and 3) hydrolysis as 








The concentration of metal ions released from the NPs depends on dissolution and adsorption. In 
the suspension, dissolution and adsorption occur simultaneously, and eventually reach 
equilibrium. Metal ions are more likely to dissolve at lower concentrations and the concentration 
of metal ions increase at lower particle concentrations. With an increase in the metal NP 
concentration, a larger concentration of metal ions tends to get adsorbed onto the NPs, leading to 
a decrease in the availability of the metal ions, which explains the reduction of metal ions in CuO 
NPs at concentrations higher than 180 µg/ml (Wang et al., 2016b). Furthermore, the dissolved 
Figure 4.6: The processes of dissolution, adsorption and hydrolysis in metal NP suspensions 
adapted from Wang et al. (2016b). 
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metal ions in the aqueous suspension can also pass through the hydrolysis process, forming 
insoluble complexes of metal hydroxides (Wang et al., 2016b).  
For P. aeruginosa, the concentrations that gave a ≥3 log(10) reduction were 8/100, 32/25, 64/12 
and 64/100 µg/ml of ZnO/Ag respectively (Table 4.2a). For S. aureus, all the tested concentrations 
gave a reduction ≥3 log(10) (Table 4.2b) apart from 16/12 and 16/25 µg/ml of ZnO/Ag respectively, 
which were also found to be ineffective in P. aeruginosa too (Table 4.2a). The chosen 
combinations of ZnO/Ag NPs respectively were 32/25 µg/ml for P. aeruginosa and 8/12 µg/ml 
for S. aureus. A 8/12 µg/ml combination of ZnO/Ag NP suspension respectively was the lowest 
combination tested against S. aureus biofilms which was found to give a significant reduction (p 
≤0.05) of 3.91 log(10), lowering the MBRC of the metal/metal oxide NPs to that of when used 
individually (16 µg/ml for ZnO and 50 µg/ml for Ag). For P. aeruginosa, the MBRC of Ag and 
ZnO when used alone was 50 and 256 µg/ml respectively whereas a combination of 32/25 µg/ml 
of ZnO/Ag gave a significant reduction (p ≤0.05) of 3.77 log(10). These results are similar to 
findings from Ghosh et al. (2012), where Ag/ZnO nanohybrids were tested against S. aureus and 
E. coli. Results demonstrated that MICs of 100 µg/ml of ZnO and 46 µg/ml Ag for S. aureus and 
127 µg/ml of ZnO and 37 µg/ml of Ag was required for E. coli individually. However, in 
combination, Ag/ZnO nanohybrids at MICs of 23, 18, 10 and 7 µg/ml for was required for S. 
aureus and 35, 25, 20 and 12 µg/ml for E. coli with Ag concentrations of 0.97, 3.79, 6.63 and 
9.10% respectively, demonstrating a synergistic effect of the nanohybrids. Moreover, ZnO/Ag 
nanohybrids showed greater ZOI in comparison to Ag and ZnO individually, suggesting hybrids 
may be preferable for the treatment of both Gram-negative and Gram-positive bacteria (Ghosh et 
al., 2012; Akhil et al., 2015).  
Clinical strains of S. aureus and P. aeruginosa biofilms in this study were also significantly 
reduced (p ≤0.05) by 3.81 and 3.69 log(10) respectively. When P. aeruginosa and S. aureus 
biofilms were treated with Ag NPs, a 90% reduction was observed for both biofilms at 
concentrations of 0.5 µg/ml and 0.7 µg/ml respectively (Gurunathan et al., 2014). Ag NPs at a 
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concentration of 2 µg/ml gave reductions of 73.7 and 66.3% when tested against P. aeruginosa 
and S. aureus biofilms respectively (Kora & Sashidhar, 2014). Both of these studies used MTP 
based models to find the most effective concentration for the inhibition of P. aeruginosa and S. 
aureus biofilms. Lower concentrations of Ag NPs were required by Kora and Sashidar (2014) and 
Gurunathan (2014) for an antimicrobial effect in comparison to the Ag MBRC concentrations 
found in this Chapter, i.e. 50 µg/ml individually and 12 and 25 µg/ml in the ZnO/Ag combination 
for S. aureus and P. aeruginosa respectively, this may be due to the methodology used.  
The reduction in the Ag and ZnO NP concentrations in combination could be due to the utilisation 
of multiple antimicrobial mechanisms. It is the ion form of Ag that is known to exhibit the 
antimicrobial effect as opposed to the NP (Durán et al., 2010). Electrostatic interactions of the 
ions to the negatively charged cell surface of the bacteria can produce free radicals, changing the 
permeability of the cell, resulting in leaking to intercellular contents (Durán et al., 2015). Ag+ 
ions react with the thiol groups of proteins, inactivating the bacteria (Durán et al., 2010). Ag NPs 
or Ag+ ions can hinder the respiratory chain in the mitochondria of the bacteria, leading to cell 
death (Durán et al., 2015). The ability of ribosomes to translate messenger ribonucleic acid 
(mRNA) into vital proteins is hindered by Ag+ ions (Kwakye-Awuah et al., 2008; Park et al., 
2009). The release of Zn2+ ions from ZnO contribute to their antimicrobial efficacy (Pasquet et 
al., 2014). Other studies have reported that ROS species released from the surface of ZnO react 
with H+ ions, producing H2O2 that can penetrate the cell membrane, eliminating the bacteria (Fang 
et al., 2015). The surface area of ZnO affects the generation of H2O2 - the greater the surface area 
the more ROS produced (Ohira et al., 2008). If the NPs are smaller than the pore size of bacteria, 
they can cross the barrier of the cell directly (Jadhav et al., 2011). Often the antimicrobial activity 
of metal oxide NPs is on the surface, whereby they bind to the protein thiol group in the cell wall, 
reducing cell permeability and resulting in cell lysis (Zhang & Chen, 2009). It may be these modes 
of action for Ag and ZnO NPs in combination that are exerting their antimicrobial effect against 
P. aeruginosa and S. aureus biofilms in this study.       
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Ansari et al. (2015) demonstrated the efficacy of Ag NPs against MRSA and methicillin resistant 
S. epidermidis (MRSE) isolated from wounds in a tertiary care hospital. The MIC determined to 
be within the range of 11.25-45 µg/ml. At 50 µg/ml, complete biofilm reduction was seen. This 
is comparable to when Ag NPs were used alone to treat biofilms of P. aeruginosa and S. aureus, 
where 50 µg/ml resulted in a ≥3 log(10) reduction (Table 4.1). Ansari et al. (2015) used the Congo 
Red method to test the effect of Ag NPs by visually assessing the presence and absence of dry 
crystalline black colonies which indicates the synthesis of glycocalyx matrix. The CDC biofilm 
reactor produces thick mature biofilms due to the continuous nutrients supply (Figure 3.7a-f). Due 
to the biofilms being treated after 48 hours of formation in this investigation, it would be expected 
that a larger concentration of antimicrobials would be required in comparison to planktonic 
cultures. The EPS which surrounds and encases the biofilm cell community constructs 90 % of 
the biofilm, providing it with protection, often making detergents ineffective (Fux et al., 2005; 
Hadi et al., 2010; Vickery et al., 2004).  
 
4.4.4 Time Point Assay 
The time needed in order to exhibit an antimicrobial effect by the metal NPs was investigated at 
1, 2, 4, 6, 8 and 24 hours. For S. aureus, between 1 and 8 hours, there was a reduction of 19.79% 
(p >0.05), between 1 and 24 hours, there was a 99.98% reduction (p 0.05) (Table 4.4). Similar 
reductions between 1-8 hours was also observed for P. aeruginosa whereby between 1 and 8 
hours, there was a reduction of 21.08% (p >0.05), and between 1 and 24 hours, there was a 99.94% 
reduction (p 0.05) (Table 4.4). This data signifies the importance of a 24 hour metal/metal oxide 
NP treatment against mature biofilm for both organisms (Table 4.4). Pourmand et al. (2013) used 
a time kill assay to show the antimicrobial activity of Ag NPs against Legionella pneumophila 
vegetative cells with an MIC of 30 µg/ml at 4°C and 25°C for 24 hours. There were no viable 
cells at 24 hours at 4°C, at 25°C though 1.2 x 105 to 5.5 x 105 cfu/ml were detected, suggesting 
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temperature affects antimicrobial efficacy. Between 0 to 8 hours, there was a reduction of ca. 2.5 
log(10) cfu/ml. A time kill assay was used to test Ag NPs at concentrations of 0.0, 6.25, 12.5, 25.0 
and 50.0 mM against vegetative cells of Streptococcus pyogenes, E. coli O157:H7 and multidrug 
resistant P. aeruginosa over 24 hours (Lara et al., 2009). At 50.0 mM, total inhibition was 
achieved for all three strains. Even though 6.25 mM was below the MIC/MBC range, the bacterial 
growth was still lower at 24 hours in comparison to the control. At 24 hours, there was a 99.7%, 
95.7 and 92.8% reduction in S. pyogenes, E. coli and P. aeruginosa respectively (Lara et al., 
2009). 
 
4.4.5 SEM, EDX and CLSM  
SEM images showed diminished biofilms of P. aeruginosa and S. aureus after a 24 hour treatment 
(Figure 4.4c and d). This is evident in P. aeruginosa biofilm (Figure 4.4b) where the cells are in 
close proximity to each other, whereas in Figure 4.4d, only the remains of the biofilm are 
observed. In S. aureus biofilm samples without treatment, it is clear that the cells are intact and 
have smooth surfaces (Figure 4.4a). However, with the treated biofilms, smaller number of cells 
can be seen with rougher cell edges showing that the ZnO/Ag NP combination (Figure 4.4c), most 
likely in the ion form, are disrupting the cells. EDX analysis has shown the presence of Ag and 
ZnO in the P. aeruginosa (Figure 4.4f and h) and S. aureus biofilm (Figure 4.4e and g), suggesting 
impregnation of some of the metal/metal oxide NPs into the biofilm or adsorption of the NPs onto 
the surface of the cell, thereby slowly releasing ions. Similar findings were seen by Ansari et al. 
(2015) when biofilms of clinical strains of S. aureus were treated with Ag NPs between 5 to 10 
nm. SEM images showed similar patterns, i.e. distortion of cell integrity and reduction of surface 
coverage. Moreover, a study by Kostenko et al. (2010) showed that nanocrystalline Ag has 
antibiofilm activity against P. aeruginosa. SEM demonstrated a reduced surface coverage of P. 
aeruginosa. CLSM imaging confirmed the antimicrobial efficacy of ZnO/Ag NPs, with cell death 
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occurring throughout the depth of the biofilm, suggesting that inhibition was not just on the 
surface of the biofilm (Figure 4.5a-f). 
Ag NPs were found on the cell membrane surface and inside the bacterial cell after their exposure 
to E. coli cells, where the former hindered permeability and the latter led to DNA damage 
(Morones et al., 2005). Alongside ion release from metal/metal oxide NPs, these could be two 
other ways by which antimicrobial activity was exerted in the present study. Ag NPs on the 
surface of ZnO in a ZnO/Ag nanohybrid were shown to have a slight electro positive charge 
(Ghosh et al., 2012). At pH 7.4, the dissociation of excess carboxylic acid groups on the bacterial 
cell surface lead to a negative charge (Morones et al., 2005; Sondi & Salopek-Sondi, 2004). 
Interaction between the cell wall surface and the Ag NP causes electrostatic attraction between 
the two oppositely charged species, therefore Ag NPs in the hybrid adhere onto the E. coli cell 
wall surface preferentially than ZnO NPs (Ghosh et al., 2012). Eventually, the Ag NPs interact 
with the cell membrane, increasing permeability and entering the cell, resulting in cell death 
(Yang et al., 2009b). In comparison to E. coli, S. aureus cell surface has a lesser negative charge, 
therefore less susceptible to the Ag+ ions. OH· signals were detected for pure ZnO, which were 
not present for ZnO/Ag hybrids, suggesting that OH· formation is quenched by Ag. This proposes 
that the antimicrobial effect on S. aureus is due to a physical attack of the ZnO/Ag hybrid on the 
cell wall, rather than the OH· radicals (Applerot et al., 2009; Li et al., 2011; Lipovsky et al., 
2009). This supports the AAS data (Table 4.5) showing that the Ag+ ions are predominantly 
responsible for the antimicrobial effect, due to the electrostatic attraction described by Ghosh et 
al. (2012). Gram-positive P. aeruginosa was found to be less susceptible in comparison to S. 
aureus in the present study, however, NP suspensions were used here whereas nanohybrids were 
used by Ghosh et al. (2012), this could explain the variation seen between studies in terms of ion 





A three step approach was used to determine a suitable combination of NPs against HCAI 
associated biofilms by: 1) using the MBRC of individual metal/metal oxide NPs against P. 
aeruginosa and S. aureus biofilms, 2) R2 values and 3) log(10) reductions of ZnO/Ag NP 
suspensions in combination. A reduction of ≥3 log(10) within the acceptance criteria set in this 
study was mandatory. This approach has not been used to date in the published literature to assess 
the efficacy of metal and metal oxide NPs against biofilms. Moreover, the antimicrobial effect of 
metal/metal oxide NPs against biofilms per se has not been studied in depth, and there is limited 
published research on the synergistic effect of metal/metal oxide NPs against biofilms. A 
reduction of ca. 3.5 log(10) after 24 hours for metal/metal oxide NPs against biofilms is promising 
due to biofilms being harder to eradicate in comparison to vegetative cells. With the ongoing issue 
of antimicrobial resistance, the combination of ZnO/Ag NP suspensions could provide an 





























Chapter 5: Antimicrobial Coatings 
5.1 Introduction  
 
The transfer of pathogens from an infected to susceptible patients is usually due to cross 
contamination from the hands of healthcare personnel. Contaminated hospital surfaces, hospital 
equipment, water and air can also be a cause of transmission both directly or indirectly (Randle 
et al., 2010).     
Surfaces can be a source of contamination in hospitals, consequently having an impact on endemic 
transmission of HCAIs (Otter et al., 2011). In particular, those surrounding patients have a greater 
chance of contamination in comparison to other surfaces within a hospital (Huslage et al., 2010; 
Hayden et al., 2008). Hospital pathogens can survive on dry surfaces for lengthy time periods. In 
specific, S. aureus can survive between 7 days to >12 months (Wagenvoort et al., 2000) and P. 
aeruginosa can survive between 6 hours to 16 months (Otter et al., 2013). Biofilms enable 
bacteria to survive on dry surfaces for lengthy periods without a source of nutrients (Yezli & 
Otter, 2012; Vickery et al., 2012).  
Recently, “no touch” methods of disinfection have been encouraged to decrease the occurrence 
of contamination of surfaces in hospital rooms, including emission of ultraviolet (UV) light and 
aerosolized/vaporised H2O2 (Rutala & Weber, 2011). However, there are limitations associated 
with these techniques as patients and healthcare personnel have to be removed from the room 
prior to cleaning, these systems are more suitable for terminal cleaning (Rutala & Weber, 2011). 
High costs associated with room decontamination and the increase in the time taken for room 
turnover make commercially available disinfection methods such as H2O2 and chlorine based 
products unfavourable to use (Doan et al., 2012). Routine and terminal cleaning is often 
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inadequate, due to less than 50% of room surfaces in hospitals being thoroughly disinfected when 
cleaned with chemical germicides (Carling et al., 2008; Goodman et al., 2008).    
An example of a self-disinfecting product is Surfacine (Surfacine Development Company, 
Tyngsborough, MA), used for disinfecting hospital surfaces. It utilises the water soluble 
antimicrobial silver iodide in a surface immobilised coating, which is modified with 
polyhexamethylene biguanide. Surfacine is capable of chemically recognising and interacting 
with the lipid bilayer of the bacterial cell membrane via electrostatic interaction (Rutala & Weber, 
2001). It can be applied to abiotic surfaces via dipping, brushing or spraying without having to 
previously treat surfaces. A 3.3 to 4.3 log(10) kill and a 2.2 to 4.8 log(10) kill has been achieved 
against S. aureus and P. aeruginosa respectively (Brady et al., 2003). It has also been shown to 
reduce MRSA and VRE by >3 log(10) (Rutala & Weber, 2001).       
The antimicrobial effect of NPs comprising of a combination of AgNO3 and TiO2 coated onto 
surgical masks were tested against E. coli ATCC 25922 and S. aureus ATCC 25923 with doubling 
dilutions of NPs from 1/2 to 1/1024. A 100% reduction in viable E. coli and S. aureus was 
observed after a 48 hour incubation of masks treated with NP dilutions of 1/128 and 1/512 for E. 
coli and S. aureus respectively (Li et al., 2006). However, for the untreated mask, there was an 
increase in viable counts by 25% and 50% of E. coli and S. aureus respectively. Li et al. (2006) 
proposed that the NPs caused damage to the bacterial enzymes or plasma membrane, impairment 
of the metabolic pathways and leakage of the cytoplasmic matter. 
Cu-coated or impregnated surfaces are often utilised in healthcare environments due to their 
promising antimicrobial properties. Cu toilet seats showed a 94-98% reduction in cfu of 
microorganisms including MSSA, MRSA, VRE, C. difficile and coliform bacteria (Casey et al., 
2010). Marais et al. (2010) showed that Cu coated desks, trolleys, tops of cupboards and window 
sills, led to a 1-2 log(10) reduction in mean cfu. A 37% reduction was observed in the total aerobic 
bacteria on Cu light switches, push plates and door knobs (Mikolay et al., 2010).     
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Bacterial adhesion can be influenced by physico-chemical factors such as the bacterial cell surface 
and substratum surface (Bayoudh et al., 2008). Attachment is also affected by environmental 
factors such as temperature and pH, surface properties such as hydrophobicity and characteristics 
of the microorganism itself such as the presence of flagella and motility (Di Bonaventura et al., 
2008), as well as the topographical features of a surface (Mitik-Dineva et al., 2008, 2009; Truong 
et al., 2009; Ivanova et al., 2010). Equal channel angular pressing (ECAP) of Ti surfaces, a 
technique used to increase the strength of material via a nanoscale grain structure, led to a greater 
anchoring of S. aureus CIP 65.8 and P. aeruginosa ATCC 9025 cells onto ECAP-modified Ti in 
comparison to un-modified Ti (Truong et al., 2010; Valiev et al., 2008). A biofilm thickness of 
approximately 3.5 µm and 6 µm was observed for P. aeruginosa and S. aureus respectively in 
comparison an unmodified surface of between 2.5 to 3 µm for P. aeruginosa and S. aureus. 
Increased cell adhesion could be due to a greater surface area and defects in the surface such as 
edges and corner sites exposed, enabling greater adherence (Truong et al., 2010). Generally 
hydrophobic bacteria adhere better to hydrophobic surfaces (Katsikogianni & Missirlis, 2004). 
The hydrophobicity of P. aeruginosa cells means that they adhered better to the hydrophobic 
ECAP-modified Ti surface, which is in conjunction with studies by Li and Logan (2004) and 
Vadillo-Rodrı́guez et al. (2004) (Truong et al., 2010). Similar findings were observed by Bohinc 
et al. (2016) when the effect of surface roughness on bacterial adhesion was investigated. A 
comparison between an untreated 304C SS disc, and a 3D polished, brushed, grinded and electro 
polished AISI 304 stainless surface was made. The 3D surface had the lowest roughness with a 
value of 25.20 nm, and the highest was obtained from the ground surface with a value of 986 nm. 
L. monocytogenes ŽM 520 and P. aeruginosa ŽM 517 adhered the most to the 3C and the grinded 
SS surface, which had the roughest surface. S. aureus ŽMJ 72 and P. aeruginosa ŽMJ 87 both 
being hydrophobic adhered best to SS, the most hydrophobic surfaces (Bohinc et al., 2016).  
Wojcieszak et al. (2015) found that E. coli and S. aureus suspensions were reduced to 0 cfu/ml 
after a 2 hour short term contact with Cu-Ti thin film. The homogenous thin film is able to provide 
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a constant ion release over time. Bacteria attaching to a cell surface produce slime as a protection 
mechanism from the environment (Oliveira & Cunha, 2008), therefore, release of Cu2+ ions from 
Cu coatings prevent adhesion and colonisation, which is a favourable property of coatings. The 
effect of ZnO polyurethane coating was tested for its efficacy on E. coli and B. subtilis (El Saeed 
et al., 2015). A range of loading levels between 0.1-2 wt. % were investigated. A 2 wt. % showed 
the a 100 % inhibition on both bacteria, owing to Zn2+ release from the ZnO powder, penetration 
of the NPs and production of H2O2 from the ZnO nanopowder (Heinlaan et al., 2008; Brayner et 
al., 2006).           
Eight strains of bacteria were studied by Li and Logan (2004) including three E. coli strains, two 
P. aeruginosa strains and two B. cepacia strains, each differed in their lipopolysaccharide (LPS) 
length, exopolysaccharide content, and adhesion properties respectively. B. subtilis is a well-
studied Gram-positive strain that lacks LPS, therefore used as a reference. Their adherence to 11 
glass and metal oxide surfaces was determined. Adhesion increased along with the LPS length of 
the three E. coli strains. P. aeruginosa PDO300 is an over producer of EPS, therefore, had 
enhanced adherence in comparison to P. aeruginosa PA01. B. cepacia G4 adhered better in 
comparison to its non-adhesive mutant Env435 strain. B. subtilis 7003 does not contain LPS thus 
it adhered less to the eleven surfaces in comparison to the other eight strains studied.  
Published research has shown that various factors affect the formation of a biofilm and its 
properties. In a study by Chen et al. (2005), a microencapsulation technique was used to assess 
the adhesive properties of biofouling deposits on surfaces of a glass test stud. The biofilm of 
Pseudomonas flourescens from the pipe’s inner surface was detached using a T-shaped probe, 
and the force applied on the biofilm was noted. The adhesive strength of the biofilm was 
dependant on the age of the biofilm, presence of nutrients, suspended cell concentration, bulk 
fluid pH, fluid velocity and surface roughness of the substratum. Increasing the fluid velocity by 
0.6, 1.0 and 1.6 m/s and the glucose concentration from 15 to 30 mg/l, the biofilm adhesive 
strength also increased from ~0.13–0.60, 0.28–0.79 and 0.51–1.0 J/m2 respectively. When the 
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glucose concentration was increased to 45 mg/l, the mean adhesive strength reduced from 0.60 to 
0.07, 0.79 to 0.28 and 1.0 to 0.30. This indicates that higher nutrient availability can increase the 
adhesive strength, although an excess of nutrients can reduce the adhesiveness (Chen et al., 2005).    
Research by Oh et al. (2009) demonstrated that increased roughness of a substrate encourages 
bacterial adherence. Biofilm formation by P. aeruginosa ATCC 27853 was assessed on sheets of 
steel, aluminium, rubber and polypropylene, which form parts of washing machines. Thickest P. 
aeruginosa biofilms were formed on polypropylene with a depth of 806.65 ± 181.12 nm whereas 
the thinnest biofilms were formed on steel with a value of 487.63 ± 144.34 nm. Polypropylene 
had the greatest surface roughness in comparison to steel. Rough valleys present on the 
polypropylene surface gave polypropylene the most roughness in comparison to steel with 
roughness at the micronanometer level (Oh et al., 2009).    
The use of antimicrobial coatings is increasing within the healthcare arena due to them reducing 
the rates of infection by preventing cross contamination between surfaces and healthcare 
personnel/patients as well as bacterial persistence in the environment. Reductions in bioburden in 
hospitals have been reported when metal and metal oxide coatings have been implemented, thus 
potentially resulting in safer hospital surfaces. Investigating factors affecting adhesion onto metal 
surfaces and how they can impact on its antimicrobial efficacy could be helpful in understanding 








5.1.1 Aims and Objectives 
 
Aim: 
The aim of this investigation was to establish the antimicrobial properties of thin film coatings of 
Ag and ZnO on a Si substrate in preventing biofilm formation of P. aeruginosa and S. aureus.  
 
Objectives: 
 To determine the most robust method for thin film coating of Si substrates with Ag and 
ZnO to withstand the testing environment in NB.  
 To establish the antimicrobial efficacy of Ag and ZnO thin film coatings. 
 To assess the effects of thin film coating of Si substrates with Ag and ZnO on the biofilm 













5.2.1 Thermal Evaporation  
 
Evaporation is a widely-used technique for the deposition of thin films, whereby the material 
source is heated to a high temperature in vacuum either by thermal or electron-beam (e-beam) 
methods; e-beam evaporation is utilised primarily for refractory materials and is beyond the scope 
of this thesis, hence only thermal evaporation will be discussed briefly here. 
 
Deposition via this method is achieved when the material in question is vapour transported to a 
substrate where it condenses to form a thin film. To initiate this process, current is passed through 
a heating element/crucible holding the source material until the resistive heating causes the 
material to evaporate (or sublimate). The heating element/crucible is usually tungsten or 
molybdenum. A high vacuum (i.e. usually < 1x10-6 Torr) is required to minimise collisions of 
source atoms with background species/contaminants and to ensure that the mean free path of 
atoms in the chamber is greater than the distance between the source and the substrate. In this 
work, thin films of Ag 99.999% pure (Advent Research Materials, Oxford, UK), and ZnO 
99.999% pure (Advent Research Materials, Oxford, UK) were deposited using an Edwards 306 
evaporation system and a tungsten heating element and whose thickness was monitored precisely 
using a quartz balance (Edwards FTMZ, Boc Edwards, Crawley, UK). Figure 5.1 shows an image 
of the thermal evaporator. Substrates were cleaned following the procedure outline (Appendix II) 
and placed into the evaporation chamber. The system was then pumped down to < 5 x106 Torr 
prior to the application of current. Once the desired thickness was reached, the process was halted 
and the samples left to cool for ~ 1 hour before removal. A schematic diagram of a thermal 


















Thin films of Ti and ZnO were sputtered using the Nordiko Ltd. 1500 RF sputterer (Hampshire, 
UK). Radio Frequency (RF) magnetron sputtering is method of ion-sputtering. In RF magnetron 
sputtering deposition, collisions between background electrons, accelerated by an RF field, and 
the sputtering gas (argon), leads to various dissociative reactions and at steady state, a plasma is 
formed between the Ti (99.993%-99.995%, Kurt J. Lesker, East Sussex, UK) or ZnO (99.993%-
99.995%, Kurt J. Lesker, East Sussex, UK) sputtering target and substrate holder. The magnetic 
field below the target traps electrons close to the target increasing the sputtering yield. Some ions 
accelerate towards the target due to the voltage drop between the plasma body and the target 
electrode; this is known as the plasma sheath. The ion bombardment of the target leads to the 
release of target species as well as secondary electrons. Atoms released from the target move 
towards the substrate form a thin film. Figure 5.2 shows a schematic diagram of a RF sputtering 
system utilised in this study.  

















5.2.3 Aluminium (Al) Evaporation  
PC coupons were plasma cleaned (PT 7100, Bio-Rad, Hemel Hempstead, UK) with oxygen and 
thin films of aluminium (Al) (Advent Research Materials, Oxford, UK) were deposited as per 
Method 5.2.1. The coupons were then annealed at 150°C in an oven (Harbour Freight, California, 
USA) to further aid the adhesion of the coating on the surface. Coating was tested in NB and 
scraped with a glass rod to observe the strength of adherence and observed whether the coating 
was being removed visually.  
 
5.2.4 ZnO Coating on PC Coupons 
Ti was first sputtered onto the PC coupon to aid adhesion. ZnO thin films were then sputtered 
onto 10 x 10 mm Si substrates at room temperature using RF sputtering at 150 W at ~6nm/min. 
The Ti target (99.993%-99.995%, Kurt J. Lesker, East Sussex, UK) and ZnO target (99.993%-





99.995%, Kurt J. Lesker, East Sussex, UK) substrate distance was 7 cm and the chamber pressure 
maintained at 8 x 10-6 Torr, with the flow rates of argon (99.999 maintained via mass flow 
controllers). The thickness of the Ti and Ag/ZnO coating were 20 and 100 nm respectively. For 
Ag coating, Ti was again sputtered onto the PC coupon to aid adhesion. Thin films of Ag were 
deposited as per Method 5.2.1.  
 
5.2.5 Efficacy Testing of Coating 
Coated samples were placed into NB for 24 hours. The coated surface of the coupons was scraped 
with a glass rod to observe the adherence of the coating. Visual observations were made to 
ascertain if there was any degree of peeling whilst in the NB or during scraping of the surface of 
the sample.  
5.2.6 Culture Methods and Microorganisms 
The test organisms used were P. aeruginosa NCTC 6749 and S. aureus ATCC 6538. All culture 
media was acquired from Oxoid Ltd. unless otherwise stated.  
Strains were stored on beads at -80°C. Cetrimide agar for P. aeruginosa and Mannitol salt agar 
for S. aureus was used to phenotypically determine the organisms.    
Organisms were grown on NA and then 1 colony per 10 ml of NB was grown aerobically for 24 
hours at 37 °C. NA was used to culture the bacteria for viable count enumeration. 
 
5.2.7 Effect of Ag and ZnO Coating Over Time  
The Ag and ZnO coated Si substrates were placed in the rods of the CDC biofilm reactor, 
containing 500 ml of NB. Biofilms of P. aeruginosa and S. aureus were formed in the CDC 
biofilm reactor as per Method 3.2.3.1 and 3.2.3.2. Once the continuous flow was added, samples 
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were taken at 2, 4, 6, 8, 24 and 48 hours and enumerated as per Method 3.2.3.3. Uncoated Si 
samples were used for the controls.  
 
5.2.8 SEM  
Ag and ZnO coated Si substrates were attached onto the rods of the CDC biofilm reactor. Biofilms 
of P. aeruginosa and S. aureus were grown for 48 hours as per Method 3.2.3.1 and 3.2.3.2, washed 
with PBS and fixed with 95% ethanol for 10 mins at room temperature. The samples were then 
mounted onto aluminium stubs, ready for imaging. Biofilms were visualised using SEM.  
 
5.2.9 Statistical Analysis 
Assumption of normality was tested using Kolmogorov-Smirnov test if sample sizes were ≥50 or 
Shapiro-Wilcox test if samples were <50. For non-parametric data, a Kruskal Wallis test was used 
and well as Mann-Whitney U test. Significance was set at p ≤0.05. 













Al was used to test the efficacy of various coating methods prior to testing. Initially, PC coupons 
were plasma cleaned, and thin films were evaporated followed by annealing to strengthen the 
adhesion of the film onto the substrate. However, the Al coating in NB over 24 hours had partially 
dissolved (Figure 5.3a), and when the surface of the PC was scraped with a glass rod, the coating 
was easily detached from the surface. Thus, due to the strong formation of thin films with better 
adhesion than thermal evaporation, RF sputtering was used instead. All Si substrates were coated 
with a thin film of Ti to aid adhesion. ZnO thin films were formed using RF sputtering. However, 
due to the costs that would incur in buying an Ag target, the Ag thin films were thermal 
evaporated, followed by annealing. The detachment of coating seen in Figure 5.3 was prevented 











Figure 5.3: a) image of dissolved Al coating in water and b) image of removed Al coating 
when scraping.   
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5.3.1 Ag and ZnO Coating Overtime 
The anti-adhesive properties of Ag and ZnO biofilms increased over 48 hours against both P. 
aeruginosa and S. aureus from little or no reduction in the first 24 hours, to a significant (p ≤0.05) 
reduction of 1.41 log(10) and 1.43 log(10) for Ag and ZnO respectively against S. aureus and 1.82 
log(10) and 1.65 log(10) for Ag and ZnO respectively against P. aeruginosa at 48 hours (Table 5.1). 
No significant differences were noted between the controls and Ag and ZnO coating at 2, 4, 6, 8 
and 24 hours for P. aeruginosa and S. aureus (p >0.05)  
Table 5.1: The log(10)  reduction of P. aeruginosa and S. aureus biofilms on coated Ag and ZnO 







  P. aeruginosa  S. aureus 
Hours/h Control Si Ag coating ZnO 
coating 
Control Si Ag coating ZnO 
coating 
2 3.36 ± 0.04 0.11 ± 0.05 0.07 ± 0.03 3.37 ± 0.03 -0.01 ± 0.03 0.05 ± 0.04 
4 3.53 ± 0.02 -0.03 ± 0.02 -0.09 ± 0.02 3.68 ± 0.01 0.09 ± 0.02 0.07 ± 0.03 
6 3.74 ± 0.02 0.04 ± 0.01 0.02 ± 0.02 3.80 ± 0.02 0.03 ± 0.02 0.01 ± 0.02 
8 3.82 ± 0.02 -0.04 ± 0.01 -0.01 ± 0.01 4.00 ± 0.02 0.05 ± 0.01 0.02 ± 0.01 
24 7.07 ± 0.02 0.21 ± 0.01 0.28 ± 0.02 5.94 ± 0.02 0.27 ± 0.02  0.10 ± 0.01  
48 8.12 ± 0.01 1.41 ± 0.01 1.43 ± 0.01 7.42 ± 0.01 1.82 ± 0.03 1.65 ± 0.02 
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5.3.2 SEM of P. aeruginosa and S. aureus Biofilms on Ag and ZnO Thin Film Coatings 
The SEM images obtained after a 48 hour growth of P. aeruginosa and S. aureus biofilms on Ag 
and ZnO thin film coating (Figure 5.4) show that visible growth can be seen on the antimicrobial 
surfaces in Figure 5.4a, b, c and d. These images do not differ greatly from the growth observed 
on the control samples in Figure 5.4e and f. The cocci shape and rod shape of S. aureus and P. 
aeruginosa can be seen clearly without any visible damage.   
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Figure 5.4: SEM images showing S. aureus and P. aeruginosa biofilm formation on Ag and ZnO thin 
films in comparison to Si substrates a) S. aureus biofilm on ZnO thin film, b) P. aeruginosa biofilm on 
ZnO thin film, c) S. aureus biofilm on Ag thin film, d) P. aeruginosa biofilm on Ag thin film, e) S. 
aureus biofilm on Si substrate, and f) P. aeruginosa biofilm on Si substrate. 
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Previous studies have shown that contact with environmental surfaces carry the same degree of 
risk as touching an infected patient directly. A study by Stiefel et al. (2011) showed that there 
was only a 5% difference between the presence of MRSA on the gloved hands of healthcare 
workers that had direct contact with the patient (45%) and the environmental surface (40%). 
Similarly, a study by Guerrero et al. (2012) showed that 50% of healthcare personnel showed the 
presence of C. difficile on their gloved hands either after direct contact with the patient or 
environmental surfaces. It is noteworthy that healthcare personnel with direct contact with 
patients exhibited better hand hygiene compliance (80%) in comparison to those in contact with 
environmental surfaces (50%), illustrating that contamination from environmental surfaces has a 
greater chance to persist for longer and therefore, is more likely to be the main source for further 
transmission (Randle et al., 2010).          
Daily cleaning/disinfection ensures that the surroundings of the patient remain visibly clean in 
order to control environmental burden. At patient discharge, terminal cleaning is performed to 
certify that the clinical area is thoroughly disinfected, ready for the next patient. Unfortunately, 
even after terminal cleaning and disinfection, environmental sampling has shown that surfaces 
are still contaminated with nosocomial pathogens (Goldenberg et al., 2012; Boyce et al., 2008; 
Otter et al., 2007; French et al., 2004; Morter et al., 2011). A study by Manian et al. (2011) 
showed that 27% of rooms after 4 rounds of bleach disinfection stayed contaminated with A. 
baumannii or MRSA, demonstrating that even numerous rounds of bleach disinfection is 
insufficient for disinfection. Furthermore, norovirus ribonucleic acid (RNA) resided on 43% of 
surfaces post one round of bleach treatment, and two rounds of bleach treatment left 16% of 
surfaces still contaminated. Disinfectants used in hospitals and bleach have shown to have 
antimicrobial activity in vitro, therefore theoretically, disinfection alone has the ability to 
eliminate contamination. The underlying issue for continuation of contamination could be due to 
inadequate distribution of the disinfectant across a surface and its contact time with the 
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contaminated area (Otter et al., 2013). Self-disinfecting surfaces - i.e. coating with an 
antimicrobial agent - could potentially address this issue by preventing adhesion of 
microorganisms to its surface. 
 
5.4.1 Thin Film Coating 
Coatings are designed to limit microorganism adhesion in the initial stages of biofilm growth and 
potentially prevent its contiguous formation. Si samples coated with Ag and ZnO thin films were 
assessed for their ability to prevent the formation of P. aeruginosa and S. aureus biofilms (Table 
5.1). For P. aeruginosa, ZnO thin films gave the largest reduction of 96.28% followed by Ag thin 
films with 96.13%. For S. aureus, the largest reduction was achieved using Ag followed by ZnO 
with reductions of 98.47% and 97.78% respectively in comparison to the uncoated Si substrates 
(Table 5.1). A slightly larger reduction was observed for the Ag and ZnO coatings for S. aureus. 
This could be due to the structural differences between Gram-negative and Gram-positive bacteria 
cell structures. The cell wall in Gram-negative bacteria contains an inner membrane with efflux 
proteins, peptidoglycan, and a double layered outer envelope made up of an outer membrane and 
LPS (Sheldon, 2005). Hydrophilic porin channels in the outer membrane manage the passage of 
solutes and prevent access of hydrophilic biocides (Lambert, 2002). Gram-positive bacteria 
however, are known to be more permeable to biocides due to the absence of an outer membrane 
(Brown et al., 2015). Even though statistically significant (p ≤0.05) log(10) reductions were 
observed on Ag and ZnO coated substrates after 48 hours (Table 5.1), the results do not show ≥3 
log(10) reduction, there may be some promise in metal/metal oxide thin film coatings because they 
did prevent further formation of biofilms over time and thus had some limiting factor. An 
explanation for the metal and metal oxide based coatings not being effective in the first 24 hours 
may be because there was inadequate release of ions from the coatings, giving rise to insufficient 
ion concentration in the surrounding media to prevent adhesion. However, at 48 hours, the 
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increase in ion release over time shows better antimicrobial efficacy (Table 5.1). In order to 
confirm this, the release rates of ions from Ag and ZnO coated surfaces overtime need to be 
further investigated using techniques such as inductively coupled plasma mass spectroscopy 
(ICP-MS). Other studies have shown that 24 hours is sufficient to reduce biofilm formation, with 
Ag coating reducing P. aeruginosa biofilms by 13-fold (DeVasConCellos et al., 2012). Li and 
Logan (2004) suggested that hydrophobicity of P. aeruginosa and the positive charge of metal 
oxide surfaces could promote the adhesion of negatively charged bacterial species. Due to the 
ZnO coating having a positive charge of Zn2+, this could be a possible explanation for the 
adherence of P. aeruginosa to ZnO coated surfaces, further confirmed by the denseness of P. 
aeruginosa biofilms seen in Figure 5.4b and d.  
Stranak et al. (2011) tested the antimicrobial efficacy of Ti-Cu thin films formed by three different 
methods of plasma-assisted magnetron sputtering. Growth inhibition of S. epidermidis ATCC 
35985 and S. aureus ATCC 25923 cells in a planktonic form occurred within the first 24 to 96 
hours, showing a high diffusion of Cu2+ ions into the media. However, the effect of Ti-Cu thin 
film coating was limited for biofilms of S. aureus and S. epidermidis. In general, S. aureus was 
more susceptible to the Ti-Cu films than S. epidermidis. There was a 3 log(10) reduction of S. 
epidermidis over 10 days whereas there was total inhibition of S. aureus in 4 days was seen after 
exposure to Cu. On the 10th day, persisting S. aureus biofilm cells re-grew, possibly owing to the 
low concentration of Cu ions after absorption of the initial Cu ions by the initially seeded bacteria 
(Stranak et al., 2011). In the present work, a 48 hour biofilm of S. aureus and P. aeruginosa was 
reduced, suggesting that the ion concentration was sufficient to result in a significant (p ≤0.05) 
reduction in comparison to 24 hours. Even though statistically there is a significant reduction, the 
reductions are very low for P. aeruginosa (1.41 and 1.43 log(10) for Ag and ZnO coating 
respectively) and S. aureus (1.82 and 1.65 log(10) for Ag and ZnO coating respectively) when 
compared to the controls (Table 5.1). The presence of persister cells may be the reason for biofilm 
growth even after 48 hours. The initially adhered bacteria may have been killed due to the uptake 
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of ions, resulting in low availability of ions for bacteria formed at a later stage (Stranak et al., 
2011). However, this cannot be confirmed here as AAS data has not obtained for ion leaching 
overtime. Moreover, factors such as QS may upregulate relevant genes, particularly those 
involved in encoding for virulence factors (Beceiro et al., 2013).  
The anti-adhesive effect of ZnO nanorod substrates and ZnO sputtered substrates for the adhesion 
prevention of P. aeruginosa and S. epidermidis in comparison to glass as a reference was tested 
previously (Jansson et al., 2012). P. aeruginosa showed a 2.5 and 1.7 fold greater reduction in 
cells on ZnO nanorod and ZnO sputtered surfaces respectively in comparison to glass substrates 
and S. epidermidis showed a ~20 and 30 fold greater reduction on ZnO sputtered and nanorod 
substrates respectively in comparison to a glass surface (Jansson et al., 2012). This difference in 
anti-adhesive properties of ZnO nanorod and sputtered substrates against both bacteria could be 
due to the variance in the cell wall structures of Gram-negative and Gram-positive bacteria e.g. 
the presence of an outer wall in Gram-negative bacteria (Silhavy et al., 2010). Cell wall structure 
differences may cause the ZnO nanorods to have different electrostatic and van der Waals 
interactions, thereby, affecting the adhesion of the biofilms. ZnO nanorods could be exerting an 
antimicrobial effect by piercing into S. epidermidis cells, leading to membrane integrity loss and 
cell death (Jansson et al., 2012). Flagella formation is required by P. aeruginosa to bind to a 
surface. Twitching motility of P. aeruginosa enables it to form mature biofilm structures with a 
slime layer (O’Toole & Kolter, 1998), which could be strong enough to overcome the 
antimicrobial effects of ZnO nanorods. 
Growth of E. coli ATCC 25922 biofilms on ZnO thin films on Si substrates has been investigated 
previously using disk diffusion and the CDC biofilm reactor (Gittard et al., 2009). The cell density 
was 13.16 ± 9.44 × 106 cfu/cm2 and 6.28 ± 3.52 × 106 cfu/cm2 on uncoated Si and ZnO thin films 
respectively over a 48 hour growth period in the CDC biofilm reactor (Gittard et al., 2009), similar 
antimicrobial properties of ZnO coatings were also observed in  other studies (Zhou et al., 2005; 
Szunyogová et al., 2007; Fang et al., 2015). E. coli grew on both coated and uncoated substrates 
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but more than 50% reduction in cell density was observed on the ZnO coating in comparison to 
Si surface. No change in growth reduction was seen on an uncoated surface in dark conditions or 
with constant fluorescent light, suggesting light is not required for antimicrobial activity (Gittard 
et al., 2009). The leaching of Zn2+ ions from the surface of the coating could be providing the 
antimicrobial activity (Szunyogová et al., 2007). In the present investigation, lower reductions 
were found, however, the method of in vitro testing could have had an effect on the results 
acquired. Jansson et al. (2012) used optical density to semi-quantify biofilm formation, and 
Stranak et al. (2011) used 24 well plates to form the biofilm to obtain cfu/ml, whereas the CDC 
biofilm reactor is a reliable real life replica of biofilm formation. The differences in reductions 
obtained could be due to the chosen in vitro biofilm formation method. 
The adhesion of S. epidermidis IE186 and 1457 to Ag-Ti carbonitrile (Ag-TiCN) antimicrobial 
coatings has been assessed previously in the literature (Carvalho et al., 2013). Three ratios of 
Ag/Ti concentrations were tested with increasing concentration of Ag with 0, 10 and 15%. As the 
concentration of Ag increases, the roughness of the S. epidermidis biofilm reduces. Only a <2 
log(10) difference was seen between the TiCN coatings with and without Ag. Increase in Ag 
concentration in TiCN coated surfaces was shown to promote biofilm formation of S. epidermidis 
strains at 24 hours, which is unexpected due to the well-known antimicrobial properties of Ag 
(Carvalho et al., 2013). This could be due to minimal levels of Ag+ released from the surface of 
the coating which are insufficient to result in an antimicrobial effect on the bacterial cells. A 
similar phenomenon may perhaps be occurring in this study whereby Ag is encouraging biofilm 
formation. Alternatively, the initial biofilm adhesion could have been prevented due to the 
antimicrobial properties of the Ag and ZnO coating and their ion release; but due to the formation 
of slime layers as well as the initiation of QS factors in the biofilm, the antimicrobial effect of the 
coating is overcome. The formation of conditioning layers could be the reason for the low log(10) 
reductions observed in this study, as the adhesion of macromolecules such as proteins can change 
the adhesion properties on the substrate, thus favouring attachment (Lorite et al., 2011; Lejeune, 
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2003). An example of this are surfaces coated with quaternary ammonium salts, which have an 
antimicrobial effect prior to conditional layer deposition (Tiller et al., 2001; Melo et al., 2011). 
Furthermore, the continuous flow of nutrients and rotation in the biofilm reactor aids biofilm 
growth and the biofilm community may be able to overcome the stress exerted by ions.  
 
5.4.2 Conclusion  
Antimicrobial surfaces aim to reduce bacterial adhesion on a surface in the initial stages of biofilm 
growth in order to prevent the formation of mature biofilms, which are then difficult to eradicate. 
Although Ag and ZnO have demonstrated their efficacy in suspensions post biofilm formation, in 
this investigation they have shown limited antimicrobial properties as a thin film coating. In order 
for metals/metal oxides in a coated form to have potential as a self-disinfecting surface within a 
healthcare setting, further development is required. The inhibition of bacterial adherence is partly 
dependent on the physicochemical properties of the substrate as well as the properties of the 
pathogen, therefore it is important to understand the underlying mechanisms of action that bring 















Chapter 6: Gene Expression in S. aureus Biofilms 
 
6.1 Introduction 
Reducing the spread of HCAIs is the responsibility of the HICPAC, through providing advice on 
ensuring valid procedures are undertaken to clean and disinfect environmental surfaces, 
eliminating nosocomial pathogens such as S. aureus (Umscheid et al., 2010). Planktonic cells 
have lower resistance to antimicrobials in comparison to cells embedded within a biofilm (Kim 
& Rhee, 2016). Bacterial biofilms express virulence factors in response to antimicrobials, 
antibiotics or disinfectants, exhibiting resistance (Gaddy & Actis, 2009; Wroblewska et al., 2008).  
Biofilms have four main stages of biofilm formation including formation of planktonic cells, 
reversible and irreversible adhesion, maturation and finally dispersion (Monds & O’Toole, 2009), 
which occur dynamically during the process of biofilm formation. Gene expression regulates the 
phenotypes associated to each stage of biofilm formation. Initially, flagella are used by bacteria 
to move towards a surface. Irreversible attachment requires the flagella genes to be repressed, and 
adhesion proteins such as curli, pilli and type I fimbriae to be expressed as motility is no longer 
required as the bacteria are in a fixed position on the attached substrate (Lazazzera, 2005; Prüß et 
al., 2006). Irreversible attachment to a surface results in the genes of exopolysaccharide 
biosynthesis to be expressed, which enable the construction of mature biofilms. For instance, 
alg8, pelF and pslA are genes required for the synthesis of three exopolysaccharides (alginate, Psl 
and Pel) essential for P. aeruginosa biofilm development (Ghafoor et al., 2011; Prüß et al., 2006; 




6.1.1 S. aureus Biofilm Forming Genes 
Adhesion is a vital step in biofilm formation on tissues and abiotic surfaces which is aided by 
adhesins in the family of MSCRAMM, present in Gram-positive bacteria (Tenover et al., 2006). 
After adhesion, bacteria multiply forming a multi-layered structure, leading to PIA production 
(Götz, 2002). PIA is a polysaccharide composed of poly-β(1-6)-N-acetylglucosamine, involved 
in the bacterial aggregation (Arciola et al., 2015). The products of the intercellular adhesin (ica) 
locus synthesise PIA, mainly via the enzyme N-acetylglucosaminyltransferase, which is encoded 
by icaA (Mack et al., 2006). MSCRAMMs are proteins that are anchored on the cell surface of 
bacteria and can bind to the extracellular matrix as well as the hosts’ plasma components (Tenover 
et al., 2006). They are mainly covalently bound to the peptidoglycan in the bacterial cell wall and 
can identify more than one host extracellular matrix factors, such as: collagen (encoded by the 
cna gene); fibronectin binding proteins A and B (encoded by the fnbA and fnbB gene); elastin 
binding protein (encoded by the ebpS gene);fibrogen (encoded by the fib gene); bone sialoprotein 
(encoded by the bbp gene); laminin (encoded by the eno gene) and clumping factors A and B 
(encoded by the clfA and clfB gene)(Seo et al., 2008; Zuniga et al., 2015). All these proteins have 
the same signal for secretion and for anchoring onto the cell wall (Atshan et al., 2013). The ica 
ADBC operon encoded by the ica gene are proteins required for PIA synthesis as well as capsular 
polysaccharide/adhesion (PS/A), which are vital in staphylococci (Chaieb et al., 2005). The 
proteins icaA, icaC and icaD are found in the membrane, whereas icaB is usually present in the 
supernatant of the culture and deacylates PIA when it adheres to a cell surface. The activity of N-
acetylglucosamine transferase activity is increased by the co-expression of icaD and icaC 
(Arciola et al., 2006). The function of the gene icaB is to encode for an extracellular protein, 
however its function is yet unclear. The gene icaC encodes for a membrane protein which is 
known to have receptor function for polysaccharides (Atshan et al., 2013). 
The ica operon is known to be vital for S. aureus biofilm formation (Mack et al., 2006), however 
O’Neill et al. (2007) showed that deleting the ica genes did not affect biofilm formation in some 
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MRSA strains. Bap is a cell wall surface protein that is also important in intercellular adhesion 
and biofilm growth (Cucarella et al., 2001). 
IcaC is a transmembrane protein that is mainly involved in translocation and elongation of the 
polysaccharide, which is essential for PIA synthesis (Rohde et al., 2010). Beenken et al. (2004) 
and Vandecasteele et al. (2003) showed that icaC gene has highest expression in the icaADBC 
operon. A study by Mirzaee et al. (2014) examined 63 MRSA isolates for the presence of 
icaADBC genes using a polymerase chain reaction (PCR) approach. All MRSA isolates had icaD 
and icaC genes, whereas there was a prevalence of 60.3% and 51% of icaA and icaB respectively 
in all the isolates. In contrast, a study by Yazdani et al. (2006) noted the presence of icaA in all 
the S. aureus strains tested. The expression of ica can be influenced by environmental factors 
such as glucose, temperature, osmolarity and its growth in anaerobic environments (Kim et al., 
2008; Beenken et al., 2004). A study by Szczuka et al. (2013) found that 23% of the MRSA 
strains tested did not show the presence of icaA and bap genes. However, they did form a biofilm, 
showing that MRSA biofilms do form without the presence of icaA, demonstrating the formation 
of ica-independent biofilms, coinciding with findings of O’Neill et al. (2008), Izano et al. (2008) 
and O’Neill et al. (2007).  
The ebpS gene encodes for the S. aureus binding protein that controls attachment to host cells by 
binding to elastin (Nakakido et al., 2014). The ebpS gene is conserved by S. aureus, which could 
explain the importance of the gene. The N-terminal region of EbpS can bind to Zn2+, resulting in 
local conformational alterations in the structure of the EbpS protein. In an EbpS deficient strain, 
growth rates had reduced, suggesting that EbpS is vital in biofilm formation regulation and vital 
for infections derived from staphylococcal species (Nakakido et al., 2014). The inhibition of 
binding of EbpS to Zn2+ could be a potential target for therapeutical agents in preventing S. aureus 
infections (Nakakido et al., 2014). 
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Fibronectin binding proteins (FnbPs) are multifunctional and encourage bacterial attachment to 
fibronectin, elastin and fibrinogen (McCourt et al., 2014). In a study by Cha et al. (2013), MRSA 
biofilm forming strains showed increased expression of the fnbB gene compared with the non-
biofilm forming strains with values of 74.4% and 45.0% respectively. Furthermore, in order to 
determine the presence of FnbA and FnbB on the cell surface of S. aureus strain LAC, ligand 
affinity blotting with biotin-labelled fibronectin was used to analyse cell wall extracts from 
cultures in the stationary phase (McCourt et al., 2014). Two reactive bands were observed for 
fibronectin-binding protein A (FnBPA) and fibronectin-binding protein B (FnBPB) but not for 
LAC∆fnbAfnbB, fnbA and fnbB deficient S. aureus USA300 isolate LAC, suggesting the presence 
of FnBPs on the cell surface of bacteria during the stationary phase (McCourt et al., 2014). In 
addition to this, bacteria were able to adhere to fibronectin during the stationary phase and is 
dependent on FnbP expression. FnbPs promote accumulation of cells as well as the attachment 
phase of biofilms (McCourt et al., 2014). Similar findings were observed by Lei et al. (2011), 
showing that FnbPs mediate primary cell attachment and biofilm accumulation in S. aureus CC30 
strain MW2.  
One approach that can be used to test the antimicrobial efficacy of antimicrobial agents is to 
measure the change in gene expression associated with biofilm formation and virulence factors, 
before and after treatment with an antimicrobial agent. This knowledge could be beneficial as the 
up and down regulation of biofilm forming genes in a biofilm due to treatment with an 






6.1.2 Aims and Objectives 
 
Aim: 
The aim of this investigation was to determine the change in gene expression of ebpS, icaC and 
fnbB of mature S. aureus biofilms caused by treatment with 8/12 µg/ml of ZnO/Ag NP 
suspensions, via quantitative PCR (qPCR).  
 
Objectives: 
 To determine the best biofilm forming method to obtain the required quantity of RNA. 
 To assess the difference in gene expression in S. aureus biofilm forming genes with and 




6.2.1 Sample Collection 
6.2.1.1 Biofilm formation in CDC biofilm reactor 
Biofilms of S. aureus were grown in the CDC biofilm reactor as per Method 3.2.3.1 and 3.2.3.2. 
A 24 hour culture of S. aureus grown in tryptone soya broth (TSB) was used. Samples were 
treated for 48 hours with 8/12 µg/ml of ZnO/Ag NP suspension. Treated and untreated control 
samples were taken at 0, 12, 24 and 48 hours by scraping the surface of the 6 PC coupons per 
sample (Method 3.2.3.3) into 1.5 ml of PBS and freezing the samples in liquid nitrogen (LN2) for 
RNA extraction. Control samples were placed in sterile water over 48 hours. 
 
6.2.1.2 Biofilm formation in 6 well plates 
Aliquots of 5ml of a 24 hour culture of S. aureus were added to a 6 well plate and incubated 
statically for 48 hours at 37°C. After the formation of a 48 hour biofilm, the biofilms were treated 
with 8/12 µg/ml of ZnO/Ag NP suspension. Sterile water was added for the control wells. At 0, 
12, 24 and 48 hours, control and treated samples were collected by removing the media, and 
rinsing the biofilms twice with PBS. PBS (200µl) was then added to each well and the biofilms 
removed by scraping. The agitated biofilm cells were then placed into a 2ml Eppendorf tube and 
frozen in LN2 prior to RNA extraction.   
 
6.2.1.3 Biofilm formation in Eppendorf Tubes 
A 24 hour culture of S. aureus was grown in TSB broth. Eppendorf tubes containing 1.5ml of 
PBS were inoculated with the 24 hour culture and incubated at 37°C (rotating incubator) for 48 
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hours. The tubes were rinsed with PBS, leaving the remaining adhered biofilm. At 0, 12 and 48 
hours, aliquots of 1.5 ml of PBS was then added to the Eppendorf tubes and sonicated in an ice 
bath for 3 mins to disrupt the biofilm. The samples were then frozen in LN2 for RNA extraction 
at stored at -80 °C. 
 
6.2.2 PCR  
PCR amplification was performed containing Go-Taq 5 x Colourless Flexi Buffer (Promega, 
Wisconsin, USA), 10µl; MgCl2 solution (Promega, Wisconsin, USA), 4µl; dNTP mix 10 mM 
(Promega, Wisconsin, USA), 1 µl; specific upstream primer (Integrated DNA Technologies, 
Coralville, USA), 1 µl; specific downstream primer (Integrated DNA Technologies, Coralville, 
USA), 1 µl; Go Taq Flexi polymerase (Promega, Wisconsin, USA), 0.25 µl; template DNA, 1 µl 
to make up to 50 µl per reaction with nuclease free water (Promega, Wisconsin, USA). The 
conditions for the Thermocycler PCR (PIKO 24, Thermo Fisher Scientific, Loughborough, UK) 
consisted of denaturing at 95°C for 30 seconds, annealing at 55°C for 30 seconds and extension 
at 72°C for 1 min.   
 
6.2.3 Gel Electrophoresis 
A 2% agarose gel (Sigma Aldrich, Dorset, UK) was prepared using the Sybr® Safe DNA gel stain 
in 1 x TAE (Invitrogen, Eugene, USA) and left to set in a gel tank (FHU6 Fisher Scientific, 
Loughborough, UK) with a well comb. The gel tank was topped up with 0.5 X TAE running 
buffer (40 mM Tris (pH 7.6), 20 mM acetic acid and 1 mM EDTA). In each well, 5 µl of 
blue/orange loading dye with 5 µl of PCR product was added. A benchtop ladder 1 kb DNA 
(Promega, Wisconsin, USA) was added alongside the PCR product. The electrophoresis was run 
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at 90V for 45 mins and the gel was visualised under ultraviolet transillumination using the Gel 
Doc™ EZ Imager (Bio-Rad, Hemel Hempstead, UK). 
 
6.2.4 RNA Extraction and Purification 
The extraction was undertaken as per the instructions in the RNeasy mini kit (Qiagen, Valencia, 
USA). Products were kept on ice throughout the extraction process to avoid degradation. In brief, 
samples stored at 4°C were defrosted on ice. The bacteria were harvested to form a pellet by using 
a 4°C chilled centrifuge (Heraeus Fresco 21, Thermo Electron Corporation, Massachusetts, USA) 
at 5000 x g for 5 mins and supernatant decanted. Buffer RLT was added and the pellet was 
resuspended. Acid wash beads were used to disrupt the cells in a TissueLyser (Retsch, Hope 
Valley, UK) for 5 mins at maximum speed. Ethanol (70%) was added and the lysate was 
transferred to an RNeasy spin column with a collection tube and centrifuged for 15 seconds at 
8000 x g. Buffer RW1 was added and centrifuged for 15 seconds at 8000 x g. Buffer RPE was 
added and centrifuged at 15 seconds at 8000 x g and then added once again and centrifuged at 2 
mins at 8000 x g. The RNeasy column was placed in a new collection tube and centrifuged at full 
speed for 1 min. The RNeasy spin column was placed in a new 1.5 ml collection tube and with 
30-50 µl of RNase-free water was added and centrifuged at 8000 x g.  
 
6.2.5 RNA Quantification  
The RNA was quantified using the Nanodrop (Nanodrop Lite Spectrophotometer, Thermo Fisher 
Scientific, Loughborough, UK). The product was run on an agarose gel (Sybr® Safe DNA gel 
stain in 1 x TAE, Invitrogen, Massachusetts, USA) at 90 volts for 25 mins in a gel tank to observe 
the presence of RNA. To purify the RNA, Turbo DNase (Thermo Fisher Scientific, 
Loughborough) was used and quantified against using the Nanodrop. 
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6.2.6 Synthesis of cDNA 
cDNA was synthesised using the iScript Select cDNA synthesis kit (Bio-Rad, Hemel Hempstead, 
UK). cDNA synthesis was performed using 5 x iScript reaction mix-4 µl, iScript reverse 
transcriptase- 1µl, nuclease-free water and RNA template (100 fg to 1 µg total RNA) to make up 
a final volume of 20 µl. The protocol used to perform the reverse transcriptase process was 25°C 
for 5 mins, 42°C for 30 mins, 85°C for 5 mins and held at 4°C.  
 
6.2.7 qPCR Assay 
Fragments of ebpS, icaC, fnbB and 16S (Integrated DNA Technologies, Coralville, USA) were 
amplified with the SensiFAST™ SYBR Hi-ROX Kit (Bioline, London, UK) following the 
manufacturer’s protocol.  
Table 6.1: Primer sequence and annealing temperatures 





5'-GGT GCA GCT GGT GCA ATG GGT GT-3' 64.8 
5'-GCT GCG CCT CCA GCC AAA CCT-3’ 65.5 
icaC 5'-TTG CAA ATC GTG GGT ATG TGT-3' 55.0 
5'-CTT GGG TAT TTG CAC GCA TT-3' 54.1 
fnbB 5'-ACG CTC AAG GCG ACG GCA AAG-3' 63.0 
5'-ACC TTC TGC ATG ACC TTC TGC ACC T-3' 62.3 
16S 5'-GGG ACC CGC ACA AGC GGT GG-3’ 66.4 




PCR amplification was performed using the following protocol: SensiFAST™ SYBR Hi-ROX 
(2x), 5µl; forward primer (10 µM), 0.1 µl; reverse primer (10µM), 0.1 µl; as well as template and 
RNase free water to make up to 10 µl final volume. 
The programme for the qPCR (PIKOREAL 96 Real-time PCR system, Thermo Fisher Scientific) 
protocol for the SensiFAST™ SYBR Hi-ROX Kit consisted of 1 cycle of 95°C for 2 mins 
(polymerase activation), and 40 cycles of 95°C for 5 seconds (denaturation), annealing 















6.3 Results and Discussion  
 
6.3.1 Biofilm Formation and RNA extraction  
Despite a number of studies reporting the expression of biofilm genes in S. aureus biofilms 
(Dunman et al., 2001; Resch et al., 2005; Beenken et al., 2004), little is known regarding the 
effect of metal and metal oxide NPs on biofilm forming genes.   
Acquiring and quantifying mRNA from biofilms is fundamental in understanding the molecular 
mechanisms of gene expression involved in biofilm formation and maturation on surfaces such 
as medical devices (França et al., 2011). However, the successful completion of RNA based 
analysis methods are based on the yield, purity and integrity of RNA (Bustin et al., 2005; Nolan 
et al., 2006). It is also important to understand that the RNA quality and quantity is based in the 
RNA extraction methods used (Nour et al., 2010; Rump et al., 2010).  
The genes ebpS, icaC, fnbB are all biofilm forming genes, known to be expressed the most during 
S. aureus biofilm formation (Atshan et al., 2013), hence were chosen for this study along with 
16S as a reference gene. An agarose electrophoresis gel to show the presence of icaC, ebpS, fnbB 
and reference gene 16S in S. aureus is shown in Figure 6.1. The gene icaC is not seen in the 
image, possibly due the melting temperature set on the PCR for the annealing step. The annealing 
temperature is vital in PCR as the set temperature allows PCR primers to anneal to their 
complementary targets (Integrated DNA Technologies, 2011). Atshan et al. (2013) demonstrated 
that after 48 hours, there was an up-regulation of fnbA, fnbB, clfB, ebpS and icaC in S. aureus 
biofilms with an increase between 7.2-21.1, 14.5-17.8, 2.4-2.8, 25.9-45.1 and 91.4-239 fold 
respectively between four S. aureus isolates. The genes fnbA, fnbB, icaC and ebpS showed the 

















Resch et al. (2005) compared planktonic and biofilm cells and found highest expression of ica 
genes between 6 and 8 hours of biofilm development. This contradicts the finding by Atshan et 
al. (2013), who reported that expression of ica genes were relatively low between 6 and 12 hours. 
Furthermore, Vandecasteele et al. (2003) found that the ica operon mainly functioned in the initial 
growth phase of the biofilm as opposed to maturation, whereas Atshan et al. (2013) showed that 
these genes were expressed higher during the 48 hours of growth. Szczuka et al. (2013) 
demonstrated that 76% of the S. aureus strains tested all produced slime and carried the icaA 
gene. However, studies by Peacock et al. (2002) and Rohde et al. (2007) showed that all S. aureus 
strains possess the ica genes. S. aureus cells isolated from orthodontic appliances were 
investigated for their ability to adhere to polystyrene and dental alloys (Merghni et al., 2016). 
Amongst the strains tested, 94% were positive for icaA and icaD (Merghni et al., 2016), whereas 
a study by Aricola et al. (2001) that showed 60.86% of S. aureus strains isolated from catheters 
were positive for icaA and icaD. These differences could be due to a factors such as 
environmental stimuli, nature of the strain and growth media resulting in differences in gene 
expressions of biofilms (Beloin et al., 2006).  






191 bp Lad 
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Various methods of biofilm formation were investigated to determine the most effective method 
to obtain the largest quantity of RNA when quantified on Nanodrop spectrometer. RNA values 
for treated samples formed in the CDC biofilm reactor, 6 well plates and Eppendorf tubes at 12, 
24 and 48 hours ranged between 0.8 to 26.5 ng/µl, and the control samples ranged between 0.9 to 
47.4 ng/µl. Regardless of the formation method used, large variations were observed within the 
samples taken at each time point and their replicates. Even though higher values (47.4 ng/µl) was 
obtained for some samples, no band was observed on an agarose gel. Treated biofilm samples at 
24 hours for instance, values of 4.6 and 0.8 ng/µl, 2.8 and 16.68 ng/µl, and 1.2 and 15.9 ng/µl 
were obtained for biofilms formed in the CDC biofilm reactor, Eppendorf tubes and 6 well plates 
respectively. Similar variation was observed throughout. The inconsistency in values, small 
quantities of RNA, and poor quality of RNA obtained meant methods after RNA extraction 
(Method 6.2.4) to qPCR (Method 6.2.7) were not performed. The lower the initial sample 
concentration, the lower the RNA yield (Nour et al., 2010), therefore taking this into account, a 
conclusion was drawn that scraping the PC coupons with a glass rod to remove biofilm did not 
provide an adequate quantity of cells to extract RNA from, even though two rods containing three 
PC each were used. The variation in RNA quantity from biofilms formed in Eppendorf tubes and 
in 6 well plates, meant these methods were not appropriate for RNA extraction. If processes after 
RNA extraction were commenced, it would be likely to prove unsuccessful as RNA yield is lost 
through each stage. A gel electrophoresis to show RNA integrity in S. aureus biofilms formed in 
a CDC biofilm reactor is shown in Figure 6.2. The presence of RNA was only seen for the control 
sample at 12 hours and 24 hours, and a sample treated with 8/12 µg/ml of ZnO/Ag NP suspension 
for 48 hours (Figure 6.2). No RNA was seen for all the treated and control samples tested. The 
low quantities of RNA in conjunction with the smeared appearance observed in Figure 6.2 could 
suggest that some of the RNA may have been degraded. If sufficient quantities of ribosomal RNA 
were present, smears would have been observed with two bands. However, a smeared appearance 












There are a few reasons that could be proposed for the low yields or lack of the presence of RNA 
in some of the samples. Firstly, high cell densities within biofilm mean increased external protein 
concentrations and polysaccharide contents, which could interfere with the RNA extraction 
process (França et al., 2011). RLT buffer provided in the RNA extraction kit was used for cell 
lysis prior to RNA extraction. RLT buffer contains guanidine thiocyanate, which is used for 
protein degradation. Phenol is known to promote greater cell lysis than using acid wash beads and 
a TissueLyser (França et al., 2011). Furthermore, the presence of the extracellular matrix can 
hinder cell lysis and RNA extraction. Even after RNA purification, the  RNA can still contain 
inhibitory substances (Santiago-Vázquez et al., 2006; Junttila et al., 2009). Furthermore, the use 
of sonication for cell lysis can also lead to degradation of the RNA, even though it was performed 
in an ice bath.  
Atshan et al. (2012) used four Gram-positive strains (MSSA ATCC 35556 and ATCC 29278, 
MRSA ATCC 700698, S. epidermidis) and two Gram-negative bacteria (P. aeruginosa and E. 
Figure 6.2: Gel electrophoresis showing the presence of RNA post RNA extraction of treated (8/12 
µg/ml of ZnO/Ag NP suspension) and control biofilms of S. aureus in a CDC biofilm reactor. 
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coli) for the RNA extraction procedure. Five commercially available extraction kits tested were 
the RNeasy Mini Kit (as used in this chapter), NucleoSpin RNAII (Macherey-Nagel, Germany), 
InnuREP RNA Mini (Jena, Germany), Trizol (Invitrogen) and MasterPure RNA Purification Kits 
(EPICENTRE Biotechnologies)(Rump et al., 2010). Apart from Trizol and MasterPure kits, the 
other three kits utilises a spin-column comprising of silica membranes technology. Trizol and 
Master Pure kits on the other hand use a protocol rather than a column to purify the RNA and 
retain the small RNA molecules that usually get washed out in methods using spin columns 
(Rump et al., 2010). RNA extraction using commercial kits was compared to using a boiling 
method containing an addition of hot phenol incubation step (Atshan et al., 2012). Low quantities 
and integrity of RNA were obtained using the commercial kits, possibly due to inadequate lysis 
of the bacterial cells embedded in the dense structure of the biofilm (Atshan et al., 2012). 
Physiological characteristics such as the cell wall which can obstruct cell lysis, in turn affecting 
the release of RNA (Ludwig & Schleifer, 2000). Higher yields were achieved with an additional 
hot phenol incubation step instead of using bead mill or enzyme. When an additional phenol step 
was used with the RNeasy Mini Kit, RNA with greater integrity was produced which did not need 
further purification. Although the phenol method can be time consuming and require more 
biochemical reagents, the highest RNA integrity was obtained using this method (Atshan et al., 
2012). Heat degradation can affect the RNA yield (Sung et al., 2003) which could be another 
reason for such low RNA recovery in the present investigation.  
MSCRAMMs found on the surface of S. aureus aid in adhering S. aureus to components in the 
extracellular matrix of the host organism (Vazquez et al., 2011). These components assist in 
biofilm formation alongside the PIA producing ica operon (Mirzaee et al., 2014). A total of 22 S. 
aureus strains obtained from hospitalised infants were examined for the presence of mecA as well 
as clfA, clfB, fnbA, fnbB, fib, eno, cna, ebpS and bbp via PCR (Ghasemian et al., 2015). The gene 
mecA is used as a standard for determining resistance as it is found in all MRSA strains (Elhassan 
et al., 2015). All isolates expressed clfAB and the occurrence of fnbA, fnbB, fib, eno, cna, ebpS 
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and bbp was 63%, 6%, 50%, 59%, 82%, 63%, 9% and 0% respectively (Ghasemian et al., 2015). 
Being aware of the gene expression in biofilm can aid in targeting certain genes for therapeutic 
purposes for treatment (Ghasemian et al., 2015).  
 
6.3.2 Gene Expression Analysis Using qPCR 
The small quantities of RNA recovered from S. aureus biofilms meant that qPCR was unable to 
be performed. After determining the antimicrobial effect of a combination of metal and metal 
oxide NP suspensions in Chapter 4, it would be expected that there would be a downregulation of 
icaC, ebpS and fnbB. This would be due to the prevention of the biofilm being formed in the 
presence of this antimicrobial, therefore preventing the biofilm genes from being expressed. 
Published research on the effect of metal NP suspensions on biofilms is limited, therefore it would 
be beneficial to investigate this further for future disinfectant development which could be utilised 
in healthcare arenas. Radzig et al. (2013) determined the antimicrobial activity of Ag NPs (8.3 
nm) against planktonic cells and biofilms of Gram-negative bacteria including E. coli AB1157, 
P. aeruginosa PA01 and Serratia proteamaculans 94. Concentrations of 4-5, 10 and 10-20 µg/ml 
of Ag NPs were required to decrease the bacterial mass of biofilms of E. coli, P. aeruginosa and 
S. proteamaculans respectively. The viability of E. coli cells within the biofilm was lessened with 
Ag NP concentrations over 100-150 µg/ml (Radzig et al., 2013).  E. coli strains containing 
mutated genes that repair DNA with oxidative lesions (mutY, mutS, mutM, mutt, nth) were found 
to be less resistant to Ag NPs in comparison to the wild type strains, suggesting that these genes 
are vital in the repairing of damaged DNA caused by Ag NPs (Radzig et al., 2013). Even though 
there is limited research on the effect of metal/metal oxide NP suspensions on biofilms, the study 
by Radzig et al. (2013) shows the antimicrobial potential of Ag NPs.  
Baker et al. (2010) demonstrated that excess Cu represses expression of Sae and Agr, two of the 
main global virulence gene regulators, as well as the protein Eap, therefore, preventing S. aureus 
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biofilm formation. Eap is an extracellular protein that is vital for biofilm formation in low iron 
conditions. Accessory gene regulator protein D (agrD), sensor histidine kinase (SaeS) and 
response regulator SaeR (SaeR) were downregulated with a fold change of -2.17, -2.00 and -2.01 
respectively (Baker et al., 2010). The agr locus represses cell wall associated protein expression 
and induces expression of exoproteins after exponential growth. The saeRS locus induces 
exoprotein expression as well as α-hemolysin and protein A (Bronner et al., 2004). On the 
contrary, heavy metals at low, sub toxic concentrations can actually induce biofilm formation 
(Perrin et al., 2009). After exposure of S. epidermidis ATCC 35984 to 1.56 and 3.13 µM of 
cadmium, qPCR showed an upregulation of atlE, embp, aap, icaA and icaB which could be due 
to the fact that cells are in a dormant state in biofilms (Wu et al., 2015b).  
Motile bacteria use flagella to move onto a substrate (Belas, 2014). For irreversible adhesion, 
flagella forming genes are repressed and expression of adhesion proteins including curli, pilli, and 
type I fimbriae occur (Lazazzera, 2005; Prüß et al., 2006). Expression and repression of genes 
occur at the relevant stage of biofilm formation they are involved in. Thuptimdang et al. (2015) 
studied the gene expressions of alg8 and csgA in P. putida ATCC 47054 biofilms at various stages 
of maturity and the effect of Ag NPs on its biofilm. Curli is a protein that is important in bacterial 
surface adhesion, and six proteins that are encoded by the operons csgBA and csgFEDG are 
involved in curli production (Saldaña et al., 2009). The csgA gene in P. putida is a vital subunit 
for curli, therefore would be expected to be expressed highly during irreversible phases of biofilm 
growth (Prüß et al., 2006). The gene alg8 encodes for the alginate biosynthesis protein, that is 
vital in P. putida KT2440 for polysaccharide production to form the biofilm structure 
(Thuptimdang et al., 2015). It would be expected that alg8 expression would be higher in mature 
biofilms due to polysaccharide production. The expressions of csgA and alg8 were greater 
between 6 and 12 hours during the early development of the biofilm and 12 and 30 hours where 
metabolic activity would be the highest. When the EPS of P. putida biofilms were removed, the 
147 
 
biofilms were more susceptible to Ag NPs, highlighting the importance of EPS in biofilm 
resistance against Ag NPs  (Thuptimdang et al., 2015).  
 
6.3.3 Conclusion 
Due to difference in gene expression and protein production between planktonic and sessile cells 
(Beenken et al., 2004; Brady et al., 2006; Resch et al., 2006), producing an antimicrobial agent 
suitable for use for both modes of growth can be challenging. However, with the promising data 
obtained in Chapter 4 on ZnO/Ag NPs suspension, using such combination suspensions could be 
a step closer to resolving the issues currently encountered with biofilm formation in the healthcare 
sector. In addition, prior to analysis of gene expression, it is essential to determine the stage of 
biofilm growth at which genes are expressed, therefore it would be beneficial to do a qPCR at 
various stages of biofilm formation overtime to determine the highest expression of icaC, ebpS 
and fnbB and then observe the effect of treatment with NP suspensions on the gene expression. 
Although qPCR was not utilised in this chapter, the effect of metal/metal oxide NP suspensions 
on biofilms and the pathways for inhibition they utilise were considered. An attempt was made to 
focus on gene expression of S. aureus biofilms post treatment with a combination of ZnO/Ag NPs 
in suspension, exploring a range of methods for obtaining RNA. For future research, a change in 
the RNA extraction kits or even inclusion of extra steps such a phenol extraction could prove 























Chapter 7: Discussion 
 
7.1 To establish the best method for biofilm formation that can replicate biofilms in hospital 
and healthcare arenas. 
 
In vitro methods of biofilm formation enable scientists to replicate bacterial biofilms to be studied 
in depth, possibly enabling the testing of potential novel antimicrobial agents to overcome the 
problem of antimicrobial resistance faced by the healthcare arena. A comparison between the 
CDC biofilm reactor and the 96 well plate method was investigated in Chapter 3, concluding that 
the CDC biofilm reactor was the most reliable and replicable method to use for initially forming 
the biofilms, and further utilising this method to treat biofilms with metal and metal oxide NP 
suspensions. Lower SE were obtained for the CDC biofilm reactor (0.02-0.11) (Figure 3.6) in 
comparison to the microtiter method when the broth was replenished at 5 and 9 days and daily 
with SE ranging from 0.05 to 0.62; and 0.07 to 0.54 respectively (Figure 3.2 and 3.3). High SE 
were also observed in Bradford protein assays carried out in the 96 well plates (Figure 3.4 and 
3.5). SEM images further confirmed the ‘stacked’ morphology of biofilms formed in the CDC 
biofilm reactor (Figure 3.7 a-d). Moreover, the CDC biofilm reactor provided a quantitative 
method as opposed to the microtiter method which gave semi-quantitative data. Absorbance 
readings were affected by the crystal violet dye in the crystal violet assay due to the adhesion of 
the dye to components of the biofilm such as the EPS. This gave a higher absorbance in certain 
wells, giving a large SE (Figure 3.2 and 3.3).  
 
When screening metal/metal oxide suspensions for MBRCs, initially the 96 well plate assay was 
used. The 96 well plate method was beneficial when mass screening numerous concentrations of 
metal and metal oxide NP suspensions to give an indication of the MBRC, however, due to the 
large variations in data and SE, the suspensions were rescreened in the CDC biofilm reactor 
150 
 
(Table 4.1). The variation in biofilm formation was reported by Leuck et al. (2014), biofilms of 
E. faecalis varied and formed minimal biofilms in 96 well plates, even when different media was 
tested. This study supports the findings of Chapter 3 and 4, whereby screening was unreliable 
using the MTP based assays for Bradford protein assays and biofilm formation (Figure 3.2-3.5). 
When 6 well plates were used for producing 48 hour biofilms for RNA extraction, minimal and 
non-visible biofilms of S. aureus formed, even though the biofilm forming properties of S. aureus 
ATCC 6538 in 96 well plates and 6 well plates have been well reported previously (Park et al., 
2012; Latimer et al., 2012; Atshan et al., 2013). O’Toole (2011) proposed that as MTP based 
assays use static and batch-growth conditions, mature biofilms comparable to those produced in 
continuous flow systems cannot be formed.  
 
7.2 To investigate the inhibitory effect of metal and metal oxide NP suspensions in 
combination against biofilms of S. aureus and P. aeruginosa.  
Many studies have shown the efficacy of metal and metal oxides, against biofilms and planktonic 
cells from a range of organisms. Sharma et al. (2015) reported an MIC of 25 µg/ml of Ag 
(AgNO3), and an MIC of ZnO NPs between ~80 to 280 µg/ml against a range of Gram-positive 
and Gram-negative (Shah et al., 2016). Most published research has focussed on obtaining an 
MIC for NPs against biofilms, however, in the present work, a three staged approach was used to 
assess the efficacy of antimicrobials against biofilms to determine the most effective combination 
of NPs. This approach consists of determination of the a) MBRC (Ag, ZnO and CuO 
individually), b) R2 value between the log(10) reductions and individual concentration range (Ag, 
ZnO and CuO) tested and c) MBRC of ZnO/Ag combined against P. aeruginosa and S. aureus 
biofilms. The strong linear relationship and high R2 values of ZnO and Ag NPs (Table 4.1) 
indicate their potential as an antimicrobial.   
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Biofilms are dynamic structures with their structure changing over time, this can lead to  bacterial 
resistance to disinfectants, antibiotics and sterilisation procedures (Bandeira et al., 2015), and can 
result in bacterial survival on dry surfaces in hospitals (Almatroudi et al., 2015). Vegetative 
bacterial cells have shown antimicrobial susceptibility to metal and metal oxide NPs, suggesting 
that their antimicrobial properties can be used to combat issues faced by the healthcare arena with 
biofilm resistance (Abdulkareem et al., 2015; Tabrez Khan et al., 2013; Mallevre et al., 2016)  
including P. aeruginosa and S. aureus (Ahmed et al., 2013). Although many published studies 
have investigated Ag and ZnO in combination, the majority have focussed on planktonic cells 
(You et al., 2011; Liu et al., 2009; Hernández-Sierra et al., 2008).   
The findings from this investigation have demonstrated the antimicrobial efficacy of ZnO and Ag 
NP suspensions on biofilms of P. aeruginosa and S. aureus, with a lower concentration of 8/12 
µg/ml of ZnO/Ag NP suspensions effective on S. aureus biofilms compared to 32/25 µg/ml of 
ZnO/Ag NP suspensions effective on P. aeruginosa biofilms; a 99.99% and 99.98% reduction for 
S. aureus and P. aeruginosa was obtained respectively (Table 4.2a and b). A 24-hour treatment 
was required in order to have a significant (p ≤0.05) inhibitory effect (Table 4.4). The efficacy of 
these concentrations are further confirmed in live/dead assays in Figure 4.5 and SEM images in 
Figure 4.4. A higher concentration of ZnO/Ag NP suspension was required for P. aeruginosa 
biofilms, possibly due to Gram-negative bacteria having an outer membrane (Tong & McIntosh, 
2004), which is absent in Gram-positive bacteria, therefore requiring a larger concentration of an 
antimicrobial agent to take effect. In general, Gram-negative bacteria are known to possess greater 
resistance to antimicrobials in comparison to Gram-positive bacteria (Silhavy et al., 2010) which 
correlates with the findings in this investigation. Nevertheless, both combinations gave a 
reduction of ≥3 log(10). In the wider context, this combination could be useful against other Gram-
positive and Gram-negative bacteria, in applications such as wipes for surface disinfection or even 
a spray so long as an equal dose of metal and metal oxide NPs are delivered.   
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Various authors have researched the combination of Ag and ZnO in terms of its antimicrobial 
efficacy but only on vegetative cells and not biofilms (Karunakaran et al., 2011b, 2011a; 
Amornpitoksuk et al., 2012; Jafari et al., 2011). The lowest inhibitory combination of Ag and 
ZnO NP in a suspension providing a log reduction ≥3 log(10) was 32/25 µg/ml and 8/12 µg/ml of 
ZnO/Ag NP suspensions for P. aeruginosa and S. aureus biofilms respectively (Table 4.2 and b), 
where both combinations had an additive effect P. aeruginosa and S. aureus (Table 4.2a and b). 
This demonstrates that the total effect of Ag and ZnO in combination is equal to the total effect 
exhibited by both when not in combination. It would be expected that in combination, its 
antimicrobial effect would actually increase due to the pathways of antimicrobial action they both 
use for bacterial inhibition. Interaction of Ag NP with bacterial cells can cause DNA damage, 
leakage of cytoplasmic content therefore prevention of replication (Chen et al., 2011) and Ag+ 
can inhibit enzymes containing thiol groups (Matsumura et al., 2003). Zn2+ from ZnO NPs can 
form ROS, permanently damaging the cell membrane of bacteria, DNA and mitochondria 
(Dwivedi et al., 2014). Many studies solely testing combinations of metal and metal oxide NPs 
have not determined the FIC index, however investigating the synergistic effect of Ag NPs and 
cefmetazole indicated an additive effect against Neisseria gonorrhoeae (Li et al., 2013), and Ag 
NPs with streptomycin, kanamycin, ampiclox and polymyxin B were all additive against a range 
of Gram- positive and negative bacteria (Jain et al., 2009). The combination of two metal and 
metal oxide NPs had a lower MBRC in comparison to when used individually. Using either Ag 
or ZnO alone would require a higher concentration to take effect as opposed to a combination of 
Ag and ZnO (Table 4.1, 4.2a and b), which is beneficial in terms of lower toxicity, cost 
effectiveness as well as reduced resistance. The combination of Ag and ZnO NPs together 
increase the antimicrobial activity exerted on the bacteria as the photocatalytic ability of ZnO and 
Ag NPs is improved, increasing its oxidation and reduction capability, inhibiting bacterial growth 
(Yang et al., 2006). 
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Even though studies have proposed that Ag NPs inherently deliver toxicity, the majority of studies 
have shown that it is the ionic form that provides the antimicrobial action (Hsueh et al., 2015). 
Kääriäinen et al. (2013) stated that the antibacterial of ZnO thin films on the biofilm formation of 
E. coli was due to Zn2+ ions, similar to findings by Franklin et al. (2007), Xia et al. (2008), 
Shalumon et al. (2011) and Kumar et al. (2012). Significant (p ≤0.05) antimicrobial activity of 
Ag and ZnO thin films for the prevention of P. aeruginosa and S. aureus biofilm formation in 
were observed in Chapter 5 after 48 hours, owing to the release of ions from the thin films.  
There is a sustained release of Ag+ and Zn2+ ions from thin film surfaces (Monteiro et al., 2009), 
therefore requires more time to release a sufficient ion concentration for antimicrobial activity. In 
a suspension, a high concentration of Ag+/Zn2+ ions are available instantly in the aqueous phase 
to interact with the cells, therefore there is greater interaction quicker. Kumar et al. (2005) stated 
that the reduced antimicrobial action of Ag-based antimicrobial fillers in polyamide against S. 
aureus, E. coli and C. albicans was due to inadequate release of Ag+ ions. This reinforces the fact 
that it is the ion release from coatings that is vital for antimicrobial activity.  
When conducting qPCR, it would have been expected that the biofilm genes icaC, ebpS, and fnbB 
studied would have been down regulated due to the reduction of biofilm formation by ZnO/Ag 
NP suspensions as confirmed by live/dead assays (Figure 4.5) and SEM images (Figure 4.4). After 
analysing the effect of ZnO/Ag NP suspensions using viable counts, the combinatory NP 
suspension has proven to be antimicrobial against P. aeruginosa (32/25 µg/ml ZnO/Ag NP) and 
S. aureus (8/12 µg/ml ZnO/Ag NP) biofilms with significant log(10) reductions within the 
acceptance criteria of ≥3 log(10) set in this study (Table 4.2a and b). This correlates to the 
antimicrobial activity of the suspensions seen in the SEM and CLSM images (Figure 4.4 and 4.5). 
The ‘stacking’ behaviour of biofilms was observed in the live/dead assays, particularly with the 
untreated biofilms (Figure 4.5). SEM images support reductions observed as the rupturing of the 
biofilms and distortion of the cells post treatment can be seen, therefore affected the further 
development of the biofilm (Figure 4.4c and d). EDX images show the presence of Ag and Zn 
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elements in the biofilm, suggesting the adherence of the NPs to the biofilm (Figure 4.4e-h). The 
integrity of cells in the SEM images obtained in Figure 5.4a-d of S. aureus and P. aeruginosa 
biofilms on ZnO and Ag coated surfaces resemble the cells of untreated biofilms of S. aureus and 
P. aeruginosa on PC coupons in Figure 4.4a and b. This demonstrates the reduced inability of Ag 
and ZnO coated surfaces to prevent biofilm formation in comparison to NP suspensions as they 
are comparable to biofilms formed on untreated PC coupons. CLSM images confirmed that the 
effect of the NP suspension is not only limited to the surface of the biofilms, but throughout the 
whole biofilm as dead (red) cells can be seen throughout the top, middle and bottom portions 
(Figure 4.5a-h). The ion release over 24 hours was monitored using the AAS. The results 
suggested that the antimicrobial activity was mainly due to Ag+ ions, as Ag+ ions were quenching 
Zn2+ (Table 4.5). For example, at 32/12 µg/ml of ZnO/Ag NPs, initially, 3.58 and 0.18 mg/l of 
Zn2+ and Ag+ ions respectively were present, whereas in combination, the Zn2+ ions reduced to 
0.93 mg/l, whereas Ag+ ions remained at a similar concentration (Table 4.5). Matai et al. (2014) 
found an increase in Zn2+ ion concentrations with increment between 6 and 24 hours from Ag-
ZnO nanocomposites, and for Ag+ ion release between 6 and 12 hours when ion concentration 
was determined using the AAS. For future studies, it may be beneficial to monitor ion release at 
a range of time intervals to identify the time at which ion release peaks.      
 
7.3 To determine the effect of thin layer coating of metal and metal oxide NPs.   
The use of antimicrobial surfaces has evolved into a topic of great scientific interest, particularly 
in light of the vastly reported cases of P. aeruginosa (Souli et al., 2013) and S. aureus (Page et 
al., 2009).  
Self-disinfecting surfaces with metal and metal oxides with innate antimicrobial characteristics 
provide antibiofilm activity for lengthy time periods (Humphreys, 2014). Coated surfaces prevent 
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the adhesion of bacterial cells to a surface after 48 hours (Table 5.1). Findings of this investigation 
suggest that Ag and ZnO thin films provide a statistically significant (p ≤0.05) reduction of 
98.47% and 97.78% for Ag and ZnO thin films respectively for S. aureus and 96.13% and 96.28% 
for Ag and ZnO thin films respectively for P. aeruginosa after 48 hours of formation, 
demonstrating that 48 hours or longer is sufficient to exert an antimicrobial effect. Although a 
statistically significant reduction has been shown for a 48 hour treatment of S. aureus and P. 
aeruginosa biofilms with Ag and ZnO coated surfaces in comparison to the control, <3 log(10) 
reduction has been observed which is much lower in comparison to the reduction by ZnO/Ag NP 
suspensions (≥3 log(10)). A 24 hour formation of P. aeruginosa and S. aureus biofilms on Ag and 
ZnO coatings show an inhibitory effect of only a 38.01% and 46.98% reduction for Ag and ZnO 
coatings respectively for P. aeruginosa, and a 40.54% and 20.46% reduction for Ag and ZnO 
coatings respectively for S. aureus which is much lower than the inhibitory effect at 48 hours 
(Table 5.1). Conversely, a 24 hour treatment of biofilms of S. aureus (8/12 µg/ml ZnO/Ag NP 
suspension) and P. aeruginosa (32/25 µg/ml ZnO/Ag NP suspension) gave a 3.91 log(10) and 3.77 
log(10) reduction for S. aureus and P. aeruginosa respectively (Table 4.2a and b).  
The gradual ion release from Ag (Reidy et al., 2013) and ZnO when attached to a surface could 
be having a limited effect on the antimicrobial effect on the bacterial cells. Virulence factors 
leading to antimicrobial resistance are able to withstand the antimicrobial effect from the ions in 
smaller quantities as opposed to metal and metal oxide NP suspensions which provide an instant 
maximum dose to a mature biofilm formed in CDC biofilm reactor (Petrochenko et al., 2014). 
ZnO forms Zn2+ due to its instability in solution and these ions are able to penetrate into the cell 
membrane of bacteria, causing disruption of metal-ion homeostasis in the cell, and exhibit toxicity 
when concentrations are high (Outten & O’Halloran, 2001). The percentage reductions were 
slightly greater for Ag (98.47%) and ZnO (97.78%) coated samples against S. aureus in 
comparison to P. aeruginosa (Table 5.1). Similarly, slightly enhanced antimicrobial efficacy for 
8/12 µg/ml of ZnO/Ag NP combination suspensions (Table 4.2a and b) against S. aureus was 
156 
 
observed with a reduction of 3.91 log(10), whereas a 32/25 µg/ml of ZnO/Ag NP gave a 3.77 log(10) 
reduction against P. aeruginosa. The lower efficacy of Ag and ZnO suspensions and thin film 
coatings against P. aeruginosa could due the shielding effect of the outer membrane present only 
in Gram-negative bacteria (Araújo et al., 2011). Kääriäinen et al. (2013) studied the prevention 
of E. coli adherence on ZnO thin films, with only a 99.7-99.5% reduction. This was lower than 
the required reduction of >99.9%, owing to Zn2+ ion release and not due to photocatalytic activity 
(Kääriäinen et al., 2013).   
Even though lower log (10) reductions were observed for coated surfaces in comparison to metal 
and metal oxide NP suspensions, coated surfaces or surfaces impregnated with an antimicrobial 
metal or metal oxide could be beneficial in the healthcare sector to prevent colonisation of 
nosocomial related bacteria and provide a sustained release of ions, although greater 
understanding and further development would be required.  
According to the BS EN 13697:2001, in order for a disinfectant to be classed as an antimicrobial, 
a minimum of a 4 log(10) reduction in ≤5 mins is required for bacterial cells (British Standards 
Institute, 2001). There is no standard in place solely for biofilms, even though most organisms 
reside in a biofilm form (Penesyan et al., 2015). Differences in physiological characteristics of 
sessile and planktonic cells means that a standard designed for planktonic cells cannot be 
applicable to biofilms (Rollet et al., 2009). Although a 4 log(10) reduction in 5 mins has not been 
achieved in the present research, the results gained in this investigation against P. aeruginosa and 
S. aureus biofilms do demonstrate the potential for Ag and ZnO thin film coated surfaces and 
8/12 and 32/25 µg/ml of ZnO/Ag NP suspension for S. aureus and P. aeruginosa biofilms 




7.4 Future Work  
Future research branching from this project would include further investigation into mechanisms 
of action of the metal/metal oxide NPs such as looking at the energy and adenosine triphosphate 
(ATP) levels affected in biofilms post treatment with the combination of ZnO/Ag NP suspension. 
Despite the difficulties faced during RNA extraction, other approaches of obtaining RNA and 
using alternative kits or methods would be trialled. In order for ZnO/Ag NP in suspension to be 
considered as a commercial product in the healthcare arena or used as part of a formula, the 
versatility of the suspension should be evaluated by testing its efficacy against other nosocomial 
pathogens - including K. pneumoniae (Bock et al., 2016), vancomycin resistant S. aureus, and C. 
difficle (Ali et al., 2016) and carbapenem resistant organisms (CRO) (Wang et al., 2016a)- as 
biofilms occur as multispecies biofilms rather than single species, this needs to be taken into 
consideration.  
Thin film coatings have only recently begun to be explored widely for their antimicrobial use and 
research has mainly focused on Ag thin film coatings. It would be beneficial to explore the 
combined effect of sputtered Ag and ZnO thin films to observe whether an enhanced antimicrobial 
effect is exerted against biofilms. Furthermore, impregnation of Ag and ZnO in combination could 
be an interesting area of research, to observe if its antimicrobial effect overtime periods longer 
than 48 hours and thus its robustness as an application. Due to antimicrobial thin film coatings 
aiming to prevent the initial stages of biofilm formation, coating the inside of taps to prevent the 
persistence of P. aeruginosa biofilms and contamination of water systems, with antimicrobial 
coatings of Ag and ZnO, could be explored in order to prevent outbreaks such as those recently 
reported in Northern Ireland where P. aeruginosa caused the morality of four babies (Walker et 
al., 2013).      
It is paramount to consider if concentrations of 32/25 µg/ml and 8/12 µg/ml of ZnO/Ag NP 
suspensions are toxic to humans and the environment. Factors such as skin irritation for 
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disinfectant applications is vital as well as eye irritation, especially for a product in a spray from. 
Previously, high toxicity levels of phenolic agents in disinfectants have been reported, yet they 
are still being used in developing countries due to the low costs associated (Singh et al., 2012). 
Ag has been reported to result in lung inflammation (Sung et al., 2009) and very high 
concentrations of ZnO have shown to target liver cells in humans, providing cellular toxicity 
(Sharma et al., 2012). Thorough investigation of such toxicity factors is necessary before any 
further development of a potential product.    
7.5 Conclusion 
In conclusion, the work from this study has demonstrated the ability of Ag and ZnO in suspension 
to treat biofilms and provide significant log(10) reductions. Using a three step approach, Ag and 
ZnO were chosen for use in combination which enabled a lower concentration of both NPs to be 
used, even though only an additive effect was observed. A combination of 32/25 µg/ml of ZnO/Ag 
NPs was also effective against a multispecies biofilm of P. aeruginosa and S. aureus. Biofilm 
reduction of clinical isolates of P. aeruginosa (32/25 µg/ml of ZnO/Ag NPs) and MRSA (8/12 
µg/ml of ZnO/Ag NPs) was also observed, showing its promise as an antimicrobial against 
biofilms. Results from this study have shown that there is potential that Ag and ZnO NPs in 
combination could be used as part of a formula for a disinfectant for the healthcare arenas. Thin 
film coatings showed limited capability for preventing biofilm formation. With further research 
into other methods of coating, it may be possible to increase the efficacy of NP thin film coating, 
enabling potential usage on hospital touch surfaces such as door handles, bed rails or even the 
inside of taps. With the increase in antimicrobial resistance in biofilms, prevalence of biofilms in 
the healthcare arena and the continuation in numbers of mortality rates from HCAIs, the 
combination of Ag and ZnO NPs could be part of a potential solution for decontaminating the 
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Case Processing Summary 
 
Cases 
Valid Missing Total 
N Percent N Percent N Percent 




 Statistic Std. Error 
Data Mean 7.4621 .04887 
95% Confidence Interval for 
Mean 
Lower Bound 7.3646  
Upper Bound 7.5595  
5% Trimmed Mean 7.4512  
Median 7.3850  
Variance .172  
Std. Deviation .41468  
Minimum 7.00  
Maximum 8.17  
Range 1.17  
Interquartile Range .81  
Skewness .249 .283 





Tests of Normality 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
Data .261 72 .000 .823 72 .000 
 















































 Group N Mean Rank Sum of Ranks 
Data PA Pl 18 18.69 336.50 
PA SS 18 18.31 329.50 










Mann-Whitney U 158.500 
Wilcoxon W 329.500 
Z -.111 
Asymp. Sig. (2-tailed) .912 
Exact Sig. [2*(1-tailed Sig.)] .913b 
 
a. Grouping Variable: Group 








 Group N Mean Rank Sum of Ranks 
Data SA Pl 18 21.47 386.50 
SA SS 18 15.53 279.50 









Mann-Whitney U 108.500 
Wilcoxon W 279.500 
Z -1.715 
Asymp. Sig. (2-tailed) .086 
Exact Sig. [2*(1-tailed Sig.)] .091b 
 
a. Grouping Variable: Group 























Silicon Wafer Cleaning  
The samples were bomb cleaned with 50% H2O2 and 50% sulphuric acid. The sample is 
ultrasonicated for 2 mins in 18 MΩ deionised water. This was repeated 5 times. The sample is 
then dipped in to buffered hydrofluoric acid (HF) (Fisher Electronic Grade) in a H2O:HF=10:1 
mixture. The sample is ultrasonicated for 2 mins in 18 MΩ deionised water again and this was 
repeated a further 5 times. The samples were spin dried at 3000 rpm under nitrogen for 30 seconds 
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